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3 Abstract
With every corner of science, engineering and business generating vast amounts
of data, it is becoming increasingly important to be able to understand what
these data mean, and make sensible decisions based on the findings.
One tool that can assist with this aim is the type of program called a self-
organising map (SOM). SOMs are unsupervised Artificial Neural Networks (ANNs)
that are used for pattern recognition, dimensionality-reduction of datasets, and
can give a visual representation of the data using topology. For this project,
SOMs were used to do pattern recognition on circular dichroism (CD) and myo-
electric signal (MES) data, among other applications.
To the first of these SOMs, we gave the name SSNN for Secondary Structure
Neural Network, as it analyses CD spectra to find structures of proteins. CD is
a polarised UV light spectroscopy, it is a useful for estimating structures (confor-
mations) of chiral molecules in solution. In this work we report on its use with
proteins and lipoproteins. The problem with using CD spectra is that they can
be difficult to interpret, especially if quantitative results are required. We have
improved the structure estimations compared with similar methodologies. The
overall error across all structures for SELCON3 was 0.2, for CDSSTR: 0.3, for
K2d: 0.2, but for our methodology, SSNN, it was 0.1.
Another difficult problem the world faces is that thousands more people every
year have limb amputations or are born with non-fully-functioning limbs. Robotic
limbs can help people with these aﬄictions, and while many are available, none
give much dexterity or natural movements, or are easy to use. To help rectify the
situation we adapted the SOM tool we developed, SSNN, to work as part of a
software platform that is used to control robotic prostheses, calling it HASSANN,
6
Hand Activation Signals, SOM Artificial Neural Network. The system works by
performing pattern recognition on myoelectric signals, which are electrical signals
from muscles. The software platform is called BioPatRec, and was developed by
Max Ortiz-Catalan and his other collaborators. The SOM HASSANN was written
by the author, who also tested how well the software works at predicting which
robotic limb movements are needed.
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4 Abbreviations
ANN – Artificial Neural Network
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CD – Circular Dichroism
CCA – Convex Constraint Analysis
CDNN – CD Neural Network, by Bo¨hm et al.
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LOOCV – Leave-One-Out Cross-Validation
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6 Introduction
6.1 Self-organising map machine learning technique
As the rate of technological development increases more fields of research, busi-
ness, education, politics etc. have started and continued to produce prodigious
volumes of data. IBM estimated in 2012 that there were 2.5 exabytes (one ex-
abyte is 1018 bytes) of data created every day10, and this will only keep accelerat-
ing. Actually research shows that technology and scientific knowledge have been
growing exponentially for some time, and it is increasing this acceleration.11 This
leads to the conclusion that what is needed is constant development of better
tools to manage the ever-growing data.
To that end we need to be sure that the software and hardware we use can
constantly grow its abilities for producing meaningful results, and that we have
enough data scientists, data analysts, software engineers and I.T. people applied
to the task. IBM estimates the world will need 4.4 million data scientists by
2015, and this will only be 1/3 filled.
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One of the fields that could greatly benefit from more automation of the
understanding of the information coming in from machines is the Biophysical
Chemistry work of circular dichroism (CD) spectroscopy. CD uses polarised UV
light to determine the conformation of certain molecules (proteins, DNA etc.) be-
fore, during and after chemical reactions, or other changes in the environment of
these molecules. This work aids in understanding the function of these molecules,
which helps with understanding biology, designing new medicines, and making
sure that the chemical reactants used are good quality.
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The research done in this project had the initial aim of developing something
that would help Chemistry researchers understand proteins, and make their work
easier, faster, and more accurate by becoming a sort of circular dichroism expert
software agent. This software, called SSNN for Secondary Structure Neural Net-
work, was designed to do pattern recognition on the CD spectra. The desired
outcome was for SSNN to learn what spectral features in the CD spectra lead to
which amounts of which secondary structures in the molecules. Though this is
not shown to users, it is just understood by the software.
The initial aim was to help CD practitioners by developing a software ap-
plication to learn about CD, however, the software developed with this aim has
grown far beyond that to include: finding the healthiest, comfortable insoles
for diabetes sufferers; controlling robotic prosthetic arms and hands, and even
matching Chemistry academics for research projects. CD, myoelectric signals
for robotic limb-control and diabetes was done by the author, the matching of
Chemistry academic primary investogators was done by Alison Rodger. This
software is now packaged in a graphical user interface (GUI), along with a guide,
so that anyone may download it from the Rodger Group website and use it on
their dataset.
As a machine learning method (see section 6.1.8), SSNN, the key software
package developed in this work, can be applied to any data set. It is the type of
software that will work on unlabelled data, where very little or no prior knowl-
edge is present (data mining). SSNN is a self-organising map artificial neural
network, or simply SOM, the SOM technique was invented by Teuvo Kohonen
circa 1982.12 It is also referred to as a self-organising feature map (SOFM), or Ko-
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honen Map. The acronym SOM is used to refer to an algorithm that constructs
an organised map, and the map itself. Hence the term self-organising map; it is
auto-organised. The self-organising map algorithm is a data-analysis technique
that works automatically, in an unsupervised manner.
This approach was employed to estimate structures (or conformations) of
proteins using circular dichroism (CD) spectroscopy, and later to control robotic
prosthetic limbs by performing the pattern recognition stage of interpreting my-
oelectric signals (MES) from patients.
This work focuses on unsupervised learning, and the SOM/SOFM or Kohonen
Map. The SOM places features of the dataset on its map in a way that enables
the user to gain knowledge about the features present, and their relationships
with other features, from the location on the map.13 The way the SOM is organ-
ised to cluster data and display it in a 2 dimensional form helps one to easily get
an impression of what the topographical relationships between elements of the
data are, especially high-dimensional data that is very hard to picture or make
clear, quick conclusions about.
In summary, a SOM takes input vectors and generates a clustered map rep-
resentation of them, with interpolations. The interpolations are calculated as
a weighted sum of the few nearest nodes that best represent the experimental
vectors; these nearest nodes are called the best matching units, or BMUs. These
BMUs are closest in Euclidean distance. The Euclidean distance depends on
differences between two vectors at the same element, see equation 1.
16
d =
√√√√ n∑
i=1
(xi − x′i)2 (1)
where x is the observed datum in the input vector at position i, and x’ is the
calculated or theoretical value of it from the model generated by the SOM. Lower
case n is the number of elements in the input vector.
For the complete training of a SOM, the following is repeated for thousands
of iterations:
1. A CD spectrum (another input) is selected at random from the database
or reference set, and compared with the map to find a BMU (Figure 1).
2. The BMU on the map is made more similar to the input vector.
3. The neighbours of the BMU are updated too (Figure 2).
Through this process the SOM makes an organised map, or a clustered map of
input vectors. Similar vectors should be close to each other, and dissimilar ones
further apart. See Figure 1 for a view of how inputs correspond to the nodes of
a SOM.
Figure 2 shows the neighbourhood of a BMU is selected for learning as well,
while the rest of the map remains static for this iteration. This is how the clus-
tering works, if it does not make the BMU neighbourhood similar to the BMU,
then there will never be regions where certain classes of vectors are clustered,
just a random collection of un-clustered vectors.
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Figure 1: Schematic illustration of a SOM. Each input vector is presented to the map, and each
node comes to represent an input vector, or the interpolation between inputs. This assignment
is completed by the time training has finished.2
See Figure 3, for an example of what one level of a SOM looks like once the
data it holds have been clustered. There is one level for each dimension of the
data space. The red, higher areas represent the regions of the data space that
have more positive values at this, the nth element of each input vector. Note how
each value has been located amongst its equals or near equals. However, there
are still two areas with larger negative values: the low region in the front–left,
and the very low region in the front right. This shows that they belong to input
vectors that are of two different types. The other elements of the input vectors
(those not in this layer) place them in different classes, even if the elements on this
layer are similar. This is because there are far more relationships between data
points in the vectors present than just this layer, so they have a much stronger
influence on the organisation of the SOM than the elements of vectors that are
shown here (this layer).
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Figure 2: Schematic of the SOM training process. The BMU (cream circle), and its neigh-
bourhood are selected for training to become more like the input data, with those closest to the
BMU learning more in the current iteration than those further from it. The rest (blue circles)
are not updated this iteration.3
19
Figure 3: The trained SOM. The example here is a view of one level of a SOM that has
clustered CD spectra; this represents the light intensities at one wavelength. Note how the
terrain undulates smoothly, forming clusters: hills and valleys.
6.1.1 Origins of SOM
SOM is similar to the simpler, older methodology called VQ, vector quantisation.
The operation VQ performs is to compress and map continuous or discrete data
for transmission or storage in a digital channel. Vector-valued input data space
is segmented into a number of adjacent regions. A single model represents each
region optimally (a single point on the map). This is called the codebook vector.
In a SOM the equivalents of codebook vectors become globally ordered in space
as well.14–16
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6.1.2 Training a SOM
There are two ways to train a SOM 1) stochastically selecting individual examples
from the dataset, or 2) batch training, by considering all reference set examples in
one batch, and all models are updated simultaneously in a single step. Stochas-
tic training needs at least a few thousand training iterations to make sure all
examples from the reference set have had a good chance to have their impact
on the map. Batch training only requires a few dozen iterations before training
is complete, this is because a batch will typically contain many individual vec-
tors, so one iteration represents many from a stochastic training point of view.
Batch training is usually quicker and more likely to converge. Batch training does
not require any learning-rate parameter either (see sub subsection 6.1.6). The
stochastic training requires two learning-rate parameters, L0, the initial learning
rate, and k1, the rate at which learning decelerates. L0 should be a small number,
in this work 0.06 or occasionally 0.1 were used. This ensures the algorithm learns
a bit each iteration, if the L0 were 1.0, then a node would become exactly the
training set spectrum in one iteration. This is not idea for clustering, it doesn’t
come to as good a convergence as slower learning. The k1 parameter should be
very small, as it multiplies the exponential in the learning rule equation, and
learning is needed throughout training.
6.1.3 Validating a SOM
One reasonably reliable way to validate the training parameters is to use leave-
one-out cross-validation (LOOCV). Here the SOM is trained with all but one of
the training set vectors, and tested on the vector that was left out of training.
This process is repeated until each of the training vectors has acted as the test
vector. Training parameters of the SOM were validated using LOOCV; the size
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of the map, the learning rate, the number of BMUs that go into making the
model, the learning equation parameters t1 and k1, and others. This is detailed
in “Paper 1”.17
6.1.4 Applications
Applications of SOM for clustering data are wide and include exploratory data
analysis, control systems, telecommunications, finance, natural science, statistical
analysis, biomedical analyses, profiling of criminal behaviour, characterisation of
galaxies, categorisation of real estate, and linguistics/organisation of texts.18–23
Some of the largest applications are bioinformatics, and huge textual databases.
In 2012, Kohonen et al. found over 10,000 applications of SOM14. Besides
SOM, there are other artificial neural networks, and there are many other ar-
chitectures, including evolutionary programs, artificial immune systems, random
forests, Bayesian networks, here the subject will be SOMs.
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6.1.5 Good practice with SOMs
The distance metric to measure the distances between data vectors on the map
needs to be decided upon. This could be Euclidean or more generally Minkowski,
Euclidean distance being Minkowski in 2 dimensions.14
The SOM is usually a square or hexagonal array of nodes containing the data
vectors. The square array is easier to build, and the hexagonal is better for vi-
sualisation purposes. It has been suggested that one should use a cyclic array,
such as a toroidal or spherical shape so that the edges of the map loop around
and become contiguous with each other. This is because there can be irregular
spacing between adjacent models at the extreme edges of the map. This format
is only suitable if the data itself is cyclic in some way.14–16,24
The size of a SOM should be large enough to include models for all spectra
or data vectors in the reference set, and to extract fine features of the data. So
if the data are expected to contain many fine features, a large map should be
used, otherwise the size should not be very large to optimise computational time.
The best way to establish the optimum size is trial-and-error. Typical sizes are
in the order of a few dozen to a few hundred nodes, and the dimensions of an
array should approximate the two principal components of the input data. Some
suggest using 4 to 10 nodes per expected class in the dataset.25 However, this
should be validated by training a map of a particular size, and comparing its
results with results of maps of different sizes.
To initialise a large map, it may be advisable to train a small map, initialised
with the principal components, then once trained to a partially complete state, to
add nodes in-between those existing, which take values interpolated nonlinearly
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from the existing nodes. After that the larger map is trained until it reaches
acceptable clustering.14
When searching for the BMU for any reference or test vector in general, one
may save a great deal of computational time by taking note of the locations of the
previous BMUs, and the corresponding training data. In subsequent iterations
the search for the BMUs can be restricted to the vicinity of the previous winners.
This may also be done by pre-training a smaller map first: the approximate
regions of likely BMUs can be given to the large map. So if a cluster of one class
of data (Class 1) is found in the top, right corner, and another cluster of different
class of data (Class 2) is found in the opposite corner, then it can be assumed
that these two clusters will be in opposite corners of any map with the same
data. Training a larger map with these data should then proceed by only looking
for BMUs in opposite corners for these inputs when they are selected. One can
search only in the top, right corner for BMUs for class 1 input, then that corner
will be trained on that class 1. Later, when Class 2 data requires a BMU corner,
the bottom, left corner could be assigned to that. This is manually biasing the
larger map, so injecting knowledge, but that knowledge comes from the earlier
clustering with the smaller map.
Another method to speed up computation, and reduce memory requirements
is to truncate the data vectors:14 for example, selecting every fifth element in
the vector can reduce computation by a factor of 5, without losing many of the
features.
On may also select features one thinks are important in each input vector,
and then make a new dataset, where the first column is Feature 1, column 2 is
for Feature 2, etc. This can greatly reduce the data, and therefore training time,
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while hopefully keeping most of the important information. Features used should
be theoretically sound, and should be tested to determine if they lead to good
predictions, if there is a desired outcome.
6.1.6 SOM applied to circular dichroism spectra
In our methodology, SSNN, the spectra are clustered in an unsupervised manner,
but the protein secondary structures corresponding to these spectra are known,
so the algorithm can be improved until a certain level of accuracy is attained.
This is done by running the software many times (validation, usually LOOCV)
while varying the iteration count. An error metric that is useful in this effort is
the normalised root mean squared deviation, or NRMSD. The formula for it is
the same as the root mean squared deviation divided by the range of the observed
data:
RMSD =
√∑
(xi − x′i)2
n
(2)
and
NRMSD =
RMSD
xmax − xmin (3)
where for the CD data, xi is an element of the experimental circular dichroism,
CD, spectrum; xi’ is the estimation of xi from the predicted spectrum; n is the
number of elements in the spectrum (for example, for us this was 51 due to the
range of CD data wavelengths: 240 nm-190 nm); xmax and xmin are the maxi-
mum and minimum of the observed values. The NRMSD is used in Dichroweb to
compare the CD analysis methodologies or algorithms available for use on that
website. On Dichroweb, each methodology used produces an NRMSD for the
spectrum of each test protein given to it. This is intended to be a guide as to the
accuracy of the structure predictions made by that methodology, for this specific
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test CD spectrum.
When testing many different SOMs with various numbers of iterations, using
a LOOCV test, the SOM arrangement with the smallest NRMSD for the test
spectrum in question is considered to have the best number of iterations.
A summary of how a SOM works is that one starts with a map, a collection
of random vectors arranged in an NxN square or hexagonal lattice. This map
comes to represent the data. This will be expanded with much greater detail later.
In our case we made a 40x40 square map of CD spectra. So the map in 3
dimensions is 40x40x51. Various sizes of map were tested, this was the best,
as is detailed in Paper 1.17 The value of 40x40 nodes in the SOM trained with
our then 48 CD spectra was arrived at by running LOOCV for various map
sizes. It was found that a larger map size generally produced smaller error, but
larger than 40x40 nodes did not improve the accuracy much, and took a lot more
computational and real time to train. We found that this very large map, with 5
or 6 BMUs to make the model spectra from produced models with elements from
each of the BMUs: different regions of the spectrum were ’inherited’ from the
BMUs. If this were a simple classification question, then having a small map with
very few models might have been successful, but we were looking for 6 numbers
adding to 1.00 for the 6 different structure types, and the sets are not boolean,
but fuzzy. So for the most part each protein contained non-zero values for all 6
structures in varying amounts. The reference or training dataset also contained
these, and the test set did not contain any of the same spectra, so the structure
results should not be the exact structures of one model spectrum. Also, when a
small map is being used, making a model out of several BMUs tends to result in
the model inheriting characteristics from most of the nodes, or potential BMUs
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in the map. For example, having a map with 9 nodes, and using 6 of those
to make the model of the test spectrum (6 BMUs) would be illogical, because
the model would be very average every time, there would not be much room for
individuality, and making a different decision (structure vector) each time.
The 48 spectra were later expanded to 53. We added 2 theoretically 100 %
α-helix proteins, by taking two helix spectra and stretching the peaks until they
were where a protein of 100 % helix would be. We added 3 truly 100 % random
coil protein spectra. We present the map with the reference set of 53 CD spectra
in the sequential, stochastic manner detailed above. SSNN selects a spectrum,
and tries to find a match for it on the map. Each vector on the map is compared
with the selected CD spectrum, and the most similar one is said to be the BMU.
A learning rule (equation 4) makes the random vector more similar to the CD
spectrum. The region around the vector or BMU on the map, the neighbour-
hood, is made more similar to the CD spectrum by a smaller amount: decreasing
toward the edge of the neighbourhood (Figure 2).
The SOM architecture is used by some other methodologies for determining
protein secondary structure from circular dichroism, e.g. the K2d family26–28, and
SOMCD13. The SOM is a good artificial neural network, ANN, for CD spectra,
as it allows one to see the clustering of the spectra without too much difficulty,
as each node of a SOM trained with CD spectra contains a spectrum; the SOM
is topological. The SOM is not the only ANN that might be used for pattern
recognition of CD spectra, but the visualisation capabilities do make it appealing
for such work.
After the SOM has clustered the CD spectra so similar spectra are close, it
does the same with the secondary structures that correspond to the CD spectra.
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These structures come from X-ray crystallography data. SSNN makes a map of
structures that correspond to the spectra by finding the CD spectra in the map
that are most similar to the reference set spectra. There are also many spectra
that are intermediate between the training set BMUs, and these are referred to
here as virtual spectra. These virtual spectra number (40x40 - 53 = 1547), more
of this is covered in Paper 1.17
Briefly, the 53 training or reference set spectra take up 53 nodes on the map,
the other 1547 nodes hold spectra intermediate between those. These are virtual
spectra, and are hybrids made from the elements from their training set neigh-
bours.
During the training process, learning proceeds so as to cause the SOM to learn
fast at the beginning, and exponentially slower towards the end of training. The
size of the neighbourhood is also reduced in size with iterations. The equation
for the learning is:
L(t) = L0 · exp(−k1·t) (4)
where L is learning rate, L0 is the initial learning rate, t is the current iteration,
and k1 is a parameter of size << 1. According to Kohonen,
14 the learning rate of
the nodes should decrease monotonically (e.g. hyperbolically, exponentially, or
piecewise linearly) with iterations.
The equation for the neighbourhood radius is as follows:
radius(t) =
(RADIUS0 − 1) · (1−
t
t1
) + 1 if t ≤ t1
1 if t>t1
(5)
where RADIUS0 is the initial radius of the neighbourhood, t1 is a parameter
about a third the size of number of total iterations.
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According to Kohonen, the first 1000 or so steps of training the SOM should be
for ordering the map topologically, the rest of the time should be spent carefully
ordering the models to reach their best states. This may take 10 times longer
than the initial topological ordering stage.14
6.1.7 Developments to SOM
Fritzke 199429 made a self-organising network inspired by Kohonen’s SOM that
adds more cells or nodes with iterations, i.e. “Growing Cell Structures”. There
are a few main differences between this and the SOM approach:
1. The learning or adaptation parameter remains fixed, while in a SOM it
reduces monotonically.
2. Only the BMU and its direct topological neighbours are updated to become
more similar to the relevant input vector, not a whole region.
3. Cells can also be removed
Removal of a cell can happen when the cell is considered superfluous, i.e. if it
has a position in a region of the data space with very low probability density; lower
than a threshold. The removal causes there to be fewer connections between cells,
and there can even be separate clusters with no links to each other, see Figure 4.
This method works using Voronoi regions, or regions created using Voronoi
tessellation.30,31 Voronoi regions result from clustering data, such that every point
in a Voronoi region of a Voronoi diagram is closer to the centre of each region than
any other centre. The centre of a region is called the seed, or centroid, and the
regions are known as Voronoi cells. This method is named for Gregory Voronoy,
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Figure 4: Voronoi regions, a) a well adapted network arrangement with good modelling of a
probability distribution the connections are mostly short. This is good, but there are still some
extraneous connections. In b) these extraneous connections have been removed, and there are
only short connections. The network now models the probability distribution nearly perfectly
30
and an alternate name is Dirichlet tessellation, after Peter G. L. Dirichlet.30,31
The map is made of k-dimensional hypertetrahedrons, which look like tri-
angles when plotted in 2-dimensions. So the deletion of cells or nodes must
always leave behind connections forming hypertetrahedrons (in high dimensions,
or tetrahedrons in 3-dimensions, or triangles in 2-dimensions), rather than just
lines connecting free-floating nodes. The connection lines, or edges represent
neighbourhood relationships.29,30One advantage of using this ‘growing cell struc-
ture’ methodology is that it makes obvious separation between different classes,
as there are no connections between nodes of different classes, due to deletion of
cells (nodes).
Fritzke et al. gave an example of classifying animals using the frequency cell
approach, with data taken from a SOM paper by Ritter and Kohonen.29,32 The
SOM classified the animals correctly, but borders between the different classes
(bird, herbivorous quadruped, carnivorous quadruped) had to be drawn in by a
human, while the self-organising growing cell structure of Fritze classified cor-
rectly, and showed the boundaries automatically (projected in 2-dimensions).
In 1997 Kohonen et al. developed a SOM algorithm for signal processing
called ASSOM, or adaptive subspace SOM.33 In ASSOM, each node of the map
adapts to become an expert for one class of transformations. ASSOM makes
statistical representations that refer to various temporal events. As a member of
the SOM family of algorithms, it works by competitive learning, where there is
only 1 winner. This is in contrast to PCA, for example, which finds average data
features that come from global properties that are not temporal.
The aim of the ASSOM algorithm is to solve the long-standing problem of recog-
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nising patterns that are simple transformations such as rotation, scaling, and
translation. Examples they looked at were speech waveforms, and coloured noise
patterns from photographic images. ASSOM was successful in finding relevant
filters.33
6.1.8 General good practice in machine learning
SOM is a neural network type of machine learning; this section describes what
machine learning is, and how best to use it.
Machine learning is the branch of computing that deals with software that
can adapt its models to datasets; it learns from the data to produce more accu-
rate predictions. There are two main types of machine learning: supervised (for
labelled data) and unsupervised (for unlabelled data). An additional method is
reinforcement learning, described just below.34
In supervised learning, the algorithm is given the input vectors, and their
target vectors, so that, during training, it may perfect its patterns to replicate
those targets/predictions. Examples of supervised learning include multilayer
perceptrons (MLPs), and genetic algorithms (GAs) with definite goals.29
In unsupervised learning, the algorithm will study the data, and find pat-
terns that are previously unknown. This process includes clustering, for example
SOM, hidden Markov models (HMM), and GAs with open-ended goals. SOM
is an unsupervised, competitive learning method.14,29,35 The ability to use unla-
belled data makes unsupervised learning useful for data mining, where the truth
is not known until correlations and patterns are found by the software, usually
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because no human can understand the data, as they are far too high dimensional,
so there can be no correction of the predictions.
There is also reinforcement learning, which is a method of programming soft-
ware agents using rewards and punishments, while not requiring an explanation of
how to perform a given task. The agent must learn using trial-and-error methods
in a dynamic environment. The two main ways to solve reinforcement problems
are 1) to search for a behaviour that performs well in the environment, and use it
(GAs and GP), and 2) to estimate the usefulness of taking actions in the environ-
ment by using statistical techniques and dynamic programming techniques.36,37
The basic goal of all machine learning, ML, techniques is to gain the ability
to generalise to much more than just the training set. This is because the ML
system will never be able to have all information about every possible situation,
however, just having vast amounts of data does not suffice to be able to generalise
well. Like a brain needs to be able to learn new knowledge, because instinct will
never give it the ability to cope with every possible situation in a changing world.
If we give a ML system a Boolean function (two possible correct answers for
each variable: true or false) with a moderate 100 dimensions, and one million
examples in the sample data, this would mean that there would be 2100 - 106 ex-
amples with unknown classes, i.e. approximately 1030 unknown classes. The way
to solve this problem, or set of problems, is to include some knowledge or at least
assumptions along with the raw data. 100-dimensional data is easily reached,
the circular dichroism spectroscopy data we work with is 57 dimensional, and the
myoelectric signals we use for robotic limb control are 63 dimensional.4,9,17,38
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Wolpert gave a name to the problem of having to include knowledge, rather
than just data, to make better learners. He called this ‘no free lunch’ theorem,
meaning that, when trying to understand all functions that are needed in the
universe, on average no learner may do better than guessing randomly. In this
sense there is no difference between algorithms without knowledge.39–41 No al-
gorithm can predict everything in the universe. It will need some knowledge to
be better than another prediction algorithm that has no knowledge, just data.
This may lead to the problem of having to supply vast amounts of data to train
the algorithm, assuming the functions that describe the patterns in a given data
space are uniformly distributed.
Fortunately, the functions that describe the samples are not taken uniformly
from all possible mathematical functions. Assuming the following: that similar
examples will have similar class membership, that the functions will be smooth,
and that complexity is finite, are all in the set of few assumptions that are suffi-
cient to understand rather well.
When learners use induction, a little input knowledge can be transformed into
a lot of output knowledge. It is superior to deduction in that it requires a much
smaller supply of knowledge to show good results.41 However, it was always be-
lieved that with inductive reasoning the correct decisions and causations cannot
be guaranteed, unlike with deductive reasoning, where they can be. More recently
this has been found to be untrue; there can be guarantees on results gained from
inductive reasoning, especially when accepting probabilistic guarantees.41
In any machine learning methodology, before beginning the training, the data
need segmenting into training set, validation set, and test set. This is so the
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classifier may a) learn the data well, b) have its parameters and architecture val-
idated, and c) be tested on a new dataset. The testing phase is needed so it may
show that it can make general conclusions about data, and is not over-trained
on specific data. This cannot really be done when the answers are not known, as
can be the case with data mining.
Having the test dataset enables one to answer the question of how accurately
the classifier needs to predict the target vectors; too little training, and the algo-
rithm does not know the data, and has not recognised any patterns (underfitting),
too much training on the specific training set, and the algorithm cannot gener-
alise (overfitting).41
Underfitting is where a learning or heuristic algorithm has not been trained
enough to recognise patterns in the dataset, and so cannot make good predic-
tions or classifications for this or any dataset. Overfitting is where a heuristic
algorithm has trained too much on one particular dataset, and believes that is
all there is to know, so it cannot predict or classify any new data well. It keeps
assuming the new data is exactly the same as, or very similar to the training data
set.41
One can understand the problem of overfitting by dividing the error of gen-
eralisation into two parts: bias and variance.42 Bias is learning the wrong thing
consistently, and variance is caused by a tendency to learn random things, and
not the true information.
There are various ways to work against overfitting. Cross-validation can help,
but fitting too many parameters with it can also cause overfitting. Regularization
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terms added to the evaluation function are also a good idea, like penalizing the
size of classifiers so that they do not get too large and have space to overfit.
The next biggest problem for machine learning is “the curse of dimension-
ality”. As dimensions (or number of features) of the data grow, generalising
becomes exponentially more difficult. If the number of features in the database
is again just 100 with a Boolean solution space (two options: true or false), and
even as many as 1012 samples are given to the classifier algorithm, the samples
still only cover 10−18 of the input space (2100 ≈ 1030).
A more deep-rooted and important issue is that the way ML algorithms clas-
sify based on similarity fails in high dimensions. When there are 100 dimensions,
and only 2 are being compared, the noise from the other 98 dimensions can act
as noise, and can drown-out the signals from the first 2.14
So is gathering more features always a good thing? No, it can be that they
offer nothing new that is not already known, and their pros can be outweighed
by their cons, when they contribute to there being too many dimensions to the
features. Assuming the examples are uniformly distributed, then the detriments
to having more data become much worse quickly. Actually, the situation is not
as bad as it may seem, as examples are not usually spread uniformly, but cluster
about the lower-dimensions.14
In success or failure of ML techniques the most vital element is that the
features used are good. When dealing with raw data, learning is not straight-
forward. However, if one forms good features from the raw data, learning can
proceed more easily. This is usually a reason for the greatest effort in ML. If
36
the ML algorithm takes raw data, it will find pattern recognition far more dif-
ficult than if it works with data that has had some important features highlighted.
Machine learning is an iterative process of 1) applying the data or features
to the learning algorithm, 2) analysing the results, 3) altering the algorithm and
maybe the data. Here learning is usually the easy stage (ML algorithms have
general application, so easily learn data), while feature engineering is the most
difficult stage, as it is domain-specific. Automating feature engineering to an
increasing degree is therefore a very worthy pursuit. This could be done by cre-
ating a large collection of features that might be useful and picking those that
help best to improve classification information.
Despite all of the above, an algorithm with vast amounts of data still wins
over a better classifier with much less, which of course might lead to computation
time issues.41
There were no computation time issues for the CD project, as the dataset
that trained the selected ML technique, the SOM, was 57 by 53 data (points),
from 57 dimensions and 53 examples. As mentioned above, the aim was to take
the CD spectra and structure knowledge, and do some pattern recognition on
them to find spectral features that link the spectra to the secondary structures.
The question was: what features lead to what structures of proteins, and in
what proportions? Aspects of the history of this field of work, along with some
chemistry and physics background knowledge on CD are summarised below.
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6.2 Circular Dichroism for protein secondary structure
estimation
Circular dichroism, CD, is a spectroscopy that has been used since the 1960s
in structural biology to study the structures of peptides, polypeptides and pro-
teins.43
CD was discovered in the 19th century by Jean-Baptiste Biot, Augustin Fres-
nel, and Aime´ Cotton.44 CD is the difference in absorption of left- and right-
circularly-polarised light (LCP light minus RCP light), see the equation below5
∆A = AL − AR (6)
where ∆A is the difference in light absorbed by the chiral molecule, and AL
and AR are the absorptions for the LCP, and the RCP light respectively.
Absorbance is the logarithm of the incident divided by the transmitted radi-
ation, as in the equation below:
A = log10(
I0
I
) (7)
where A is absorbance, I0 is the incident radiation, and I is the transmitted ra-
diation.45–47
In order for a CD spectrum to produce a useful, non-zero signal, the molecules
have to be in a suitable solution (known as a buffer), and the molecule must have
some chirality (explained just below). A buffer is a solution that resists changes in
acidity, so if a small amount of acid or a base is added to the buffer solution that
contains the protein being studied, then the acidity (pH) should remain approxi-
mately the same. A good buffer should be transparent in the wavelength of light
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that is being used. A chiral molecule cannot be superposed onto its mirror image,
the arrangement in space is very similar, but not exactly the same, just in the
same way that a left and a right hand are not arranged in exactly the same way,
and are not simply reflections of each other. CD is based on the Cotton Effect
or Optical Rotatory Dispersion, which is where the biased absorption between
LCP and RCP light by stereoisomers of a chiral molecule causes redistribution of
electrons in a helical way, for certain transitions, at particular wavelengths. By
studying the CD spectrum of a chiral molecule, the handedness of the changes in
electron positions can be found. Some aspects of the structure of the molecule in
three dimensions can be derived from this.43,48 Stereoisomers are molecules that
have the same atoms and sequence, but different spatial arrangements.49,50
The basis of the CD spectrum is electronic transitions, this gives rise to spec-
tral features: peaks and negative bands. In Figure 5, we can see the CD spectral
features that arise from the structures present in a chiral molecule. α-helices
have a characteristic large peak at about 190 nm, and two negative bands at 208
nm (called the pi → pi∗ transition) and 222 nm (n → pi∗ transition). β-sheets are
characterised by a peak between 195 nm and 202 nm (pi → pi∗ transition), and a
negative band between 215 nm and 220 nm. Turns are negative at 180 nm to 190
nm, and positive at 200 nm to 205 nm. A disordered structure has a negative
band at 200 nm. These are for the same set of electronic transitions, they just
shift in wavelength a little for different structure types.
Electronic transitions involve electrons jumping energy levels near the ground
state. The n → pi∗ transition is when the electron in the ground state transfers
from the n molecular orbital to the pi∗ molecular orbital. The pi → pi∗ transition
results from a pi ground state electron jumping up two levels to the pi∗ level.5,17
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Figure 5: The different CD spectra that are produced by the various structures of chiral
molecules.4
CD can be measured in terms of molar extinction coefficients, or ∆, also
called molar absorptivity, which has the units L mol−1 cm−1:
∆ = L − R (8)
and
∆ =
∆A
cl
(9)
where L and R are the molar extinction coefficients for the LCP and RCP light,
c is the concentration of the chiral molecule in solution measured in mol·l−1, and
I is the cell pathlength, measured in centimetres. The pathlength is the width
of the (usually quartz or glass) vial that containing the sample, which the light
40
passes through.
We worked with ∆ values, which are per mol, so our data are independent
of the number of residues. Equation 9 is derived from Beer Lambert’s Law:5
A = cl (10)
∆ values can be converted to mean residue ellipticity (MRE or θ) using the
simple equation:
θ = ∆ ∗ 3298.2 (11)
MRE is measured in degrees cm2 dmol−1 residue−1. CD spectrophotometers
output the CD signal in units called millidegrees. This is because, historically,
the change in polarisation of linearly polarised light into elliptically polarised
light passing through the sample was measured as the CD signal. Millidegrees
can be converted into ∆ units using the equation below:
θ/millidegrees = 32, 982 · cl (12)
which is the Beer Lambert Law (equation 10) restated for different units.5
LCP light is defined as: when viewed from the source, the electromagnetic
field of LCP light rotates in an anti-clockwise direction, and the EM field of a
beam of RCP light rotates in a clockwise direction.51
6.2.1 Where CD signals come from
Circularly polarised light has a magnetic dipole moment that rotates (a magnetic
dipole transition moment, m), and an electric transition dipole moment (µ) that
oscillates linearly (back and forth). These two moments combine to form a helical
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motion of the electromagnetic field. The helical motion of the EM field causes
an electron to move in a helical path, as can be seen in Figure 6.5,6
Figure 6: The magnetic dipole transition moment,m exhibits circular motion, and the electric
dipole transition moment, µ, exhibits linear translation. These combine to make helical motion
of the EM field.5,6
So the EM field moves in a helical motion, but how do CD practitioners find
the signals these helical motions of light produce? The CD machine, which is
called a spectrophotometer or spectropolarimeter records the CD spectra. An
extremely important part of a circular dichroism spectropolarimeter is the com-
ponent that makes sure the machine produces exactly equal intensities of both
LCP and RCP light. This component is the PEM, or photoelastic modulator.
The UV light source is a xenon arc lamp, which also emits visible light. Various
mirrors, prisms and slits are needed to collimate the light from the lamp. Subse-
quently, the light is linearly polarised (as would be useful for linear dichroism),
and the PEM circularly polarises the light.
The PEM is made of crystalline quartz stuck to a piece of isotropic quartz (sil-
ica). Light travels through the silica section. The light is split into two orthogonal
beams, and due to the birefringence in the PEM, the two beams experience dif-
ferent refractive indices. An alternating current, AC, is applied to the crystalline
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section of the PEM, this makes it oscillate at 50 kHz. Varying the amplitude
of the voltage causes the PEM to select alternately for light polarised in one
direction, followed by the orthogonally polarised light.
So the PEM effectively forms a wavelength-dependent quarter-wave plate that
is needed to make circularly polarised light. In Figure 7, see a diagram of the
optics of a CD spectrophotometer (another name for a CD machine). The PMT
(photomultiplier tube) detects the light that was not absorbed by the sample,
and converts it to an electrical signal; it vastly multiplies the current received,
and is a very sensitive detector.
The CD signal is then determined by the ratio of the AC to DC elements
detected by the PMT, see equation 13. The sign of the CD derives from the
phase of the AC element using a lock-in amplifier that uses the AC voltage of the
PEM as a time reference.5,36
CD =
< AC >
DC
(13)
Instruments can now hold the DC current constant, with the use of a servo that
adjusts the PEM voltage. With a constant DC voltage, the CD is proportional
to the <AC> voltage.
6.2.2 Buffers
To perform CD analysis of chiral molecules, an appropriate buffer should be used.
A buffer is a solution containing a weak base and its conjugate acid, or a weak
acid and its conjugate base. The purpose of a buffer is to resist changes in pH
when small amounts of acid or base is put in it52. A buffer should be at a concen-
tration in the solution such that it may withstand variations in the pH due to the
addition of a highly charged ligand, for example ATP4−. The buffer must be used
within approximately 1 pH unit from the appropriate pKa, the acid dissociation
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Figure 7: A diagram of the optics that go into making a CD spectropolarimeter. It contains a
xenon arc lamp, mirrors, prisms, slits, polarisers, a lens, a PEM and a PMT . The xenon lamp
emits white light with a maximum flux in the 300 nm to 400 nm region. Mirrors direct the
light to the slits and prisms. Prisms select the relevant wavelength of light, polarisers perfect
the linear polarisation before the PEM makes it circularly polarised.5
44
constant. The pH should be checked at the temperature the buffer will be used
at; some buffers have high temperature coefficients.53,54
Buffers can affect the CD spectra when they are used for solutions of proteins
or other chiral molecules. Every time a CD spectrum is taken of a chiral molecule,
the base line should also be scanned. This is the CD spectrum without the chiral
molecule present, i.e. just the buffer solution. This should then be subtracted
from the CD spectrum for the molecule of interest to obtain the true spectrum.
This should also be done to check the quality of the buffer, as some can cause
the high tension, HT, voltage to rise to a level where the CD spectrum becomes
too noisy to be useful. This is due to the buffer having a high absorbance in this
wavelength range. The high tension voltage is the voltage applied to the PMT.
Absorbance in a CD spectrum due to the buffer solution can cause degradation
of the signal, to the point that the signal to noise ratio becomes too low. Kelly et
al.53 found that absorbance is wavelength dependent, and more noise is caused
at short wavelengths, particularly the 190 - 200 nm region. The absorbance is
measured by the HT voltage. This is the voltage applied to the photomultiplier
tube (PMT). This means the PMT has to work hard in the short wavelength
region. For good CD spectra the HT should be at most 600 V, but this depends
on the CD machine.53
For this reason synchrotron light sources with much greater light fluxes than
xenon arc lamps are used to gather what is termed SRCD, or synchrotron ra-
diation CD. With a synchrotron, useable CD spectra can currently be obtained
down to approximately 160 nm. However, due to noise from most desktop CD
machines, most CD-to-structure estimation algorithms do not use data below 190
45
nm.
Unwarranted interactions, like chelation (the formation or presence of bonds
between separate binding sites on the same ligand and one central atom) of
essential metal ions can also cause trouble with phosphate buffers among others.53
6.2.3 Algorithms for circular dichroism pattern recognition
With knowledge of where the CD signals come from, and how to prepare the
buffer, the data analysis stage needs to be considered, as the CD spectra are
not easily read by non-expert CD practitioners. Despite being able to tell which
structures are present, even the experts cannot say exactly what proportions of
structures are present. For this statistical or learning algorithms should be used.
There are various methodologies for CD pattern recognition to find secondary
structures of proteins: CDSSTR, SELCON3, VARSLC, CONTIN, LINCOMB,
MLR, CDNN, SOMCD, K2d, K2D2, K2D3, as well as our own: SSNN.13,26–28,55–57
Here is a brief review of the methods used. SELCON3, CDSSTR and K2d were
tested and reviewed in attached papers. The methodologies are based on multi-
ple linear regression (MLR), singular value decomposition (VARSLC, SELCON,
CDSSTR), ridge regression(CONTIN), convex constraint analysis (CCA), self-
consistent method (SELCON), constrained least squares analysis (LINCOMB),
and neural network (CDNN, SOMCD, K2d, K2D2, K2D3, SSNN).58 The struc-
tures for these databases generally come from X-ray crystallography. See Figure
8.
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Figure 8: A picture of a protein with the different structures present: β−lactamase: α−helix
in yellow (long helices), 3-10 helix in blue (short helices), β−sheet in green, turns in orange,
random coil in grey. The atomic-scale detail, along with hydrogen bonds, is also shown for two
small sections: α-helix and β-sheet sections. The hydrogen bonds are the purple/pink lines
between the red and white atoms. Atoms are carbon in turquoise, hydrogen in white, oxygen
in red, and nitrogen in dark blue.
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Greenfield’s review
In reference58 Greenfield compared the structure prediction qualities of MLR,
LINCOMB, SVD, CCA, CONTIN, SELCON, Bo¨hm et al.’s NN, and K2d.
Most of the algorithms are good at predicting the α-helix structures from
CD, but have more difficulty with all other structures. The helix structures were
predicted by all algorithms with Pearson correlation coefficients (P) of 0.88 or
higher, and standard deviations (σ) of usually about 0.1. The β-sheet and β-turn
structures were not as well done, and were far more variable. β-sheets were pre-
dicted with P of 0.00 to 0.91, and σ of 0.07 to 0.28. The β-turns were predicted
with P values of -0.56 to 0.84, and standard deviations of 0.05 to 0.27.
K2d does not predict the structure type β-turns, it uses the structure types
1) α-helix, 2) β-sheet and 3) other.26,58
MLR (non-constrained least squares analysis) predicts α-helix, β-sheet parallel
and anti-parallel, β-turns, and random conformations.
LINCOMB predicts α-helix, β-sheets, β-turns, and “random coils”. Bo¨hm et
al.’s neural network predicted helix, parallel and anti-parallel sheet, turns, and
remainder.
A likely reason these algorithms predict β-turns so poorly is because there
are at least 4 different types of turns, which do not have very similar spectral
features associated with them.
MLR predicts helix well, sheet with some correlation with experimental, and
turns very poorly. Similar to MLR, LINCOMB predicts helix well, sheet with
some correlation (very variable), and turns rather badly.
SVD predicts helical structures very well, but sheets and turns extremely
variably, and rather poorly. It predicts as follows: sheets 0.00 ≤ P ≤ 0.68, and
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0.12 ≤ σ ≤ 0.27, and turns -0.56 ≤ P ≤ 0.22, and 0.1 ≤ σ ≤ 0.27. Here P is
Pearson’s correlation coefficient, and σ is the standard deviation. So a large P,
closer to 1.00, is better (higher correlation), and a small σ is good (small error).
CCA makes good predictions of helical structure, but its estimates of sheets
and turns are worse than that of other methods.58
CONTIN gives good helix predictions, and its turns predictions are better
than MLR, SVD and CCA. VARSLC produces excellent helical structure pre-
dictions, while sheet and turn predictions are much improved over the above,
especially the sheet predictions. Data needs to be collected to 184 nm to make
useful predictions/estimations, which is a handicap.58–60
SELCON’s predictions for globular protein helix, sheet and turns are all very
good. There does not seem to be much detriment to using a reduced data range of
240 nm - 200 nm. The 1996 version of SELCON worked well for globular proteins,
but did not predict well the structures of polypeptide with large percentages of
sheet; it over-estimated helix content, while under-estimating sheet content quite
badly. For a comparison between SELCON3, a more recent version of SELCON,
and SSNN see Paper 117 and Paper 34.
The Neural Network for protein secondary structure estimation that was writ-
ten by Bo¨hm et al. was extremely good at predicting helical, and antiparallel
sheet structures. The correlation coefficients were 1.0 and 0.91. The only prob-
lem appears to be when the wavelength is restricted to 250 nm - 200 nm, the
sheet estimation is negatively correlated.61
K2d gives good sheet estimates when the wavelength range is restricted. It does
not estimate turns.
For these applications, most of the algorithms are operating in the range 240
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nm - 200 nm, VARSLC uses the range 260 nm - 184 nm, and SELCON uses
260 nm - 200 nm. Bo¨hm’s NN (neural network) used 83 element input vectors,
representing the intensities at 260 nm - 178 nm.58 MLR does not require an exact
value of the protein concentration. According to Greenfield, CCA does not find
the secondary structures of unknown proteins easily, given no extra information,
but it is very good for analysis of spectra of proteins and peptides with regard to
temperature, pH and ligand binding.
MLR, SVD and CCA do not have selection procedures for known spectra
to make model spectra of unknown proteins. The known spectra do not neces-
sarily have similar features to the test spectra. This leads to the models being
very dependent on the spectra which were chosen to make the models. So, the
suggestion was to introduce these similarity selection measures. That is what
has been done with (1) ridge regression, (2) variable selection, and (3) neural
networks; examples of these are (1) CONTIN, (2) VARSLC (which is SVD with
variable selection) and SELCON (VARLSC modified), and (3) K2d. Algorithms
with selection perform better than those without. SELCON, or self-consistent
method by Sreerama and Woody gains a speed advantage by routinely removing
the spectra least like the test spectrum.58,62–64
It should be noted that the algorithms that produce the best spectral predic-
tions do not necessarily produce the best structure estimates. Greenfield points
to CONTIN as “almost always [giving] excellent agreement between the experi-
mental and calculated CD curves, even when the fits are relatively poor compared
to other methods.” Greenfield says that K2D often produces very poor spectral
models, while making very good structure predictions.58 Another example of this
is CDSSTR; it produces beautiful spectral models, among the best of all CD-to-
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protein-structure algorithms, but its structure predictions/estimations are not as
good as some competitors (e.g. SELCON3 and SSNN). SELCON3 has possibly
the best structure predictions besides SSNN.58
The most sensible way to analyse CD spectra to get structure predictions is
to use at least a few different methods, and see where they agree. If the predic-
tions vary greatly, then one cannot have great confidence about the structures
present.4,58
Greenfield says that if one needs structure predictions, but does not know the
concentration accurately, then non-constrained least-squares analysis programs
like MLR are the only options, but these do not give the best predictions. This
issue is dealt with in reference38 also known as Paper 2 in this thesis.
K2d
In their 1993 paper, Andrade et al. introduce K2d, their SOM methodology
for estimating protein secondary structures from CD spectra.26 This paper lends
more detail about K2d and its proteinotopic map, than given by Greenfield,
mentioned above. A proteinotopic map is a topological map of some information
about proteins.
The training set for the K2d SOM is 24 CD spectra. One of these proteins is
poly-L-lysine, which has different CD spectra depending on pH and temperature;
for this reason it is used as a model protein for the various spectral features.
Eighteen of the proteins have known (static) structures, and 3 are constructed
from 15 proteins of known structure originating from Chang et al. 1978.65 More
information on this reference set can be found in Yang et al. 1986.66
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The K2d map is a 13x13 square lattice of nodes and, like other SOMs, it in-
terpolates between experimental CD spectra, but does not extrapolate. For this
reason, unlike some methodologies, K2d does not give structure estimates with
negative values, which would be physically impossible.
As Unneberg et al.13 point out, the database size determines the possible sizes
of the map: a map needs to have enough data space to store all the examples,
but must not be so large as to make all BMUs in a region essentially the same,
and negate the use of multiple BMUs. That would cause the SOM to produce
poor spectra models. So with 24 spectra in its training set, K2d needs a smaller
map than a SOM with more spectra would.
Due to the CD data used by K2d being of the wavelength range 240 - 200 nm,
there are 41 data points. The SOM does not use CD spectral data beyond 240
nm, as there is not much information from the peptide backbone in that region.
For reasons of wavelength range and how much information can be extracted
from such a range, there are 3 structures types estimated by K2d, α-helix, β-
sheet and “random coil”, or other. There are not enough electronics transitions
that emit light in this region to provide information to resolve more than α-helix
and β-sheet. The n → pi∗ transitions are between 190 nm and 200 nm. This
means that there are only 2 independent variables, for the helix and sheet; the
random coil value is calculated by subtracting the helix and sheet values from
1.00.26 It should be pointed out that random coil is a particular structure type,
though rather difficult to generate, but is often used as a category for everything
that does not fit into any other categories, like the group “other” structures.
Conversely there is a lot of information from the CD spectrum with regard
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to the structure of the protein, or other chiral molecule, in the short-wavelength
range below 200 nm. However, this data is much harder to access due to the
high energies required, and most desktop CD spectrophotometers cannot get CD
spectra in this range without increasing the absorbance to such levels that there
is a great deal of noise (at the time of writing, May 2014).
As mentioned above, this is a reason to use SRCD, the synchrotron overcomes
this absorbance issue, see the section on SRCD, section 6.2.4.
Some later algorithms inspired by K2d do use data in the 200 - 190 nm range.
The Andrade team point out that while collecting spectra without the shorter
wavelength region, the methodology cannot hope to reliably estimate multiple β
structures, hence why they decided to estimate just one helix structure and one
sheet structure.
K2d uses a parameter to track the training progression of the SOM, it is
called the distortion parameter, D. D is the sum of all the distances between
each training set spectrum and the model spectrum most similar to it. If this
value is generally decreasing, then training is headed in the right direction. If
it stalls, and does not continue decreasing, then training has stopped being useful.
With regard to the success of clustering CD spectra, the K2d SOM team
found that each of the three structure labels claimed a corner of the map; in the
random coil corner, those spectra of proteins with high random coil clustered,
with the same result for sheet- and helix-rich proteins.
K2d uses a BMU count of 2. This is the number of BMUs, or model spectra
from the map that go into making the final output model of the test spectrum,
see above. Studies of the effects of using different map sizes revealed that a
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smaller number of BMUs constructing the model spectrum are appropriate for
smaller maps. The size of the map for the SOM we made (SSNN) is 40x40 nodes,
and K2d’s map is 13x13 nodes. In our work we found that SSNN made better
structure estimations when using 3 BMUs for a map size of 20x20, so this is in
agreement with the K2d team findings.
Unneberg et al.13 note that K2d maps were the product of the averaging of
several map-trainings; SOMCD (see below) and SSNN only require one training.
SOMCD
SOMCD is a SOM methodology inspired by K2d, and developed by some of
the same team that made K2d.13 In addition to the functions of K2d, SOMCD
also estimates percentages of β-turn structures, the training set spectra now
number 45. The resulting estimates of the different structure types are more
uniform than from K2d: the estimates for different structure types are about as
good as each other.
SOMCD uses 45 spectra, an additional 21 from that of K2d. SOMCD was
tested with leave-one-out cross-validation where the SOM is trained with all but
one training spectrum, and the one left out serves as the test spectrum, then
this is iterated until each spectrum has acted as the test example, and all others
the training examples. The method was used to validate training parameters
like map size and initial neighbourhood radius, among others, for SOMCD as for
SSNN. A map size of 16x16 was chosen for SOMCD based on these validations.
SOMCD uses three BMUs, an additional one compared with K2d. This makes
sense given the larger map and training set. One BMU would produce just a
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model of one of the training set CD spectra, so a few are needed to take elements
from different training set spectra to make a model of the test spectrum. There
need to be more than one BMU because just one would produce a model of the
training set spectrum at those coordinates. If there are two or more, they can
come together to make new and different models of spectra not on the map.
The additional structure, β-turns, seems to have been harder to fit in with the
clustering, as the map at the turns level does not show an obvious peak, while
each of the other structures does have a peak in its corner. Indeed the team
state that this is the worst predicted structure. It is interesting to note that the
team use a histogram to show that the mode of turn structures in the training
set is 10-15 % turn per protein. This is a reason for the poor estimation of turn
structures; only one protein in the set has more than 20 % turns.
The SOMCD group use the som pak or SOM PAK67 package, made by Ko-
honen et al., to study the continuity of weights in the map. They wanted to
find that neighbouring nodes hold very similar vectors (model spectra). A figure
shows that this is the case for almost all regions of the map, see Figure 9. In this
way som pak helps the user to see if the SOM has clustered well.
The SOMCD Discussion section shows that the structure predictions for all
similar structure types were better estimated by SOMCD than by K2d; this is
based on the RMSD and the Pearson correlation coefficients. There is also a web
version of SOMCD for testing one’s CD spectra.
K2D2
Another K2d-inspired algorithm for protein secondary structure estimation
from CD spectra is K2D2.28 This was developed by Perez-Iratxeta, and Miguel
Andrade-Navarro who was from the K2d team. They also set up a webserver
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Figure 9: Figure from SOMCD paper showing that like proteins are clustered close together.
The grey scales represent the Euclidean distances between nodes: darker grey means the nodes
are further apart.
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(http://k2d2.ogic.ca/) to handle protein structure enquiries to their SOM.
This methodology only uses helix and sheet structures, like K2d does, but
they have extended the wavelength range to 190 nm, and increased the reference
set protein spectra to 49, or 43 for validation, both improvements help to improve
the structure estimations over K2d. The average RMSD values for helix and sheet
prediction were 0.08, and 0.09. These contrast with K2ds 0.11 and 0.14 averages.
The K2D2 group also made use of the SOM PAK package, and they changed
the map size to 18x18 nodes. Like K2d, the final map was the average of many
maps; in this case 100.
Noting that CD spectra-to-structure-estimation software packages do not cur-
rently use membrane protein information, they included in the training set 13
transmembrane (TM) proteins. TM proteins are usually extended between the
extracellular space, across the cell membrane, to the intracellular space, so from
just outside the cell into the aqueous volume inside of it, see Figure 10.
Unfortunately, for the team, and CD practitioners, this resulted in a decrease
in performance. They conclude that TM proteins would need a separate map
trained with only TM protein spectra, to get good estimations of structure. We
concluded the same, but have not made a trained map with TM proteins. We
did, however, test TM proteins (from another laboratory in the department) with
our globular-protein-trained SOM; the results were predictably very poor. Maps
trained on globular protein spectra should not be used to estimate the structure
content of transmembrane proteins; that is the conclusion from that paper, and
from the author’s experience.
The K2D2 group used “more than 6” BMUs to make the model spectra of the
test proteins, a relatively large number compared with K2d, SOMCD and SSNN.
K2D2 is platform independent and was written in Perl programming language.
57
Figure 10: A simple 2 dimensional representation of a transmembrane protein, E is extra-
cellular space (outside the cell, which is an aqueous environment), P is the plasma membrane
(inside the membrane, which is a non-polar, phospholipid environment, so it’s oily), I is the
intracellular space (inside aqueous environment of the cell).7
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K2D3
In a further paper written four years later, in 2012, the two authors from
the K2D2 group with the addition of Caroline Louis-Jeune wrote a follow-on
K2d-inspired code called K2D327. Here the team sought to greatly increase the
training set by including theoretical spectra generated by DichroCalc by Bull-
heller and Hirst68. The aim was to make a non-redundant collection of protein
spectra that would represent most of the proteins in the Protein Data Bank,
PDB, http://www.rcsb.org/pdb/home/home.do69. They report improvements
over K2D2, especially for sheet predictions, and in the range 240 - 200 nm. In-
deed, their results show that there is an improvement for that range, but for the
240 - 190 nm range the results were not statistically significantly different.
To compile a training set, Louis-Jeune et al. searched the PDB, and found
140,624 protein chains, then clustered them into 23,406 groups, from 8,265 PDB
files (multiple protein chains per file). For each group they used selection criteria
borrowed from NCBI’s Structure Group70 that aim for proteins with most simi-
larity along their full sequence. More criteria were applied until there was only
one protein in the group. The PDB file for that protein represented the group.
With these structures DichroCalc was used to calculate spectra for 16,050 protein
chains.
When it came to validation of the methodology, the inclusion of proteins with
different sequence lengths in the SOM caused the additional problem of the BMUs
of a protein having very different lengths (different numbers of residues making
up the proteins). To manage this, the group introduced an additional selection
criterion of having a similar length to the query protein. This produced slightly
better correlations for α-helix predictions, and much better for beta-sheet pre-
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dictions.
K2D3 group tested these theoretical spectra to see if they had correctly repro-
duced known protein spectra using a benchmark dataset of 83 protein spectra.
They report that the models matched the experimental spectra well, and noticed
very good matching in the 210 - 240 nm range. Although most information about
structures present is in the short wavelength region.
The plot of Pearsons correlation coefficient against wavelength shows that
most of the average spectrum correlates with r = 0.8 approximately, but at 200
nm this drops precipitously to about 0.2. The correlation is between the model
and the experimental spectrum, see Figure 11.
The K2D3 team assigned secondary structure compositions to experimental
and theoretical spectra using Define Secondary Structure of Proteins, DSSP;
they only used helix and sheet types.1. K2D3 was subject to leave-one-out cross-
validation with the full set of 83 proteins in the BENCH83 dataset to validate all
of the parameters for training.
K2D3 has reduced performance accuracy when dealing with very high beta-
sheet proteins, due to its reference set not covering these structures. When
predicting structures of polypeptides with nearly 100 % sheet structure K2D3
predicts sheet percentages far below their actual values, and helix percentages far
above. A polypeptide they mention, with regard to this, is poly(L-lysine). This is
surprising, as we have studied this peptide in one of our papers using our SOM,
SSNN.4 We managed to get the low error of 0.032 (NRMSD: normalised root
mean squared deviation, see equation 3) from our spectral model of polylysine
with very beta-sheet structure.38
This K2D3 application is also available on a webserver, http://k2d3.ogic.
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Figure 11: Plot from the K2D3 paper by Louis-Jeune et al. 2012 showing the Pearson
correlation coefficient against wavelength predicted by DichroCalc.
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ca/. The server accepts differential absorption units (∆) or mean residue el-
lipticity units (θ). The size of the protein may also be entered, which, as said
above, might greatly help the beta-sheet prediction. The size of the protein can
be reported in number of amino acid residues or in molecular weight, kDa. They
report that many of the queries of protein structure to their K2D2 server have
the range 240 - 200 nm.
Louis-Jeune et al.27 say that alpha-helix predictions do not leave much room
for improvement, as they are so accurate, however they saw an improvement in
beta-sheet prediction from using K2D3.
6.2.4 Synchrotron radiation CD
Due to HT voltage problems with CD spectra caused by buffers and samples
absorbing too much of the circularly polarised light, blocking it from interacting
with the sample molecule, and being registered by the PMT, synchrotron radia-
tion is used to produce much better CD data, and at wavelengths down to 170
nm, as reported in Kelly et al.53
Wallace et al.71 use SRCD because it only needs small volumes of solution, it
is high-throughput, it uses very short wavelength, high intensity, UV light. More
electronic transitions72 are visible in the short wavelengths below the 190 nm
used by most benchtop CD machines in most CD laboratories. Two examples
of peaks and troughs in the vacuum ultraviolet (VUV) region are the 160 nm
and the 175 nm transitions that are thought to originate from interamide charge
transfer transitions.73
The first use of SRCD was in 1980, but only at the turn of the 21st century
did anyone manage to obtain high-enough quality SRCD spectra to be able to
analyse the secondary structures of proteins in solution at wavelengths as short
as 160 nm.
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As of the writing of that article, there were only 3 sites where SRCD spec-
tra could be gathered, with another in construction, so SRCD is not nearly as
widely available as standard CD.71 The sites were Synchrotron Radiation Source
(SRS) in the UK, Aarhus Storage Ring (ASTRID) in Denmark, the National Syn-
chrotron Light Source (NSLS) in the USA, and there was another light source
under construction: the Beijing Synchrotron Radiation Facility (BSRF) in China.
Nevertheless, SRCD provides some great benefits, like a much cleaner signal due
to higher signal-to-noise ratios than conventional CD laboratory machines. This
reduces the volume requirement of the protein in solution. Other benefits are:
the chance to work with CD samples that have high concentrations of absorbing
materials such as buffers and salts, and shorter measurement times.
Indeed, compared with crystallographic work, the SRCD sample volumes are
100th to 1000th the size, and the measurement times are 1000th to 10,000th the
length.
The possibility of gathering CD spectra to 160 nm means that sheet and helix
peaks can be more easily resolved, as their amplitudes at wavelengths shorter
than 190 nm have opposite signals, while the sheet component can be drowned
by the helix component at wavelengths slightly longer than 190 nm. This means
that, with SRCD spectra, the sheet estimations can be more accurate than with
spectra from regular CD laboratories. Part of the reason for these improvements
is due to the higher number of structural types that can be resolved due to the
use of shorter wavelength data.
For these reasons, SRCD could become a valuable method for high-throughput
functional and structural genomics, and proteomics screening investigations.
From at least the time of writing that paper (2001) the Wallace Group saw
that determining membrane protein secondary structures would be a sensible
63
expansion of their work, and they have since done so.74 The database is now
available on the Dichroweb site75. Membrane proteins are such an important
expansion of their work because they comprise about 60 % of drug targets and
approximately a third of the proteins in the human body.
6.2.5 Crystal structures
In order to have CD spectra with known structures (or conformations) for ref-
erence sets, work needs to be done to find those structures, and X-ray crystal-
lography is one way to get them. We attach these structures to the CD spectra
of known proteins to form our training sets. First the proteins have to be crys-
tallised, exposed to X-rays, then have their patterns analysed to calculate their
structures.
Research teams around the world have managed to crystallise many thousands
of proteins, and determined their structures, but not all proteins take well to the
crystallisation processes used.13 However, there is another problem: proteins la-
belled with structure types in different ways. Searching for a protein database
with proteins all labeled in the same way, thousands could not be found, in fact
not even hundreds. The search only managed to reveal 48 similarly labelled pro-
teins: (CDDATA.48 from CDPro), which we used to train SSNN.56,62
Our group later added five more spectra and structures: 2 extrapolated to
have 100 % α-helix, and 3 100 % random coil, which brought the count to 53
(“CDDATA.48+5”). The last 5 spectra are Sulf–KK (100 % Random coil), 100 %
α-helix calculated (extrapolated) from Myoglobin, then Estimated 100% α-helix
protein from Aurein 2.5 peptide, then N–formyl acetic acid (100% Random coil)
and N–acetyl valine (100% Random coil). Every group labels their protein sec-
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ondary structures in slightly different ways, this is due to personal interpretation.
Some have 5 structure types, some have 6, different groups determine in different
ways what is a helix, what is a sheet, and what the distorted versions of those
spectra are. Some have poly-proline II helices, some don’t; there are numerous
variations.
6.3 Myoelectric signals for control of robotic upper limbs
Alongside the work on pattern recognition of CD spectra and their structures, the
project also looked at controlling robotic limbs. It was realised that the ML SOM
methodology could be applied to other datasets, and an opportunity arose to work
on myoelectric signals; the electrical information from muscle contractions; for
the control of prosthetic robotic arms. The myoelectric signals are extremely
complex for a human to recognise, and program into a control system, so a
machine learning technique was applied.
What follows is some background on the myoelectric signals, and their use to
control robotic limbs.
Myoelectric signals (MES) are the electrical signals produced by impulses from
the brain, and they can be measured from muscles when they move. Research
into control of robotic limbs using myoelectric data began in the 1960s, but was
first theorised in the 1940s. However, the technology did not have a large impact
clinically until the 1970s. This was made possible by the reduction in cost, size
and energy requirements of semiconductor technology.76
A reported 12,000 people had upper-limb abnormalities in the UK in 2001.
Globally this number has been reported to be as high as 3 million (of the 10
million amputees).77 According to the NHS78, about 5000 to 6000 major limb
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Figure 12: An annotated diagram of the intact human hand, by the American Society for
Surgery of the Hand.8
amputations are performed every year in the UK. 70 % of the cases are due to
loss of blood supply, this is called critical ischaemia. 57 % of upper limb amputa-
tions are due to trauma, and diabetes sufferers are 15 times more likely to need
amputations than the general populace. The most common age group to receive
amputations are the over 70s, and men have twice the risk of needing one than
do women. The CDC in the USA reports that in the US approximately 1,450
people are born each year with upper limb deformities, only about 700 with lower
limb deformities.79
When making a prosthetic to replace the hand and arm, it is good to have a
model of the existing biological system that evolved to be so useful in our daily
lives. Figure 12 shows the names of sections of the human hand for reference
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when describing parts of it in the discussion below.
The human hand is underactuated, meaning that there are more degrees of
freedom for the hand than there are actuators, or from a ML point of view: there
are more outputs than inputs.
The distal phalanx of each finger (shortest segment furthest from the wrist) can-
not move independently, but can be bent in towards the palm when the middle
and proximal phalanges are bent towards the palm. This type of movement en-
ables the hand to grip an object of any shape without having special movements
for each shape. Said in another way, the hand has many degrees of freedom.
The human hand movements require a great deal of coordination between
different muscles in the hand, wrist and arm, and the mastery of this may take
several years. There are various levels of control present, from the low-levels for
fine-tuning the forces required to maintain grasp by individual digits all the way
up to the high-level which decides the type of grasp needed.
Those in the field of robotic prosthetic hands try to mimic the functions and
strengths of the human hand, so there are some pre-set movements or grasps that
are used. The prosthetics community suggests there are five basic movements that
the human hand regularly uses:
1. The pincher grasp (with thumb, index and middle fingers together)
2. Key grasp (thumb resting on the side of the index finger)
3. Hook grasp (used to carry things e.g. books, suitcases)
4. Spherical grasp (for holding a ball)
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5. Cylindrical grasp (for holding a cylindrical object)9,80
The work reported on in this section of the thesis is to do with the software
platform for myoelectric robotic limb control called BioPatRec developed by Max
J. Ortiz-Catalan et al. at Chalmers University, and Integrum both in Sweden.81,82
The BioPatRec control system is designed for use with a variety of robotic wrists
and hands with 4 fingers and one thumb each, with the 10 pre-set movements
plus rest:
1. open hand
2. close hand
3. flex hand (move hand from wrist in direction of palm)
4. extend hand (move hand from wrist in direction of back of hand)
5. pronation (place palm down)
6. supination (place palm up)
7. side grip or hook grasp (e.g. for opening a fridge door/carrying suitcases)
8. fine grip (similar to pincher)
9. agree (thumb up, fingers bent in)
10. pointer (pointing with index finger)
11. rest (resting position of hand)
The average human hand weights about 500 g, so the challenge includes mak-
ing a hand that has enough actuators and possible movements and positions,
while weighing no more than 500 g, and fitting onto a person without looking
incongruous (e.g. too large). If the aim is to make a small enough prosthetic
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for anyone, the researchers should concentrate on the smallest arms and hands.83
Variety Village even produce prosthetic hands, wrists and arms for children of
different ages.84,85 In the past, for certain prosthetics, this was not possible for
anyone but adult males, due to the combined size of all the components.84 Gow et
al. decided to design their prostheses for the smallest and shortest people so that
everyone could have something tailored for them, by using a modular system.
Of course not all people with limb abnormalities have the same issues, there
will be those with partial loss of hands, some will need wrists, some elbows, and
some will need everything up to and including shoulders. Of course there need
to be available both left and right hands and arms. A robotic prosthetic system
needs to be customisable for each person.
According to Ajiboye et al. in86 surface electromyogram, or sEMG is the state-
of-the-art hardware for externally-powered transradial prostheses. A transradial
prosthesis is for the arm below the elbow. However, most of these are two site
devices with one DoF, and some have two DoF, but to use one component, the
other has to be switched off. To attain full multifunctional myoelectric control,
the system must allow all functions to operate simultaneously with other control
functions, and not inhibit them.
In86, Ajiboye et al. used 4 states of activity or input membership functions:
High, Medium, Low and Off. They used a threshold for the dividing line be-
tween rest state and any other state. This was set to the mean value recorded
from subjects when they were not attempting to move their arms. The mean for
performing some movement was called MED. The LOW and HIGH were chosen
to so that there was a 50 % overlap between two neighbour membership functions.
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To collect the signals, the intact limb test subjects underwent the following
movements: wrist extension, wrist flexion, ulnar deviation, and finger flexion re-
peated eight times.
The control algorithm used by Ajiboye et al. is a fuzzy logic method. The
system is made up of three elements: 1) the fuzzifying stage: numerical inputs are
converted to linguistic variables using input membership function; 2) a pattern
classification by processing linguistic inputs; 3) the defuzzifying stage outputs
a single number from the inference rule base linguistic outputs. The core part
of the fuzzy system is the inference rule base (IRB). This carries out the classi-
fication by pattern recognition of the MES signals, and works by studying the
relative amplitude of the EMG signals. The IRB is a set of IF (condition based
on signals present), THEN (outcome movement) statements. The rules can be
given differing weights depending on scenario likelihoods.
In the real-time tests the subject performed a movement, then returned their
arm to a fully rested state, as is standard with these prosthetic robotic limb tests.
Although, this system can recognise desired movements and transition between
them without returning to rest between them, which was also tested. Their real-
time results for all 7 movements achieved accuracies ranging from 94.79 % to
98.27 % for the 4 subjects tested. The seven movements were: off, wrist ex-
tension, wrist flexion, supination, pronation, ulnar deviation, and finger flexion.
Flexion is moving inwards (towards the palm), extension is moving outwards.
Supination is placing the palm up, while pronation is palm down. Ulnar devia-
tion or flexion is moving the wrist in the direction of the little finger.
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The system developed by Schwartz et al. was tested with PVA, (population
vector algorithm), optimal linear filters, maximum likelihood estimation, SOFMs,
and a recurrent neural network. With this system, control of the prosthesis was
performed by populations of single- and multi-unit motor cortex spiking activ-
ity. The real-time population vector is populated by the preferred directions of
the units in the population that is recorded, put into a vector sum. The sum is
weighted by the instantaneous firing rates of the units.
Schwartz et al. also tested optimal linear filters, which is essentially a sum
of firing rates for all cells going backwards in time; it makes use of temporal
information, unlike PVA. The maximum likelihood estimate is the movement di-
rection that maximises the probability of observing a particular firing rate of a
cell. Therefore, the discharge or firing rates of neurons determine the movement
desired.87
The recurrent neural networks output vector managed to cluster after several
iterations. The output vectors formed a clear peak, with one mode, in the region
of an output movement. The peak showed which direction is most likely. Gaus-
sian noise, from the input is removed by the nonlinear activation function in the
output.
Another thing that Schwartz et al. comment on is that correlation within
and between parameters has not been fully looked into with regard to decoding
algorithms. It is well documented that various parameters involved in movement
covary, this includes both intrinsic and extrinsic parameters of the arm.88–90
71
6.3.1 Time windows for MES
In pattern recognition of MES the recordings are usually divided into small sec-
tions called time windows, so that features can be extracted from them. If one
were to find the mean of a MES spectrum over the entire recording, the data
would be lost, one would get a flat signal. So the means of these time windows
are used, along with other features specific to the methodology used. These may
include zero-crossing rate, integral absolute value, variance, waveform length,
autoregressive coefficients, Fourier transform coefficients, linear cepstrum coef-
ficients and adaptive cepstrum vectors, and principle components from PCA.
Autoregressive models model stochastic processes by assuming that future values
can be predicted by past values91,92.
Cepstrum results from taking the inverse Fourier Transform of a logarithm
of the estimated spectrum. “Ceps” is “spec” backwards.76,93–95 Engelhart and
Hudgins in76 used a majority voting to post-process the decisions made by their
LDA classifier. For a decision point, the majority vote done for this sample was
voted on by: 1) the sample, 2) m samples before it, and 3) m samples after it
(2m+1). The winner is the class with the most occurrences in the (2m+1) voting
window. Voting has the effect of removing spurious decisions.
Using a long time window for analysis (e.g. 256 ms) means that classifications
or predictions will be more accurate, and there will be lower variance. However,
longer analysis windows require more processing time, threatening control lag on
the limb (time delay). If using a very short time window for analysis (e.g. 32 ms),
then the error for each windows decisions will be higher due to higher variance.
However, the number of decisions on the desired motion of the prosthetic limb
will be higher too, this means the motion can be corrected more quickly, and
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have more fine control. Also, the large number of votes makes averaging out the
errors easier.
6.3.2 Other ML and MES advice
Before they can be studied, the MES have to be gathered from people’s arm
muscles, this is usually done with electrodes. Historic systems attempted to use
a large number of MES recording channels (e.g. electrodes), but the computation
was too much for the systems to handle. Later systems have used feature extrac-
tion to maximise the ratio of possible movements to MES recording channels or
sites, for example Hudgins et al.96 in 1993.
Most algorithms require that various sources of variance be explicitly speci-
fied, as some optimal function is being modelled to the cell response. However,
the SOFM approach is partially immune to this failing due to the fact that it
clusters its output nodes based only on the similarities of its input patterns. PVA
also has some resistance here, due to its ability to deal with two parameters (or
maybe more) simultaneously: direction and speed of the arm.87
There are two nearly universal factors that determine the success of all the
algorithms; uniform parameter distribution and unimodal tuning functions. The
parameters here account for variance in the spike train. Clustering parameters in
a non-uniform way leads to more damaging noise. A unimodal tuning function
is useful because, even in Machine Learning techniques, where tuning functions
are likely to have many modes, this multimodal nature causes a decrease in the
likelihood of locating an obvious winner or BMU.
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6.4 Contribution to knowledge of the research reported
in this thesis
6.4.1 CD spectra fitting for protein structures
For this project the following has been developed: SSNN, a SOM artificial neural
network software methodology for protein secondary structure estimation from
circular dichroism spectroscopy, that compares well with methodologies that have
similar aims. The tests performed showed that SSNN, the author’s methodology,
has produced better estimates of structure than all competitors. When com-
pared based on individual structure types, SSNN performed better on most, and
on others equalled the best for that structure type.4,17,38
6.4.2 Concentration correction
To help ensure the structure predictions are accurate, and all given knowledge
is correct, SSNN was adapted for finding the correct concentrations of globular
proteins in solution. SSNN was tested by running multiple structure estimation
tests from CD spectra of proteins with unknown, unavailable structures. The
best spectral models showed the region of the most likely correct concentration
given as a number relative to the user-reported concentration. The best spectra
models were selected based on their NRMSD values. For this reason two versions
of SSNN were produced; one to run SSNN just once for structure estimation, and
another to search for the correct concentration and make structure estimates at
each concentration step.
For example, if there was a protein in a buffer at a reported concentration
of 0.1 mg/ml, and the CD spectrum was run through SSNN, the CD spectrum
would be multiplied by 0.1, 0.2, 0.3, etc. up to perhaps as high as 4.0. If the
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NRMSD of the model spectrum with respect to the original CD spectrum was
found to reduce between 1.0 and 2.0, then increase again, and the 2.0 was the
smallest point, then the original concentration would be believed to be half what
it was reported: 0.05 mg/ml. It would need multiplication up to twice the orig-
inal to become a spectrum that is most recognised by the SSNN methodology,
and therefore most likely to be realistic. Thus the conclusion that it is in fact
only half of the reported 0.1 mg/ml.
Each of these versions is also in two divisions: one to just test the structures
or concentrations of unknown proteins, and another to re-train SSNN with new
data sets. So this methodology can be applied to any dataset; the data size can
be changed and various training parameters can also be changed for optimisa-
tion. The team wanted to make this useful software application family available
to everyone, so all these above versions of SSNN were made downloadable by the
public on the Rodger Group97 website along with detailed guides on how to use
both. There are Windows- and Mac-compatible stand-alone MATLAB applica-
tions of these.
6.4.3 HASSANN for BioPatRec
Continuing the biomedical engineering vein from the insoles research, in the final
section of the PhD project SSNN was adapted for use as part of the BioPatRec
platform, so it became known as “HASSANN”.
BioPatRec is a modular software platform written in MATLAB, that takes
MES data, and uses them to enable people to control robotic prosthetic arms.98
To gather data for BioPatRec, electrodes were placed on the upper arms of up
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to 20 test subjects (different numbers for different tests), some with incomplete
arms, some with full, healthy arms. Four electrodes were used, producing four
channels of myoelectric spectra.
We used the BioPatRec TVA version of the platform. There are five stages
to using BioPatRec for control of robotic arms:
1. Data collection
2. Signal processing
3. Feature selection and extraction
4. Pattern recognition
5. Real-time control (movements are sequential)
Once the real-time sequential work is done, a later stage of the development
can be looked into: real-time simultaneous control, here a few movements can be
performed at once.
The BioPatRec development team have tested several other different pat-
tern recognition algorithms. For this PhD the author has developed and tested
HASSANN, or Hand Activation Signals SOM Artificial Neural Network, to com-
plement the BioPatRec research by other machine learning experts. Other al-
gorithms tested by the BioPatRec team include Regulatory Feedback Networks
(RFN), Linear Discriminant Analysis (LDA), and Multi-layer Perceptron (MLP).
BioPatRec is hosted online at http://code.google.com/p/biopatrec, where there
is also a wiki on its development and updates.
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HASSANN is derived from SSNN, Secondary Structure Neural Network. There
are 11 movement categories: 10 movements, and rest. A rest category is impor-
tant so that the limb only moves when the person controlling it desires it. It
needs to have a threshold level of electrical activity, as there is electrical activity
even when the controller does not intend to perform any tasks with the limb.76,98
6.5 Further work
6.5.1 Diabetes patient insoles and clustering academics for collabo-
rations
As SSNN/HASSANN can be applied to any dataset, to solve many different prob-
lems, we wanted to use it for problems we had. SSNN has also been applied to
such diverse goals as helping to select the most comfortable, least harmful insoles
for the shoes of diabetes sufferers, and suggesting collaborations between chem-
istry academics (both not shown). The work on selecting insoles for diabetes
sufferers was done for an Engineering masters student as a side-project to this
PhD, and the collaborations between academics study was done with the soon-
to-be-head of the Chemistry Department, Alison Rodger. Both side-projects are
unpublished work, although the insole selection work is reported on in the mas-
ters thesis of Okem Molokwu, supervised by Evor Hines, then of the University
of Warwick School of Engineering.
When people who have diabetes move into advanced stages of the disease they
may lose sensitivity in their extremities, such as their feet. This can cause them
to walk with gaits damaging to their feet. For this reason Molokwu’s masters re-
search focussed on looking for ways to select insoles that caused the least damage
to the patient’s feet.99 This was done by recording the forces present at many
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locations in the shoes of individual diabetes patients while they walked with dif-
ferent insoles, then applying machine learning or “intelligent systems” methods
to the data. SSNN was one of the methods used; it made some good predictions,
but could benefit from some optimisation.
For the clustering of Chemistry academics study, the SOM was trained on the
research collaborations of 20 professors, and tested on research collaborations of
the 24 non-professorial principal investigators in the department. The academics
were listed in alphabetical order and a 44x44 matrix created. Academics were
asked to indicate with whom they collaborated. In their row of the matrix each
collaboration was indicated by a 1, while a 0 denoted no collaboration. Intrigu-
ingly the matrix was not symmetric. The aim of this application was to identify
research clusters within a group of 44 academics. The main result was to make
it apparent that there was a network of collaborations among the group rather
than clear clusters. It was, however, possible to use the results to cluster the
individuals more effectively than had been possible from the raw input data of
collaboration vectors.
7 Introductions to publications
Here the work on SSNN, and later HASSANN, is expanded on, giving a feel for
the published, and to-be-published work that came out of this project.
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7.1 Paper 1: “Elucidating Protein Secondary Structure
with Circular Dichroism and a Neural Network” by
V. Hall, A. Nash, E. Hines, A. Rodger
The first paper is published in the Journal of Computational Chemistry and is
on the work of SSNN, Secondary Structure Neural Network. SSNN is introduced
as a SOM that clusters CD spectra of globular proteins and their corresponding
secondary structures in 6 different structure types: α−helix-regular, α−helix-
distorted, β−sheet-regular, β−sheet-distorted, turns, other.
Here SSNN is compared with SELCON3, K2d algorithmic methods for find-
ing protein secondary structures using CD data. There are 48 proteins used to
train SSNN here, the same exact spectra and structures that were used to train
algorithms on Dichroweb when the reference set 7 is selected.
SSNN is compared with SELCON3 in a LOOCV manner, so the algorithms
take on the names SELCON3-47 and SSNN-47 as they are repeatedly trained
with 47 spectra and structures. Here K2d is trained with 24 spectra, as we could
not find a re-trainable version of K2d, so a K2d-24 comparison was performed.
The structure NRMSDs are compared with 3 structure-types, as these are the
most that K2d can predict. Summed over all structure types, the NRMSD for
SSNN-47 come out best at 10.67, followed by SELCON3-47 with 11.05 then K2d
with 12.32. The best helix NRMSDs come from K2d, the best sheet and Other
NRMSDs from SSNN-47.
A study of which algorithm best predicts proteins that are rich in each struc-
ture type is also done. In this test SELCON3-47 is the best predictor for helical
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proteins, SSNN-47 for sheet-rich proteins, and also proteins rich in Other struc-
tures.
7.2 Paper 2: “Protein Secondary Structure Prediction
from Circular Dichroism Spectra Using a self-organising
Map with Concentration Correction” by V. Hall, M.
Sklepari, A. Rodger
This paper has been accepted by Chirality journal. Here we follow on from
the excellent structure prediction capabilities that SSNN achieved earlier in the
project, and succeed in making the methodology more robust.
A new tool is built to suggest corrections of reported concentrations for pro-
teins submitted to CD spectrophotometers. The concentration of a protein in
solution is of paramount importance for understanding its structure and there-
fore its function.43 points out that it is “absolutely essential to have precisely cor-
rect concentration measurements (not just estimates from colorimetric assays)...”
Greenfield says that least-squares analysis programs are the only options that can
be used to estimate concentrations of proteins in solution. This is one reason we
developed SSNN to perform concentration correction, now it is possible to get
good structure predictions when the concentration is not known accurately.
In this paper, we show how SSNN with concentration-correction has been used
to find the correct concentrations of lipoproteins and proteins. The motivation
for this is that when dealing with very small weights (micrograms µg) and vol-
umes (micro litres, µL), it is very difficult to accurately measure protein powders
and buffer, and other liquid volumes. For this reason, errors easily arise when
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making solutions of proteins to work with in the lab. This is done by multiplying
the original spectra by scaling factors, effectively scaling the concentrations then
submitting them to the test module of SSNN. The CD spectrum is multiplied by
numbers usually between 0.1 and 10, this produces spectra that match the spec-
tra SSNN was trained with to greater or smaller amounts. Matching to greater
amounts shows that those scaled spectra are closer to the real spectra that are
expected by SSNN, and so are more faithful representations of the actual nature
of the protein in question. This shows that their concentrations are more accu-
rate than that reported.We find that predictions of proteins with high random
coil and extremely high helical content can be improved, so add 5 spectra: 2
theoretical, extrapolated 100 % helical proteins, and 3 truly 100 % random coil
proteins. This takes the training set up to 53 spectra.
We study proteins from the laboratory that were previously abandoned due
to not knowing their correct structures. We study β-sheet polylysine; a set of
4 lipoproteins; ZapA WT and mutants; some toxins; and Sufl polypeptide in
various solvents. Best concentrations are found using NRMSDs plotted against
concentrations. With the concentration correction, we manage to obtain fairly
reliable structure predictions for all molecules looked at.
We also report in this paper that we made a GUI of SSNN, and uploaded it to
the Alison Rodger Group website for free academic use, and licensed commercial
use via Warwick Ventures.
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7.3 Paper 3: “SSNN, a method for neural network pro-
tein secondary structure fitting using circular dichro-
ism data” by V. Hall, A. Nash, A. Rodger
This paper has been published in Analytical Methods journal. Once SSNN be-
came available for download, and use by anyone for their data mining or machine
learning research, there needed to be somewhere users of the application could
get guidance on installing and running it for examples they could implement for
their own protein and CD work.
Here SSNN is compared with CDSSTR, by Curtis Johnson et al. as CDSSTR
is one of the best CD spectra modelling, and structure prediction methodologies,
and we needed to understand how useful SSNN would be in the structure fitting
field. Again, we found SSNN compared well, and had additional uses compared
with what is available in the field.
The guidelines on how to set-up and run two versions of the SSNN method-
ology are also included: “SSNNGUI” for quick use by anyone wanting structures
from CD spectra, and “SSNN1 2” for re-training the SOM with any data set.
These include the single run for structure determination, and the multiple run
SSNN for concentration correction. This software is given (with examples) for
Windows and Mac operating systems. The SSNN applications available online
are stand-alone MATLAB GUIs that do not require MATLAB to run, but come
with the Compiler Runtime from MATLAB.
Some more example tests of SSNN are done, with reasonable model spectra,
and generally good structure predictions resulting.
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When comparing with CDSSTR-47, and looking again at previous results for
SELCON3-47 and SSNN-47, we find that the additional 5 spectra with 100 %
single-structure-type proteins greatly improves the structure estimations given by
SSNN-52. SSNN-52 being SSNN trained and tested with 52 spectra in a LOOCV
method. SSNN with the expanded training set is now best algorithm overall, as
well as for each structure type, although it is joint best with CDSSTR-47 for ≥
30 % β−sheet proteins.
7.4 Paper 4: “Self organising map pattern recognition for
real-time prosthetic control: HASSANN” by V. Hall,
M. Ortiz-Catalan
This paper is in preparation. As the capabilities of SSNN grew, we wanted to see
how far it could be pushed to achieve more, so it was applied to something very
different from CD spectra and protein structures.
This final paper on SSNN’s applications, is on the adaptation of the SSNN
SOM to myoelectric signal processing for control of robotic arms and hands.
This version has the new name “HASSANN”, for Hand Activation Signals SOM
Artificial Neural Network. The paper briefly describes the BioPatRec software
platform that HASSANN is part of.
This paper shows results of oﬄine tests of HASSANN: performing pattern
recognition on the MES, and deciding which limb movement is required. An ex-
ample of the output is shown: a model spectrum is plotted with the myoelectric
signals and the residual, also the locations of the BMUs on the SOM.
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An RMSE of 0.0371 is obtained for the validation runs, validating the map
size, the initial learning rate, the number of BMUs, the neighbourhood size etc.
The NRMSE for the model shown is 0.00939, a very good value.
A confusion matrix figure shows how good HASSANN is at predicting move-
ments, and a value telling the same: 0.90 ± 0.08 mean accuracy over the 11
different movements. The range of accuracies is 0.692 to 1.00; this is the value
of the number of times HASSANN predicted the movement correctly out of all
trials with that movement.
The next work with HASSANN will be for Max Ortiz-Catalan et al. to test
the capabilities with sequential movements in real-time with people who have
incomplete arms, and also people with complete arms. That work will be followed
by using HASSANN to recognise diverse movements required simultaneously, so
that the limbs can be operated in as natural a motion as possible; sequential
movements are not natural, and do not allow much ease of use.
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8 Discussion and Conclusions
Every field of science, engineering, business and government produces vast amounts
of data these days. Practitioners of circular dichroism spectroscopy have the
problem of translating the CD spectra into structures of the molecules they are
studying. We set to making a code that could help by learning about CD spectra,
and the corresponding structures of proteins, and could become a type of software
CD expert that could be copied to anyone who needs more experience in getting
structure knowledge from the spectra. Having good knowledge of the structure
of a protein is a great help to understanding how it interacts with other proteins,
ligands, drugs, pathogens and nucleic acids. This needs to be done for a protein
whenever it is used in an experiment, as the molecule will react to every different
environment it is placed in. This helps with drug design and quality control.
SSNN, the self-organising map software that was developed for the project was
successful in estimating protein secondary structures; protein solution concentra-
tions; and recognising patterns in myoelectric signals, as part of the BioPatRec
software platform developed by Max J. Ortiz-Catalan et al., to control robotic
arms. For the MES application, the SSNN-derived algorithm took on the name
HASSANN.
The SOM architecture is a neural network developed by Teuvo Kohonen in
1982, it has an input layer, and a very large output layer. This output layer is
where all the models for the input vectors are clustered, there are no obvious
class devisions, rather they have fuzzy boundaries.
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8.1 SSNN: CD spectra to structure prediction
SSNN stands for secondary structure neural network, as it takes CD spectroscopy
data in the ultraviolet range (240-190 nm), and clusters it to produce estimations
of secondary structures of globular proteins and lipoproteins. The fuzzy bound-
aries from SOM are appropriate, as most proteins and other chiral molecules do
not fit into one category, but have varying amounts of each structure type. The
exceptions are molecules that are 100 % one structure, or example 100 % random
coil.
The dataset that SSNN has been trained with is only 57 by 53 elements, that
is light intensity values at 51 wavelengths plus 6 structure types, and 53 CD
spectra. Despite the small size of the dataset, this still represents 57 dimensional
data, which of course cannot be visualised or understood by a human brain. This
is why a neural network approach must be employed.
ML techniques make it easy to cluster the data, and see how spectra are re-
lated. Some other teams made neural networks for CD data, so we thought we
could go further, and make better spectral models, and structure predictions.
Compared with others we used a longer wavelength range than some to get the
short-wavelength electronic transition information, we gave our SOM a larger
training set, with more coverage of the data space, and more structure types (6)
than some. We used a larger map to house this greater range of spectra and
conformations. We used more BMUs to construct the models than most research
groups in the field of making algorithms for predicting protein secondary struc-
ture from CD spectra. We gave a figure of where the BMUs were taken from on
the map, and a read-out of which spectra these were. Further, we allowed for
concentration errors.
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A wavelength range of 240-190 nm was chosen, as it is a widely used range,
and due to the electronic transitions being in that region, and shorter wave-
lengths, but not longer. So there did not appear to be any good arguments for
including lower-energy data (wavelengths > 240 nm), as there are only aromatic
group transitions in that range, which we are not interested in.
The reason we did not use wavelengths shorter than 190 nm was the difficulty
of getting reliable data in that realm without using the rare and expensive syn-
chrotron light sources that are sometimes used for this work (SRCD), where it
is possible to get reliable data at least as far as 160 nm.71 Because most prac-
titioners of CD, in the laboratories where they work regularly, cannot get short
wavelengths for their spectra, we concentrated on the 240-190 nm range.
In Papers 1-3 (in subsections 7.1, 7.2, 7.3), and in the Introduction (section
6) we compared SSNN with similar CD-to-structure methodologies: SELCON3,
CDSSTR, K2d, SOMCD. Some of these are statistical programs, and others are
neural networks.
In Paper 3 we highlighted which methodologies would best be used for which
structure types; SSNN-47 was one of the best, and SSNN-52 was better than that.
SSNN may be good, but it is still advisable to use at least a few methodologies
for each CD spectrum to see where they agree, and where certain methods are
poor or good predictors of particular structures compared with others. This gives
a more statistically sound, and reliable estimation of one’s protein or lipoprotein
structures.
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SSNN was also used to correct the concentrations of proteins in solution. This
was done by running SSNN repeatedly, scaling the input spectrum with different
factors, these factors being what the concentration is relative to the original input
spectrum’s concentration. So an input spectrum with a reported concentration
of 0.1 mg/ml is scaled by 10, and if that turns out to be the correct concentration
(smallest NRMSD of all concentrations), then the actual concentration was orig-
inally 0.01 mg/ml. The correction is rarely this extreme, it is much more likely
to be in the 0.5 to 2.0 range.
Results show that this approach works well, the spectra obtained are very
good (Paper 2). The user needs to look carefully at the region with the lowest
NRMSD values for the spectrum, it should not be an isolated low point, it should
be in the middle of a large depression in NRMSD. If there is a reasonably good
model in the 1.0 region, this should be looked at with less scepticism than those
far from 1.0, where 1.0 is the original experimental spectrum from the user.
Also, the short wavelength region of the spectrum is more important for de-
termining secondary structures, due to the locations of the electronic transitions.
If two spectral models are competing for best, then the spectrum with a more ac-
curate short-wavelength region should be trusted more. Closest attention should
be paid to the locations of the electronic transitions that lead to the peaks and
troughs in the CD spectrum: does this model predict them well?
Making a SOM give better predictions?
To get a more realistic SOM representation of the data space, one might trial
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different map shapes. One approach is to use a SOM that loops around to form a
toroidal (doughnut) or spherical shape. We did not attempt this with CD data,
but it would probably not have worked well, as the edge structures of proteins
in the CD work are extremes, not cyclic, and the edge spectra are not cyclic
either. We also did not do this for MES. It is not immediately clear whether the
spectra or features for the MES data are cyclic, but the movements are not cyclic.
Where to get the SSNN SOM
SSNN is available on the group website for Windows or Mac, SSNNGUI for
pre-trained SSNN with CD spectra from globular proteins, or SSNN1 2 for re-
training the SOM with any data set. Instructions on how to use these stand-alone
applications are also given, and the software can be licensed by commercial users,
or downloaded for free by academics. SSNN is on the A. Rodger Group website
here: http : //bit.ly/1p9vbUK.
8.1.1 SSNN further work
The more reference or training set data that a ML technique has, the better it
can be trained to recognise patterns in said data. Of course one must not fall into
the trap of over fitting, as touched on in the Introduction, section 6. SSNN-52
made better structure estimates than SSNN-47 did (the final version available on
the website has 53 spectra).
The aim must be to increase the reference set for SSNN. Indeed, this could be
done if all publicly available CD spectra and protein structures were labelled in
the same way. There is no widely-recognised gold standard for secondary struc-
tures. A very worthwhile task would be to learn all of the labelling methods,
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and then translate the disparate protein structures into one large database. This
should enable SSNN and other ML techniques to produce better structure esti-
mations. The secondary structure remarks in the PDB are generated by DSSP.
The results are up to interpretation by the person using them: one may decide
that residues are slightly different lengths from that suggested by DSSP, so there
is no definite ruling.100
We would like to train SSNN with transmembrane CD spectra and structures.
This would enable its use for such proteins, as they cannot be studied using
SSNN trained with globular protein spectra, as it currently is. These structures
and spectra are too dissimilar for even reasonable structure estimations or spec-
tral models to be made using the other’s reference or training set.
For the application to become adopted by more people we consider it advis-
able to make a Linux-compatible SSNN available online, perhaps even with a few
different Linux OSs, especially as a lot of scientific computing is done in Linux
environments these days.
An idea for a great tool would be to gather spectroscopic data from vari-
ous different spectroscopic sources, such as CD, Raman spectroscopy, ROA (Ra-
man Optical Activity), IR (infrared radiation spectroscopy), and put them all
together in a SOM application. There are some techniques that already look
at Surface Enhanced Raman Spectroscopy (SERS), IR spectroscopy, and FT-IR
data:101–105. These techniques use evolutionary algorithms, genetic programming,
random forests, and artificial neural networks.
The aim being to have the ability to test a protein with different techniques,
to get different views of the same system, comparing the results. This is a similar
idea to combining the results from different CD-to-secondary-structure method-
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ologies, as discussed above, but with a much wider information base, and with
more applications. Of course, using a transmembrane protein database for CD
spectra and structures from PDB files (or from some other method like NMR or
X-ray crystallography) with the IR, Raman, ROA data source would be appro-
priate and sensible.
Maybe the application would have one SOM trained with data from all spec-
troscopies, or likely it would need to possess multiple SOMs one for each structure-
determining technique. Perhaps the best approach would be to use various ML
techniques, one for each spectroscopic technique, then combine them in one soft-
ware application.
The concept of having such an intelligent piece of software is exciting; it could
be applied to many other fields of research that produce lots of data that need to
be interpreted. So many new insights could be gained by looking at essentially
the same data from various points of view.
It would be interesting to try other ML techniques for CD spectra training,
other than SOM. If there had been more time available, this would be a likely
subject to explore. The literature seems to show that more complex ML algo-
rithms are producing more accurate predictions. For example: Jianhua Yang’s
thesis.106
The literature shows that the best way to arrange the algorithms for these
more complex forms that produce better results is to use one machine learning
technique on the lowest-level of data, and apply its findings to another ML algo-
rithm, repeating this for N levels, each time learning more high-level information.
This is called (hierarchical) deep learning.107
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In his thesis Yang106 1) used a GA to evolve the best inputs for a neural net-
work, then 2) used the NN to form models for classification or prediction, then
there was a round of mathematical programming that was used to find regression
rules. Jianhua Yang is a PhD graduate of the School of Engineering at the Uni-
versity of Warwick. Independent Component Analysis was also used with the NN.
There is some evidence that the human brain learns to arrange information
in a hierarchical manner; the nth level of the system extracts a bit of informa-
tion, then passes the rest of the information, and its own findings on to the next
level up.108 The first level might recognise a short horizontal line, the next might
gather information from the outputs from the first level and realise it is looking
at a letter “E”. The next level sees the letters “England”, and realises that is a
word, higher levels realise this is a country on an island, part of the continent of
Europe. Eventually some level might think that there are a lot of literary works
produced from this country in the eponymous language.109
Applying this approach to CD spectra work would probably proceed like this:
a PCA methodology could be used to feed the principal components to a SOM,
which then does the protein conformation estimation more easily.
Or a SOM could be used to find the clustering and structure results, then one
could use a genetic algorithm (GA) to evolve SOMs with different parameters
like map size and learning rate.
Another approach would be to train various different ML algorithms, of dif-
ferent types with the CD and conformation spectra and knowledge, and combine
them in an application to compare the results, then try to understand what char-
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acteristics that lead to those conformation findings with higher accuracies. So
these ML techniques would all be on the same level of abstraction, they would
take in the same data.
However, it is not clear that CD spectra are this difficult to learn: the data are
not that expansive, and many structures are known. (Well, perhaps the technique
would be useful if there is the additional problem of having protein structures
annotated differently with the diverse structure labelling methods). This would
better be applied to data mining a vast quantity of unlabelled data that also does
not demand low latency.
The aim of a machine learning technique is always to find the best solution,
or the solution with the lowest error, or highest correlation coefficient. It stands
to reason that a truly clever learning algorithm would expend lots of comput-
ing resources to explore an apparent global minimum in error or energy usage
(much like all other ML techniques), but also keep feelers out in the rest of the
data space, giving a small amount of computing time (per square solution space,
if you excuse the 2 dimensional analogy) to search in case lower minima are found.
This seems like a strategy that would hedge bets very well, while still finding
all of the local minima as the pattern recognition progresses. This way it would be
making little successes along the way, but would still end up finding the global
best solution. Of course, at the beginning, an acceptable size for the solution
space to be explored would have to be decided, so too much computational time
is not used.
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8.2 HASSANN: myoelectric data for limb movement
HASSANN stands for Hand Activation Signals SOM Artificial Neural Network; it
takes pre-processed myoelectric data recorded using electrodes on people’s arms.
This is very high-dimensional data, so the pre-processing to extract signal fea-
tures is very important, as it makes the classification much more accurate, and
reduces processing time greatly. The pre-processing is done by the earlier stages
of BioPatRec. HASSANN is introduced in Paper 4, in subsection 7.4 or refer-
ence9.
The MES (myoelectric signal) data is 36,000 by 4 by 10; 36,000 dimensions is
too much to cluster with a SOM. In MATLAB on a laptop it would take weeks
to get results, given that the SSNN work took about 20 minutes to run the 57
by 53 element data. The raw MES signal data is 476.66 times the size of the CD
data, so running on the same Mac with the same SOM parameters, it would take
at least 159 hours, 9 short of a week. That is just for one patient of 20. The
program would be comparing very long spectra as well, which would greatly slow
many stages of the program training validation, and testing.
There were at least three databases in the BioPatRec repository, previously
gathered by the BioPatRec team, the one HASSANN was trained on was 10
movements (besides “rest”), 4 electrode channels, 20 patients, all able-bodied.
Other databases use 6 movements and 8 channels, some have simultaneous move-
ments. The work reported on in98 was approved by the Swedish Regional Ethics
Committee in Gothenburg (626-10, T688-12).
It has been suggested that batch training a SOM is faster than using stochas-
tic individual training, and has a higher chance of convergence, but we did not
find it necessary with SSNN or HASSANN, the stochastic individual selection
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for many thousands of iterations produced maps that made good estimations or
predictions. SSNN needed 28,000 iterations, HASSANN only 5,000, but with a
slightly higher initial learning rate, L0: SSNN: L0 = 0.06, HASSANN: L0= 0.1.
The results of this work came without much optimisation, it worked well early on.
The error of SSNN now that it is trained with 53 spectra is very good, better
than any methodology it was compared with, and the accuracy of HASSANN’s
movement recognition is also very high.
The confusion matrix (Figure 13) in the regions not on the diagonal is entirely
the first three shades of blue.9 This shows that movements were recognised incor-
rectly between 0 and about 0.2 of the time. The worst movement for recognition
being movement 3, flex hand with an accuracy of 0.692.
Further work on the methods used to gather the MES data, and how many
channels should be used is needed. The team have experimented with 4 or 8
channels. Historically, researchers have found that using too many channels can
just lead to confusion with regard to the software, and too much pressure on the
computing hardware. However, with this use of pattern recognition software, fea-
ture extraction that greatly reduces the difficulty of the problem, coupled with
hierarchical deep learning, and ever increasing processing power, the issues of
many channels, should they prove helpful, should become less and less daunting.
The feature extraction employed by BioPatRec is not the same as the deep
learning mentioned in section 8.1.1 on further work with SSNN. Feature extrac-
tion of BioPatRec is more manually coded than that. The programmer decides
what features are extracted, rather than some genetic algorithm, PCA or neural
network. Some features used are: how many times the signal crosses zero, the
95
Figure 13: The confusion matrix of HASSANN, reproduced from Paper 4, reference9.
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absolute mean values of the time windows (small divisions), median, variance,
standard deviation, the peaks, the mean velocity, the slope changes. These can
be found on the BioPatRec website: https://code.google.com/p/biopatrec/
wiki/SigFeatures.
8.2.1 HASSANN further work
Future work for the HASSANN application would be to test it in real-time, and
then to train and test it for simultaneous movements. Perhaps it could be trained
with data from all of the patients, once the data set has been divided into train-
ing, validation, and test sets, as it was divided for the work in Paper 4.
The aim for BioPatRec is to use it as a platform to compare and improve
pattern recognition software for limb control. The hardware is not the focus of
the work, as there are various companies and groups working successfully on the
hardware side of things. The software is the most difficult component right now,
and the industry needs the complexity and accuracy of the software to grow in
the coming years to make more capable and easy-to-use prosthetic limbs.
Ultimately, of course, the systems that use the BioPatRec and HASSANN
software should perform natural movements with no delay and great reliability.
Therefore, any work towards improving prediction accuracy, comfort, speed and
or simultaneous actions would be advantageous.
8.3 Final summary
The software reported on in this thesis has been applied to diverse datasets, and
has returned very competitive results in the circular dichroism-to-secondary struc-
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ture estimation field; providing the correct concentrations of protein solutions;
and pattern recognition of myoelectric signals for control of robotic prosthetic
limbs.
The SSNN neural network application that is freely available, could be applied
to any dataset: labelled or unlabelled for supervised learning or unsupervised
data mining in data dimensions that cannot be understood by a human brain. As
any Machine Learning methodology should, SSNN produces very concise results
that condense the pattern recognition findings, while allowing the user to see the
big picture of how the data elements are related to each other.
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Elucidating Protein Secondary Structure with Circular
Dichroism and a Neural Network
Vincent Hall,[a,b,c] Anthony Nash,[a,d] Evor Hines,[c] and Alison Rodger*[b,e]
Circular dichroism spectroscopy is a quick method for deter-
mining the average secondary structures of proteins, probing
their interactions with their environment, and aiding drug dis-
covery. This article describes the development of a self-
organising map structure-fitting methodology named second-
ary structure neural network (SSNN) to aid this process and
reduce the level of expertise required. SSNN uses a database
of spectra from proteins with known X-ray structures; predic-
tion of structures for new proteins is then possible. It has
been designed as 3 units: SSNN1 takes spectra for known pro-
teins, clusters them into a map, and SSNN2 creates a matching
structure map. SSNN3 places unknown spectra on the map
and gives them structure vectors. SSNN3 output illustrates the
process and results obtained. We detail the strengths and
weaknesses of SSNN and compare it with widely accepted
structure fitting programs. Current input format is DE per
amino acid residue from 240 to 190 nm in 1 nm steps for the
known and unknown proteins and a vector summarizing the
secondary structure elements of the known proteins. The for-
mat is readily modified to include input data with, for exam-
ple, extended wavelength ranges or different assignment of
secondary structures. SSNN can be used either pretrained with
a reference set from the CDPro web site (direct application of
SSNN3, with the provided output from SSNN1 and SSNN2) or
all three modules can be used as required. SSNN3 is available
trained (with the reference set of the 48-spectra set used in
this work complemented by five additional spectra) at http://
www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/
arodgergroup/research_intro/instrumentation/ssnn/. VC 2013
Wiley Periodicals, Inc.
DOI: 10.1002/jcc.23456
Introduction
The function of proteins and their interactions with other mol-
ecules is completely dependent on their structures. One aspect
of this is the local secondary structural motifs formed by
neighbouring amino acids in a protein. Circular dichroism (CD)
spectroscopy is perhaps the simplest technique that is used to
estimate the average secondary structure of a protein. CD is
useful, for example, in determining how new drugs interact
with biomolecules, for example,[1] and how chiral molecules
react to different temperatures, for example,[2] and pHs; for
example,[3] it can also be used to find reaction rates, for exam-
ple,[4] and long-term stabilities (shelf lives) of proteins for
example,[5] Estimating secondary structures of proteins using
CD requires an expert, and a range of programs have been
developed to aid this process as discussed later.
The ability of CD to distinguish changes in protein confor-
mation arises from its dependence on how electronic transi-
tions in the polypeptide backbone of a protein, including the
peptide bonds, give different absorption spectra for left- and
right-circularly polarized UV light. The absorption spectra also
vary depending on the protein’s conformation. The CD signal,
DA, is the difference between the absorbances of left- and
right-circularly polarized light:
DA5AL–AR (1)
where AL and AR are absorbances of the left- and right-
circularly polarized light, respectively. To express CD in terms
of DE, the parameter used in the plots in this article, the Beer-
Lambert Law is used:
DA5DEcl (2)
where c is the concentration of the sample, and l is the path
length.[1] DE is the difference between the extinction coeffi-
cients for left- and right-circularly polarized light:
DE5EL2ER (3)
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One of the issues for protein CD spectroscopy is to decide
what units to use for DE. The most common choice is to use
units of molar concentration of amino acids (or amide bonds),
in other words the molar concentration of protein times the
number of amino acids. This then avoids situations such as
dimeric proteins having twice the DE measured for the equiva-
lent monomer concentration.
Protein secondary structures are fairly well defined due to
the rigid nature of the peptide bond and the free rotation
about bonds either side of it. A consequence of this is that
the CD spectra can be expressed as a weighted sum of the
spectra corresponding to different structural motifs. Deconvo-
lution of spectra can, at least in principle, be used to deter-
mine the different proportions of secondary structure motifs
present in the protein. For example, an a-helix is character-
ized by a large positive band at 190 nm (part of the p!p*
exciton couplet), and two smaller negative bands at 208 nm
(the other p!p*component) and 222 nm (n!p*). b-sheets
give different signals from a-helices and vary from protein to
protein presumably dependent on orientation (parallel/anti-
parallel), the relative size of the sheet, its three-dimensional
twist. There are, however, approximate b-sheet signatures: a
positive peak between 195 and 202 nm, and a negative sig-
nal between 215 and 220 nm. b-turns have a large negative
band at 180–190 nm, a positive signal in the 200–205 nm
range (p!p*), and a negative signal at 225 nm (n!p*). The
structure often referred to as “random coil” has a negative
signal at 200 nm, which is very similar to both the spectrum
of a class of b-sheet proteins and poly-proline II spectra.[6] It
is now widely accepted that this 200-nm negative band is
dominated by contributions from residues with poly (Pro) II-
type conformations.[7] CD data are easy to gather, require
minimal sample preparation, and the amount of protein
required typically required is 10 mg, although it can be as low
as 0.3 mg,[8] but the interpretation of the spectra can be chal-
lenging, and to quantify the proportions of different struc-
tures with any level of accuracy is not possible without
carefully designed software.
A number of secondary structure analysis programs exist,
for example.[9–12] It is possible to make use of some of these
on Dichroweb, an online server hosted at Birkbeck, University
of London.[13] Here, researchers may upload CD spectra and
receive secondary structure analyses. Most fitting programs are
based on patterns of CD spectra from known proteins of
known secondary structure. Most of the available programs
use either statistical methods or intelligent systems. The com-
monly used statistical methods which are available on Dichro-
web include: CONTIN which is a ridge regression technique;
CDSSTR (an update of “VARSLC”) which is a variable selection,
or feature selection method; and SELCON (now SELCON3)
which is a self-consistent method together with a singular
value decomposition algorithm. Dichroweb includes one intel-
ligent system approach, called K2d,[12] which is a self organiz-
ing map (SOM) neural network approach. SOMs are also called
self organizing feature maps or Kohonen maps after the inven-
tor of SOMs, Teuvo Kohonen.[14] Kohonen invented the SOM in
1982, and the K2d code was developed by Andrade et al. in
1993. Although the intelligent systems approach appears to
have many advantages, K2d has not gained widespread accep-
tance in the CD community, perhaps because it originally lim-
ited its wavelength range to between 240 and 200 nm and
considered only three secondary structure motifs: a-helix, b-
sheet, and “random coil” (or “other”). K2d has been revised
subsequently to K2D3,[15,16] by generating additional theoreti-
cal reference spectra using Dichrocalc.[17] The performance of
K2D3 does not seem to provide any significant improvement
over K2d. SOMCD,[18] whose authors include members of the
original K2d team, adds turns as a structural category, expands
the wavelength range down to 190 nm, and enhances the ref-
erence set used to train the SOM. It is available only as a pre-
trained SOM.
The motivation for this work was that the SOM approaches
seem to have attractive features, but with what was available
in the public domain it was possible neither to test them rig-
orously nor to develop them further by, for example, adding
new members of the reference set. We, therefore, developed a
new CD structure fitting SOM: secondary structure neural net-
work (SSNN) based on concepts similar to those of K2d.[12] It is
not possible to compare the details of SSNN to K2d and its
successors as these details are not available in the literature. In
summary, SSNN has three independent pieces of code that
operate in sequence.
i. SSNN1: this module takes spectra for a set of proteins of
known secondary structure content (the reference set)
and trains (organizes) them so that related spectra are
put near each other on the map. The map has many
more nodes to put spectra in than there are spectra, so
the gaps are filled-in with intermediate, virtual spectra.
Hence the title self-organizing map.
ii. SSNN2: using vectors of the secondary structure con-
tents of the reference proteins, and the same weighting
for the virtual nodes as used for the spectra, protein sec-
ondary structures are allocated to all nodes on the SOM,
thus constructing the structures map.
iii. SSNN3: a CD spectrum of an unknown protein is input,
and the output is an estimate of its secondary structure
and a model spectrum.
SSNN1 and SSNN2 need only be performed once for a given
reference set.
The aim of this work was to develop a SOM to predict pro-
tein secondary structure from CD spectra using any chosen
wavelength range and any chosen basis set of spectra with
associated secondary structure compositions. Various ele-
ments of the SOM were modified in an attempt to improve
its performance: map size, number of training iterations, the
learning rule, neighbourhood size, wavelength range, and the
number of best matching units (BMUs). The work includes an
extensive analysis of how SSNN compares to existing CD-to-
secondary-structure programs including the widely used sta-
tistical program SELCON3 and also K2d to determine if
the SOM approach has any advantages over statistical
approaches.
FULL PAPER WWW.C-CHEM.ORG
Journal of Computational Chemistry 2013, DOI: 10.1002/jcc.23456 WWW.CHEMISTRYVIEWS.COM
Methods
Reference data set
The reference data set used to train SSNN was taken from
the CDPro website: http://lamar.colostate.edu/!sreeram/
CDPro/. This reference set has been developed by various
researchers, and compiled by CDPro and denoted CDDATA.48.
The data are the same data as is used on Dichroweb: http://
dichroweb.cryst.bbk.ac.uk/html/home.shtml as Reference set 7.[6]
The spectra are given in per residue molar absorbance units
(DE5mol21 dm3 cm21). This is the largest available reference
set that has been consistently annotated with secondary struc-
tures. Figure 1 shows an overlay plot of the members of
CDDATA.48 showing how it covers the spectra space. The input
reference set has 48 proteins with 57 numbers each. In order
they are: 51 for the spectrum, and six for the structure values in
the order: (a-helix regular, a-helix distorted, b-sheet regular, b-
sheet distorted, turns, and other structures). The CDPro website
and its references explain the structure types which are summar-
ized.[19] In the reference set there is nonuniform representation
of the structure space, for example, the data set contains more
a-helix-rich proteins than other structures. The view might be
that this would lead to overfitting the SOM for a-helix-rich pro-
teins. However, this is not the case as the proteins in the data
set are unrelated. Some of them have similar secondary structure
percentages but different sequences, folds, and arrangement of
the secondary structure. None of the spectra are identical. Some
will, for example, have 35% a-helix, but that could be in one
large helix, or in three helices that make up 35% of the protein,
or a variety of other arrangements. The CD spectra of these are
therefore different.
Although the proteins in CDDATA.48 are soluble globular
proteins and we only use the data from 240 to 190 nm, SSNN
is not limited in this way. SOMs and neural networks in gen-
eral are applied to many diverse fields and databases, so we
expect SSNN would cope with different reference sets for dif-
ferent classes of proteins. The most important feature of any
reference set used with SSNN (or any fitting program) is that
all the spectra in a reference set must have their secondary
structure vectors determined by the same methodology. In
this work, we have shown that CD data over the wavelength
range 190–240 nm can give reliable results if a large reference
set is used,[19] so we do not anticipate problems from this
wavelength range.
In the leave-one-out tests reported in this article, each spec-
trum in the reference set was removed in turn and used as
Figure 1. Plot of spectra in the CDDATA.48 reference set.[19]
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the test spectrum. SELCON3 or SSNN1 and SSNN2 was/were
run with the resulting 47-member reference set.
Outline of a SOM and SSNN1
A SOM is usually an array, a square, or hexagonal lattice of
“nodes,” that in some way represents the input data. SSNN1 cre-
ates a square SOM from the input CD reference set. Map sizes
are named by the length of one side of the square grid, for
example, a map size of 40 has 40 3 40 nodes5 1600 nodes.
Each node holds a vector of numbers, called a weight vector.
The initial SOM has vectors of N random numbers between zero
and one at each node, where N is the number of data points in
a CD spectrum (in this work 1 datum per nm, so data from 240
to 190 nm is a 51 component vector). The way the SOM is
trained is to adjust the weight vector at each node to minimize
its distance from each input vector considered in turn. This pro-
cess changes the weight vectors in a way similar to clustering.
In the end, the weight vectors come to mimic the reference set
vectors, with the input vectors with vectors that are similar close
to each other, and dissimilar ones far apart. Specifically, at each
iteration of the training process, one of the input reference set
protein spectra is compared to each of the weight vectors to
find the most similar weight vector for that spectrum; this is
done by calculating a Euclidean distance between each input
vector and each nodal vector. The weight vector or “node” with
the smallest Euclidean distance from a given input vector from
the reference set is given the name “best matching unit,” or
BMU*. Next a neighborhood of that BMU* is defined. Initially the
neighborhood nodes will be random vectors with similar x and
y coordinates in the weight map (spectra map). After the weight
map has been trained, the neighborhood nodes will contain
spectra very similar to that of the BMU* at the center of the
neighborhood. At each step, each weight vector of this neigh-
borhood is brought a little closer to the BMU* by a factor of L, a
distance-dependent learning rate, in our case
Learning tð Þ5L0e 2k1tð Þ (4)
where L0 is the initial learning rate, t is the iteration number,
and k1 is a measure of how fast the learning rate decreases.
The neighborhood radius changes at each iteration using an
equation; SSNN’s is
r tð Þ5 r021ð Þ 12
t
t1
! "
if t $ t1
1 if t > t1
8><>: (5)
where r is the radius, r0 is the initial radius, usually half the
size of the map, t1 is the point when the radius of the neigh-
borhood reaches one, it then stays at one until the end of
training. The further away a neighboring weight vector is, the
less influence and BMU* will have. This is repeated for a num-
ber of iterations, usually thousands.
Characteristics of SSNN1
The SSNN SOM is thus a square lattice of nodes each contain-
ing 51 points that are the CD spectra—one point for each
wavelength in the range 240–190 nm. SSNN1 was run for
28,000 training iterations. For SSNN, t1 was set to 7000 itera-
tions, k1 was 5 3 10
26, r0, the initial radius, was set to 20, for
a map size of 40 (length of one side). The vectors that are not
the BMU*s of real protein spectra, are virtual protein spectra
derived as interpolations between the real protein spectra.
The structures map: SSNN2
SSNN1 completes the construction (training) of the SOM, but
SSNN includes another step: the assigning of structures step,
which involves the creation of a second map, the structures
map, and forms the module SSNN2. This is done by con-
structing another map of 40 3 40 nodes. Each node contains
a vector of the fractions of each secondary structure corre-
sponding to its spectral vector. Our reference set of spectra
has six secondary structure elements assigned to each pro-
tein, but the structure vectors in the structures map have
seven numbers. The first six numbers are assigned values cor-
responding to the fraction of each structure type in the pro-
tein (e.g., if 40 amino acids are assigned as a-helices (of the
“regular” category) in a 100 amino acid protein, the first entry
of that vector will be 0.40). The seventh number is to say
whether it is a BMU* of (i.e., essentially the same as) a real
protein spectrum; the number of these will match the refer-
ence set size. To add structure vectors of the reference set
proteins to the SSNN2 map, we start by locating the BMU*
for each of the protein spectra in the input reference set on
the SSNN1 spectra map. The corresponding nodes in the
SSNN2 map are given the structure values for each reference
set protein. The other nodes in the map are given structure
values by calculating the Euclidean distances between the
spectrum of the node and the BMU*s in the SSNN1 map then
giving them a structure vector as a weighted sum of a num-
ber of nearest BMU* structure vectors with the weighting
being the inverse of the distances
Si5
X5
n51
Bin
1
dn
! "
(6)
where 1 $ i $ 6, Si is the structure vector component for
structure type i, Bin is the ith component of the structure vec-
tor for the nth BMU*, dn is the Euclidean distance from the
input spectrum to the nth BMU*. For the 48-spectrum refer-
ence set, n is optimized at five as discussed in the results and
discussion section.
Making the predictions: SSNN3
Once the SOM has a spectra map (from SSNN1) and a struc-
tures map (from SSNN2), it can be used to assign secondary
structure estimates of proteins with known CD spectra, but
unknown structure. SSNN3 locates where the protein with
unknown structure would lie on the SSNN1 map, and gives
it a structure assignment based on a weighted sum of the
structure vectors of the five closest nodes (its BMUs) in the
same way as structures are assigned to nodes in SSNN2.
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An example of the output from SSNN is illustrated in Figure
2. It includes
a. SSNN1: a 3D surface plot of the spectra map at a chosen
wavelength (currently set to 222 nm)
b. SSNN2: a similar plot of the structures map for one struc-
ture type (currently set to a-helix regular)
c. SSNN3: the positions of the 5 BMUs on the maps in (a)
and (b), along with the positions of the reference set
proteins
d. SSNN3: an overlay of the unknown and model spectrum
together with the difference between them and the
spectral normalized root mean square deviation (NRMSD)
defined in this work (but not in Dichroweb)[6] as
e.
NRMSD5
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiX
i
xi;experiment2xi;model
$ %2
N
0B@
1CA
vuuuut
M2m
(7)
where xi is the value at each wavelength, N is the number of
data points, M is the largest intensity, and m is the smallest, so
M–m is the range. (The structural NMRSD is defined in the
same way—but can only be calculated when we know what
the “answer” should be.) In addition to this output, there is a
text file with the structure vector.
Figure 2. Example of SSNN output, in this case for alcohol dehydrogenase (protein 2 in the reference set, using a reference set with alcohol dehydrogenase
excluded): (a) SSNN1: the spectra map at 222 nm (red is high intensity, blue is low); (b) SSNN2: the structures map for a-helix regular (red is high intensity,
blue is low); (c) SSNN3: the locations of the BMUs of the unknown protein; (d) SSNN3: the model spectrum (blue dashed line) overlaid on the unknown
input spectrum (solid black), with the residual (red dashed line) and the spectral NRMSD. Parameters: number of iterations5 28,000, map size5 40 3 40,
initial neighborhood size5 20, L05 0.1, t15 7,000, k15 5 3 10
26, SSNN2 BMUs5 5, SSNN3 BMUs5 5.
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Testing SSNN
The first stage of testing SSNN involved training SSNN1 with
47 of the 48 reference set proteins, and testing its perform-
ance on that missing protein. This was repeated for each of
the 48 proteins in the reference set (thus retraining the SOM
each time), and is called the leave-one-out method or leave-
one-out cross-validation (LOOCV). LOOCV is a kind of k-fold
cross-validation (this k refers to the size of reference set), and
has been found to be nearly unbiased in its estimate of the
true generalization ability of the model being evaluated.[20] All
tests were run with a wavelength range of 240–190 nm,
except for the wavelength range test. In the final version,
SSNN1 was trained for 28,000 iterations, which we found
ensured convergence. Convergence was measured by the dis-
tortion, which is a sum of all the distances from each reference
set spectrum to its BMU, becoming constant. This is a standard
test for the performance of a SOM (data not shown).
Results and Discussion
SSNN modules
SSNN1 the SOM-training module, SSNN2, the structure assign-
ment module, and SSNN3, were written in MATLAB. SSNN3 is
available trained (with a reference set of the 48-spectra set
used in this work complemented by five additional spectra) at
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/
arodgergroup/research_intro/instrumentation/ssnn/. An exam-
ple of the pictorial output is given in Figures 2c and 2d. This is
accompanied by a text file with the predicted structures in
order: (a-helix regular, a-helix distorted, b-sheet regular, b-
sheet distorted, turns, and other structures). Before assessing
the fitting efficacy of SSNN in general, it was necessary to
decide the parameter values to be used. The map size was
first varied to see if the SOM needed more data-space to
explore for interpolations between protein spectra, or if it
would help to reduce the complication by reducing the map
size. The number of BMUs was then varied. The learning rate
equation was changed from linear to exponential, and the ini-
tial learning rate was varied. The wavelength range was then
reduced to check the conclusion from other methods that a
smaller range reduced the spectra information content too
much. Greater and greater errors in concentration were then
introduced to see how robust SSNN is against this common
experimental error. Errors in wavelength were also introduced
to simulate the problems due to incorrectly calibrated CD
machines. Finally, comparison of fitting performance to SEL-
CON3, K2d, and SOMCD was performed.
Map size
The average spectral NRMSDs as a function of map size
showed a nonlinear decrease (Supporting Information, Fig. S1)
in error. Although, “bigger is better” for this parameter, bigger
also means more computation time, so we chose a map size
of 40 as optimized for most of the subsequent calculations
(unless we needed to save computer time) because after this
point (larger than 40) the improvement was marginal.
Wavelength range
It is widely accepted that using data only down to 200 nm (as
done by K2d) does not give enough spectral information for a
good structural estimation unless the protein is either highly
helical or has no helical structure. We tested SSNN to see what
effect a reduced wavelength range had on the quality of the
fit. Supporting Information, Table S1 shows the structural
NRMSDs for three different wavelength ranges. The “error
bars” are a standard deviation of the NRMSDs, so measure the
variation rather than an error. As expected the structural
NRMSDs improve significantly with more data, being: 0.14 for
data to 200 nm and 0.10 with data to 190 nm. The variations
in the NRMSDs increase when shorter wavelengths are
included, probably due to the decreasing quality of the data
at higher energies.[9] For this work, we selected our wave-
length range to be 240–190 nm (although SSNN in not
restricted in this way).
Number of BMUs
Comparison of structural NRMSDs as a function of number of
BMUs in SSNN3 (Supporting Information, Fig. S2) showed the
lowest NRMSDs for 5, with a slight improvement in average fit
observed for increasing the number of BMUs from 2 to 5, and
little change from 5 to 25. Performance was worse above 25
BMUs. We were initially surprised at this having expected
again that more would be better. However, consideration of
area to distance ratios leads to the realization that at a larger
radius from the first BMU there are many more nodes than at
a smaller radius. This could cause distant nodes to have a
large effect on the construction of the model thus reducing
the quality of predictions. For K2d with a reference set of size
24, Andrade et al. found that 2 was the best number of BMUs
to use,[12] whereas for K2D3 with a much larger map, 400
BMUs was adopted.[16] We, therefore, conclude that the opti-
mal number of BMUs is dependent on the size of the refer-
ence set and map and should be chosen to ensure the BMUs
do cluster about unknown spectra (test spectra) on the map.
Learning rate
An initial learning rate of L05 0.06 produced the lowest struc-
tural NRMSD of all L0s tested in the range 0.01–0.8 (Supporting
Information, Fig. S4). L05 0.1 is only slightly worse than 0.06
and converged more quickly so was generally adopted. Notice-
ably larger L0s likely move the nodes in the map to local best
approximations of the spectra too early in the training, rather
than allowing the map to fully explore the data-space for bet-
ter approximations. The learning rate was allowed to exponen-
tially decrease with iterations in accord with eq. (4).
Concentration errors
In practice, the biggest problem with protein sample prepara-
tion for CD spectroscopy is determining the concentration
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accurately. In our experience of various statistical methodolo-
gies, errors in concentration for helical proteins translate into
similar errors in a-helical estimates. Concentrations determined,
for example, by BioRad assays or A280 nm measurements,
[21]
give declared protein concentrations that are usually within
620%. As shown in Supporting Information Figure S5, concen-
trations errors do worsen the SSNN fit with underestimates
being worse than overestimates. As the error is less for an
overestimate of protein concentration, erring in this direction
is to be advised. It should be noted that K2d is reputed not to
need the concentration of the protein solution as input. How-
ever, both K2d and SSNN (as currently configured) are based
on assuming all reference set and unknown spectra are in DE
values for molar concentration of amino acids. They, therefore,
do need accurate concentrations.
Wavelength errors
Specifications for CD instruments usually accept wavelength
errors of up to 1 nm and operators may well be even more
relaxed about this parameter. We, therefore, considered the
effect of wavelength error on the quality of structural esti-
mates, as summarized in (Supporting Information, Fig. S6). In
summary, “blue” (to shorter wavelength) shifts are worse than
“red” shifts (toward the visible) with the average error for a 5-
nm blue-shift giving approximately the same NRMSD as a 10-
nm red-shift. The 2-nm shifts seem to produce no more error
than when using a correctly calibrated machine. A 10-nm blue
shift is worse than a 10-nm red shift, most likely because a
blue shift loses important electronic transition information rep-
resented by the intensity of the CD signal in the short wave-
length region, while the long wavelength region is relatively
flat, with no peaks and little information content.
Comparison of SSNN with SELCON3
Three structure fitting programs are widely used: CONTIN,
CDSSTR, and SELCON3, which are all implemented on Dichro-
web.[6] Sreerama and Woody have performed a comprehensive
comparison of the three codes, so in this work we compared
SELCON3 to SSNN. We used the executable version of its code
available on the CDPro website (http://lamar.colostate.edu/
!sreeram/CDPro/main.html) so that we could run it in a
LOOCV manner which we denote SELCON3-47, to compare
directly with SSNN-47. The estimated structure vectors and a
comparison with the real values are given in Table 1 for the
two methods. The SSNN plots for the 48 proteins are given in
the Supporting Information, Figures S7–S54.
The overall performance of SSNN-47 and SELCON3-47 (see aver-
age values in the final rows of the table) is similar: SELCON3-47
“wins” for 23 out of 48 spectra and SSNN-47 “wins” for 25. On
average, when working with six structure types, one might prefer
SELCON3-47 for a-helix and other structure estimates and SSNN-
47 for b-sheets and turns. However, if one considers high and low
percentages of a particular secondary structure type their average
performance ranking changes (Table 2).
For both SELCON3-47 and SSNN-47, of the structure types
considered here, the most difficult types to predict are mixed
a/b proteins (30–50% a-helix) and high b-sheet (>30%). SEL-
CON3-47 gives structural NRMSDs of 0.36 0.3 and 0.36 0.2,
respectively, and SSNN-47 gives 0.26 0.2 for both (errors indi-
cate variations in fit as noted above). Inspection of the overlay
of model spectra with experimental data proteins suggest this
is in part due to the overlap of the a-helix and b-sheet p-p*
transitions around 190–195 nm and in part due to the compa-
ratively small contribution to the spectral NRMSDs of any error
in the 215-nm region of the spectrum, but the significant con-
tribution to structural error indicated by this region. The differ-
ence between a single b-sheet negative maximum at 215–219
nm and two a-helix negative maxima at 208 and 222 nm is
obvious to the human eye but does not make much contribu-
tion in the simple error metric (NRMSD) used in both SELCON
and SSNN. So we still recommend complementing fitting pro-
grams with a visual inspection of the overlay of experimental
data and model spectrum.
Proteins with lots of turns are also hard to analyze, as such
spectra are extremely varied and give high spectral NRMSDs,
although the average error in prediction is not high. The struc-
ture type called “other” is really an amalgam of all the struc-
ture types that do not fit into any of the previous structure-
type categories. Due to this, one might not expect this cate-
gory to be predicted with accuracy, and yet the mean NRMSD
is reasonable indicating that a sufficiently varied spectral/struc-
tural landscape is included in the reference set.
Overall, the best way to classify the structure of a new pro-
tein is to use a few different methodologies to find whether
they confirm each other’s predictions. If they disagree, then it
is likely that better data need to be collected—whether that
be concentration determination or spectra quality.
Comparison of SSNN with K2d
We compared K2d to SSNN-47 and SELCON-47 using the pre-
trained version available on Dichroweb that uses a smaller ref-
erence set and a wavelength range limited to 200 nm.[12] K2d
uses a 13 3 13 grid of nodes, 2 BMUs, 41 nm of spectral data
(240–200 nm), and three structure categories. Unfortunately,
we did not have access to the database used for K2d to run
SSNN and K2d back-to-back, so the K2d reference set included
some of the test proteins, which means its apparent perform-
ance is artificially enhanced. As K2d uses only three structure
types, SELCON3-47 and SSNN-47 structural predictions were
put into three-structure format by summing the two a-helix
predictions, summing the two b-sheet types, and including
turns into the other category. The results are summarized in
Table 3 and given in more detail in Supporting Information,
Table S2. With this gathering of structure types, overall SSNN-
47 performs significantly better than the other two and K2d is
worse than SELCON3-47. K2d (with the advantage of test pro-
teins in the training set) performs best for the a-helical struc-
tures. SSNN-47 is best for b-turns and other.
Comparison of SSNN to SOMCD
Our attempts to compare properly to SOMCD[18] were
defeated by its lack of availability in any form except a final
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Table 1. Structure vectors outputted from SSNN-47 and SELCON3–47 for all proteins in CDDATA.48 from the CDPro web site.
Protein
number Protein name Method a-regular a-distorted b-regular b-distorted Turns Other
Structural
NRMSD
Fit minus
real: a-regular
Fit minus
real: a-distorted
Fit minus
real: b-regular
Fit minus
real: b-distorted
Fit minus
real: turns
Fit minus
real: other
SELCON3 NRMSD -
SSNN NRMSD
1 a-Bungarotoxin Real 0.000 0.000 0.014 0.095 0.284 0.608
SELCON3-47 0.003 0.032 0.299 0.129 0.155 0.388 0.409 0.003 0.032 0.285 0.034 20.129 20.220 0.112
SSNN-47 0.018 0.056 0.211 0.121 0.166 0.428 0.297 0.018 0.056 0.197 0.026 20.118 20.180
2 Alcohol
Dehydrogenase
Real 0.139 0.115 0.139 0.096 0.214 0.297
SELCON3-47 0.131 0.110 0.131 0.078 0.231 0.297 0.052 20.008 20.005 20.008 20.018 0.017 0.000 20.142
SSNN-47 0.149 0.111 0.181 0.093 0.224 0.242 0.193 0.010 20.004 0.042 20.003 0.010 20.055
3 Adenylate Kinase Real 0.340 0.206 0.077 0.052 0.012 0.313
SELCON3-47 0.261 0.158 0.078 0.064 0.178 0.258 0.411 20.079 20.048 0.001 0.012 0.166 20.055 20.032
SSNN-47 0.243 0.162 0.073 0.072 0.185 0.265 0.443 20.097 20.044 20.004 0.020 0.173 20.048
4 Azurin Real 0.047 0.062 0.141 0.109 0.312 0.328
SELCON3-47 0.130 0.104 0.169 0.090 0.230 0.288 0.278 0.083 0.042 0.028 20.019 20.082 20.040 20.041
SSNN-47 0.142 0.110 0.142 0.097 0.229 0.280 0.319 0.095 0.048 0.001 20.012 20.083 20.048
5 b-lactoglobulin Real 0.056 0.111 0.287 0.123 0.216 0.207
SELCON3-47 0.101 0.081 0.171 0.100 0.212 0.321 0.294 0.045 20.030 20.116 20.023 20.004 0.114 20.014
SSNN-47 0.111 0.097 0.186 0.120 0.212 0.274 0.308 0.055 20.014 20.101 20.003 20.004 0.067
6 Bence Jones Protein Real 0.000 0.028 0.294 0.196 0.229 0.252
SELCON3-47 20.006 0.009 0.164 0.117 0.200 0.539 0.245 20.006 20.019 20.130 20.079 20.029 0.287 0.129
SSNN-47 0.023 0.035 0.311 0.139 0.199 0.293 0.116 0.023 0.007 0.017 20.057 20.030 0.041
7 Bovine Pancreatic
Trypsin Inhibitor
Real 0.069 0.138 0.172 0.069 0.190 0.362
SELCON3-47 0.091 0.101 0.152 0.100 0.235 0.304 0.178 0.022 20.037 20.020 0.031 0.045 20.058 0.077
SSNN-47 0.052 0.071 0.180 0.100 0.208 0.389 0.100 20.017 20.067 0.008 0.031 0.018 0.027
8 Carbonic Anhydrase Real 0.058 0.104 0.170 0.116 0.240 0.312
SELCON3-47 0.031 0.044 0.113 0.061 0.109 0.619 0.243 20.027 20.060 20.057 20.055 20.131 0.307 20.043
SSNN-47 0.028 0.032 0.059 0.039 0.059 0.784 0.286 20.030 20.072 20.111 20.077 20.181 0.472
9 CGA Real 0.053 0.082 0.210 0.110 0.210 0.335
SELCON3-47 0.049 0.072 0.096 0.060 0.138 0.586 0.220 20.004 20.010 20.114 20.050 20.072 0.251 20.029
SSNN-47 0.050 0.065 0.077 0.049 0.099 0.660 0.249 20.003 20.017 20.133 20.061 20.111 0.325
10 a-Chymotrypsin Real 0.069 0.045 0.208 0.106 0.200 0.371
SELCON3-47 0.028 0.041 0.153 0.073 0.142 0.544 0.156 20.041 20.004 20.055 20.033 20.058 0.173 0.049
SSNN-47 0.033 0.074 0.176 0.097 0.161 0.459 0.107 20.036 0.029 20.032 20.009 20.039 0.088
11 Colicin A Real 0.529 0.225 0.000 0.000 0.044 0.202
SELCON3-47 0.479 0.215 20.005 0.012 0.113 0.205 0.073 20.050 20.010 20.005 0.012 0.069 0.003 0.008
SSNN-47 0.486 0.214 0.016 0.013 0.095 0.176 0.065 20.043 20.011 0.016 0.013 0.051 20.026
12 Concanavalin A Real 0.000 0.038 0.329 0.135 0.236 0.262
SELCON3-47 0.029 0.059 0.246 0.128 0.209 0.315 0.155 0.029 0.021 20.083 20.007 20.027 0.053 0.062
SSNN-47 0.012 0.053 0.332 0.124 0.178 0.301 0.093 0.012 0.015 0.003 20.011 20.058 0.039
13 Carboxypepsidase A Real 0.254 0.127 0.111 0.052 0.212 0.244
SELCON3-47 0.120 0.113 0.251 0.110 0.173 0.229 0.599 20.134 20.014 0.140 0.058 20.039 20.015 0.065
SSNN-47 0.088 0.080 0.263 0.117 0.212 0.239 0.535 20.166 20.047 0.152 0.065 0.000 20.005
14 Cytochrome C Real 0.214 0.194 0.000 0.000 0.233 0.359
SELCON3-47 0.182 0.152 0.093 0.081 0.228 0.273 0.339 20.032 20.042 0.093 0.081 20.005 20.086 20.008
SSNN-47 0.173 0.122 0.101 0.089 0.224 0.292 0.347 20.041 20.072 0.101 0.089 20.009 20.067
15 EcoR1 Endonuclease Real 0.192 0.127 0.098 0.080 0.210 0.293
SELCON3-47 0.180 0.147 0.091 0.079 0.202 0.297 0.049 20.012 0.020 20.007 20.001 20.008 0.004 20.124
Table 1. (Continued)
Protein
number Protein name Method a-regular a-distorted b-regular b-distorted Turns Other
Structural
NRMSD
Fit minus
real: a-regular
Fit minus
real: a-distorted
Fit minus
real: b-regular
Fit minus
real: b-distorted
Fit minus
real: turns
Fit minus
real: other
SELCON3 NRMSD -
SSNN NRMSD
SSNN-47 0.189 0.181 0.052 0.060 0.253 0.265 0.173 20.003 0.054 20.046 20.020 0.043 20.028
16 Elastase Real 0.021 0.087 0.225 0.117 0.208 0.342
SELCON3-47 0.020 0.024 0.058 0.061 0.142 0.651 0.238 20.001 20.063 20.167 20.056 20.066 0.309 0.010
SSNN-47 0.024 0.033 0.081 0.075 0.148 0.639 0.227 0.003 20.054 20.144 20.042 20.060 0.297
17 Flavodoxin Real 0.209 0.108 0.108 0.108 0.264 0.203
SELCON3-47 0.136 0.117 0.153 0.090 0.212 0.290 0.274 20.073 0.009 0.045 20.018 20.052 0.087 0.052
SSNN-47 0.160 0.125 0.108 0.074 0.227 0.306 0.222 20.049 0.017 0.000 20.034 20.037 0.103
18 c-Crystalin Real 0.006 0.086 0.299 0.161 0.109 0.339
SELCON3-47 0.003 20.006 0.237 0.116 0.254 0.392 0.200 20.003 20.092 20.062 20.045 0.145 0.053 20.018
SSNN-47 0.035 0.049 0.303 0.124 0.219 0.270 0.219 0.029 20.037 0.004 20.037 0.110 20.069
19 Green Fluorescent
Protein
Real 0.004 0.064 0.347 0.093 0.191 0.301
SELCON3-47 0.022 0.045 0.245 0.118 0.242 0.293 0.181 0.018 20.019 20.102 0.025 0.051 20.008 0.047
SSNN-47 0.049 0.049 0.306 0.131 0.204 0.261 0.134 0.045 20.015 20.041 0.038 0.013 20.040
20 Glyceraldehyde-3-
phosphate
dehydrogenase
Real 0.172 0.102 0.115 0.093 0.217 0.301
SELCON3-47 0.157 0.134 0.097 0.078 0.226 0.300 0.080 20.015 0.032 20.018 20.015 0.009 20.001 20.002
SSNN-47 0.168 0.137 0.095 0.079 0.224 0.298 0.081 20.004 0.035 20.020 20.014 0.007 20.003
21 Glutathione
Reductase
Real 0.188 0.142 0.140 0.096 0.172 0.262
SELCON3-47 0.145 0.134 0.102 0.080 0.221 0.316 0.163 20.043 20.008 20.038 20.016 0.049 0.054 20.058
SSNN-47 0.125 0.117 0.115 0.096 0.247 0.300 0.222 20.063 20.025 20.025 0.000 0.075 0.038
22 Hemoglobin Real 0.537 0.223 0.000 0.000 0.105 0.136
SELCON3-47 0.498 0.228 0.000 0.000 0.167 0.156 0.062 20.039 0.005 0.000 0.000 0.062 0.020 0.003
SSNN-47 0.497 0.217 0.013 0.009 0.078 0.185 0.059 20.040 20.006 0.013 0.009 20.027 0.049
23 Hemerythrin Real 0.478 0.197 0.000 0.000 0.111 0.215
SELCON3-47 0.441 0.198 0.052 0.043 0.064 0.209 0.093 20.037 0.001 0.052 0.043 20.047 20.006 0.018
SSNN-47 0.447 0.227 0.037 0.027 0.084 0.180 0.075 20.031 0.030 0.037 0.027 20.027 20.035
24 Rat Intestinal Fatty
Acid Binding
Protein
Real 0.053 0.061 0.432 0.152 0.152 0.152
SELCON3-47 0.117 0.093 0.189 0.094 0.219 0.267 0.685 0.064 0.032 20.243 20.058 0.067 0.115 20.183
SSNN-47 0.217 0.134 0.101 0.073 0.210 0.264 0.868 0.164 0.073 20.331 20.079 0.058 0.112
25 Insulin Real 0.294 0.235 0.020 0.040 0.050 0.361
SELCON3-47 0.253 0.217 0.072 0.061 0.195 0.199 0.487 20.041 20.018 0.052 0.021 0.145 20.162 0.115
SSNN-47 0.212 0.154 0.092 0.074 0.175 0.293 0.372 20.082 20.081 0.072 0.034 0.125 20.068
26 Lactate
Dehydrogenase
Real 0.277 0.161 0.088 0.073 0.155 0.246
SELCON3-47 0.276 0.178 0.073 0.054 0.158 0.264 0.064 20.001 0.017 20.015 20.019 0.003 0.018 20.073
SSNN-47 0.329 0.199 0.063 0.050 0.098 0.262 0.137 0.052 0.038 20.025 20.023 20.057 0.016
27 Lysozyme Real 0.202 0.217 0.016 0.047 0.298 0.221
SELCON3-47 0.213 0.172 0.060 0.062 0.152 0.325 0.294 0.011 20.045 0.044 0.015 20.146 0.104 20.014
SSNN-47 0.167 0.129 0.086 0.084 0.218 0.315 0.308 20.035 20.088 0.070 0.037 20.080 0.094
28 Myoglobin Real 0.582 0.222 0.000 0.000 0.052 0.144
SELCON3-47 0.629 0.247 0.037 20.001 20.018 0.142 0.060 0.047 0.025 0.037 20.001 20.070 20.002 20.073
SSNN-47 0.462 0.218 0.010 0.012 0.070 0.227 0.134 20.120 20.004 0.010 0.012 0.018 0.083
Table 1. (Continued)
Protein
number Protein name Method a-regular a-distorted b-regular b-distorted Turns Other
Structural
NRMSD
Fit minus
real: a-regular
Fit minus
real: a-distorted
Fit minus
real: b-regular
Fit minus
real: b-distorted
Fit minus
real: turns
Fit minus
real: other
SELCON3 NRMSD -
SSNN NRMSD
29 Nuclease Real 0.094 0.101 0.081 0.107 0.289 0.328
SELCON3-47 0.175 0.150 0.091 0.067 0.206 0.317 0.217 0.081 0.049 0.010 20.040 20.083 20.011 20.119
SSNN-47 0.185 0.148 0.113 0.085 0.197 0.272 0.336 0.091 0.047 0.032 20.022 20.092 20.056
30 Papain Real 0.137 0.123 0.094 0.075 0.175 0.396
SELCON3-47 0.109 0.091 0.165 0.102 0.229 0.343 0.187 20.028 20.032 0.071 0.027 0.054 20.053 0.071
SSNN-47 0.080 0.073 0.147 0.088 0.167 0.444 0.116 20.057 20.050 0.053 0.013 20.008 0.048
31 Parvalbumin Real 0.278 0.287 0.000 0.037 0.194 0.204
SELCON3-47 0.285 0.193 0.031 0.054 0.194 0.266 0.190 0.007 20.094 0.031 0.017 0.000 0.062 20.107
SSNN247 0.229 0.171 0.064 0.061 0.155 0.321 0.297 20.049 20.116 0.064 0.024 20.039 0.117
32 Phosphoglycerate
Kinase
Real 0.210 0.135 0.043 0.067 0.231 0.313
SELCON3-47 0.367 0.222 0.045 0.040 0.107 0.244 0.288 0.157 0.087 0.002 20.027 20.124 20.069 0.010
SSNN-47 0.276 0.197 0.077 0.060 0.143 0.246 0.278 0.066 0.062 0.034 20.007 20.088 20.067
33 Pepsinogen Real 0.051 0.154 0.235 0.151 0.165 0.243
SELCON3-47 0.035 0.035 0.256 0.123 0.223 0.316 0.227 20.016 20.119 0.021 20.028 0.058 0.073 0.011
SSNN-47 0.033 0.053 0.269 0.130 0.228 0.286 0.216 20.018 20.101 0.034 20.021 0.063 0.043
34 Prealbumin Real 0.031 0.031 0.307 0.142 0.165 0.323
SELCON3-47 0.011 0.082 0.273 0.121 0.214 0.282 0.140 20.020 0.051 20.034 20.021 0.049 20.041 20.081
SSNN-47 0.060 0.093 0.283 0.144 0.192 0.229 0.222 0.029 0.062 20.024 0.002 0.027 20.094
35 Rhodanase Real 0.150 0.147 0.041 0.068 0.235 0.359
SELCON3-47 0.214 0.154 0.092 0.076 0.185 0.284 0.240 0.064 0.007 0.051 0.008 20.050 20.075 0.063
SSNN-47 0.204 0.140 0.086 0.071 0.198 0.301 0.177 0.054 20.007 0.045 0.003 20.037 20.058
36 Ribonuclease A Real 0.113 0.097 0.218 0.113 0.218 0.242
SELCON3-47 0.114 0.109 0.154 0.102 0.220 0.306 0.184 0.001 0.012 20.064 20.011 0.002 0.064 0.049
SSNN-47 0.083 0.101 0.191 0.098 0.228 0.297 0.135 20.030 0.004 20.027 20.015 0.010 0.055
37 Substilin BPN Real 0.171 0.131 0.098 0.080 0.225 0.295
SELCON3-47 0.108 0.082 0.136 0.105 0.223 0.325 0.162 20.063 20.049 0.038 0.025 20.002 0.030 0.111
SSNN-47 0.187 0.138 0.087 0.078 0.207 0.302 0.051 0.016 0.007 20.011 20.002 20.018 0.007
38 Substilin novo Real 0.113 0.102 0.065 0.073 0.295 0.353
SELCON3-47 0.202 0.139 0.117 0.083 0.199 0.275 0.352 0.089 0.037 0.052 0.010 20.096 20.078 0.015
SSNN-47 0.229 0.161 0.073 0.070 0.165 0.302 0.337 0.116 0.059 0.008 20.003 20.130 20.051
39 Superoxide
Dismutase
Real 0.000 0.018 0.248 0.119 0.298 0.316
SELCON3-47 0.060 0.091 0.224 0.122 0.210 0.280 0.253 0.060 0.073 20.024 0.003 20.088 20.036 0.002
SSNN-47 0.083 0.081 0.177 0.098 0.183 0.378 0.251 0.083 0.063 20.071 20.021 20.115 0.062
40 T4 Lysozyme Real 0.421 0.244 0.049 0.037 0.116 0.134
SELCON3-47 0.446 0.214 0.033 0.028 0.092 0.175 0.063 0.025 20.030 20.016 20.009 20.024 0.041 20.034
SSNN-47 0.432 0.210 0.028 0.022 0.091 0.217 0.097 0.011 20.034 20.021 20.015 20.025 0.083
41 Thermolysin Real 0.282 0.133 0.070 0.095 0.215 0.206
SELCON3-47 0.258 0.156 0.107 0.065 0.148 0.270 0.218 20.024 0.023 0.037 20.030 20.067 0.064 20.052
SSNN-47 0.265 0.214 0.045 0.048 0.114 0.315 0.270 20.018 0.081 20.025 20.047 20.101 0.109
42 Tumor Necrosis
Factor
Real 0.000 0.019 0.293 0.140 0.219 0.329
SELCON3-47 0.075 0.122 0.340 0.202 0.091 0.063 0.488 0.075 0.103 0.047 0.062 20.128 20.266 0.392
SSNN-47 0.017 0.055 0.303 0.149 0.189 0.287 0.096 0.017 0.036 0.010 0.009 20.030 20.042
43 Triose Phosphate
Isomerase
Real 0.236 0.210 0.090 0.064 0.124 0.276
Table 1. (Continued)
Protein
number Protein name Method a-regular a-distorted b-regular b-distorted Turns Other
Structural
NRMSD
Fit minus
real: a-regular
Fit minus
real: a-distorted
Fit minus
real: b-regular
Fit minus
real: b-distorted
Fit minus
real: turns
Fit minus
real: other
SELCON3 NRMSD -
SSNN NRMSD
SELCON3-47 0.339 0.181 0.060 0.049 0.150 0.230 0.175 0.103 20.029 20.030 20.015 0.026 20.046 0.012
SSNN-47 0.331 0.187 0.061 0.052 0.136 0.234 0.163 0.095 20.023 20.029 20.012 0.012 20.042
44 Apo-cytochrome C
(5%C) denatured
Real 0.020 0.020 0.020 0.020 0.020 0.900
SELCON3-47 0.023 0.031 0.053 0.040 0.061 0.754 0.088 0.003 0.011 0.033 0.020 0.041 20.146 0.012
SSNN-47 0.028 0.034 0.058 0.040 0.063 0.776 0.076 0.008 0.014 0.038 0.020 0.043 20.124
45 Apo-cytochrome C
(90%C) denatured
Real 0.020 0.020 0.020 0.020 0.020 0.900
SELCON3-47 0.038 0.034 0.075 0.060 0.113 0.673 0.163 0.018 0.014 0.055 0.040 0.093 20.227 20.406
SSNN-47 0.040 0.062 0.175 0.099 0.199 0.426 0.569 0.020 0.042 0.155 0.079 0.179 20.474
46 Ribonuclease (20%C)
denatured
Real 0.020 0.020 0.020 0.020 0.020 0.900
SELCON3-47 0.021 0.059 0.073 0.051 0.100 0.729 0.117 0.001 0.039 0.053 0.031 0.080 20.171 0.049
SSNN-47 0.024 0.035 0.055 0.039 0.060 0.788 0.068 0.004 0.015 0.035 0.019 0.040 20.112
47 Staphyllococcal Nucle-
ase (6%C) denatured
Real 0.020 0.020 0.020 0.020 0.020 0.900
SELCON3-47 0.004 0.025 0.040 0.032 0.064 0.823 0.046 20.016 0.005 0.020 0.012 0.044 20.077 20.033
SSNN-47 0.028 0.037 0.058 0.040 0.065 0.772 0.079 0.008 0.017 0.038 0.020 0.045 20.128
48 Staphyllococcal Nucle-
ase (70%C)
denatured
Real 0.020 0.020 0.020 0.020 0.020 0.900
SELCON3-47 0.039 0.047 0.098 0.055 0.098 0.647 0.188 0.019 0.027 0.078 0.035 0.078 20.253 0.026
SSNN-47 0.035 0.049 0.084 0.057 0.102 0.674 0.162 0.015 0.029 0.064 0.037 0.082 20.226
Sum of absolute
values
SELCON3-47 10.56 1.84 1.65 2.78 1.32 2.98 4.49 20.121
Sum of absolute
values
SSNN-47 10.69 2.17 1.93 2.57 1.28 2.81 4.53
SSNN was trained with 47 proteins in a LOOCV for 28,000 iterations, a map size of 40 3 40, initial neighbourhood of 20, BMUs5 5, L05 0.1, t15 7,000 iterations, and a k15 5 3 10
26. SELCON3-47 was run using the executable
code available at http://lamar.colostate.edu/!sreeram/CDPro/main.html using input files based on CDDATA.48 and SSDATA.48 but with one spectrum removed to be the test spectrum and structure each time.
trained SOM which in our hands produced clearly poor results
with inconsistencies between the model spectrum and the
spectral prediction. As we could not find a retrainable execut-
able version of SOMCD, we took the structure predictions/esti-
mations that were available in the SOMCD paper (although we
could not reproduce these date with the available code).[18]
The proteins tested and reported on in that paper include a
subset of 33 proteins from CDDATA.48. Supporting Informa-
tion, Table S3 contains a comparison of SELCON3-47 and
SSNN-47 to the published SOMCD output in the 4 structure
format used.[18] In summary, the mean structural NRMSDs of
SOMCD, SELCON3-47, SSNN-47 are 0.46 0.1, 0.46 0.3, and
0.46 0.4, with SSNN-47 performing better than SOMCD for 22
of the 33 proteins.
Conclusions
This work has built upon the basis of the concepts of the
K2d[12] and SOMCD[18] neural network concepts to make a
new SOM neural network, called SSNN or “secondary structure
neural network” to determine structural knowledge from CD
spectra. SSNN comes in three independent parts: SSNN1 which
is the spectral training stage that sorts the reference set spec-
tra on a grid (currently implemented with a 40 3 40 grids)
and interpolates to place a spectrum at each node; SSNN2
which allocates secondary structure vectors that correspond to
the spectra to the nodes on a second 40 3 40 map; and the
SSNN3 module which identifies the structure vector of an
unknown spectrum and outputs a measure of its accuracy vis-
ually by plotting experimental and fitted spectra and numeri-
cally with the spectral NRMSD. SSNN is available in a
pretrained version that includes wavelengths from 240 to 190
nm from CDPro reference data set CDDATA.48. When compar-
ing the overlay of the best-fit spectrum on the original spec-
trum and the structure percentage accuracies, SSNN is an
improvement on the previous SOM approaches. Further exten-
sions simply require the SSNN1 and SSNN2 modules to be per-
formed with a revised reference set, including structures.
SSNN compares well to the statistical program SELCON3 for
protein secondary structure prediction from CD spectra. Over-
all SELCON3 predicts a-helical and other structures slightly bet-
ter than SSNN which is better for b-sheets and turns. However,
the difference is small. In a comparison of the most commonly
used statistical methods, SELCON3, CONTIN, and CDSSTR,
Sreerama and Woody found SELCON3 does best for a-regular,
b-regular, and turn structures, CONTIN is best for a-distorted
and turns, and CDSSTR is best for b-distorted.[19] Sreerama and
Woody’s overall conclusion was to try all three methods. We
would suggest adding SSNN into this process and having con-
fidence in a structure prediction if the methods are in accord
and investigate further if they are not. Due to the simple met-
rics currently used by all fitting programs to assess goodness
of spectral fit, we still recommend complementing fitting pro-
grams with a visual inspection of the overlay of experimental
data and model spectrum, particularly in the 215-nm region of
the spectrum. Because of the restricted formats in which K2d
and SOMCD are available we do not recommend them.
Most of the statistical protein structure prediction methodolo-
gies occasionally make structure predictions of negative num-
bers, for example, they will predict that a protein has 21.8%
turn structure (unless a check is put on them). This is, of course,
physically impossible, and happens because the methodologies
make extrapolations from the structures present in their refer-
ence sets (reference spectra have no negative numbers in them
as they are from real proteins). Due to the fact that SSNN only
makes interpolations between protein spectra and structures, it
can never predict negative structure percentages. However,
with SSNN, when the BMUs of the protein are on the edge of
the map, the structure prediction may not be very good. Other
warning signs are large spectral NRMSDs or the situation where
the NRMSD is reasonable, but either the experimental or model
spectrum has a negative maximum in the 215-nm region and
the other does not (i.e., the b-sheet/a-helix identity).
The agreement between SSNN-47 and SELCON3-47 on the
structure of proteins 44–48 in the CDDATA48 database (i.e. the
denatured proteins) yet their similar differences from the
somewhat arbitrarily assigned (0.02, 0.02, 0.02, 0.02, 0.02, 0.9)
suggests that the structure vectors for these five proteins
should be replaced by an average of the SSNN-47 and SEL-
CON3-47 structures in Table 3.
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Table 2. Structural NRMSDs for SSNN-47 and SELCON-47 from the data in
Table 1 for different structural classes of protein.
Program Overall
>50%
a-helix
30–50%
a-helix
>30%
b-sheet >50% Other
SSNN-47 0.26 0.2 0.26 0.1 0.26 0.2 0.26 0.2 0.26 0.1
SELCON3–47 0.26 0.2 0.16 0.1 0.36 0.3 0.36 0.2 0.26 0.2
K2d 0.36 0.2 0.16 0.2 0.26 0.1 0.36 0.2 0.36 0.3
“Errors” are one standard deviation of the variation between proteins in
the class.
Table 3. Structure NRMSDs and sum of absolute values of the model
spectrum structure minus the real value for the three structural catego-
ries a-helix, b-sheet, and Other for SSNN-47 and SELCON3-47 for all pro-
teins in CDDATA.48 using data from Table 1 and for K2d using its
available format on Dichroweb but testing on CDDATA.48 (some of the
test spectra are in the K2d training set).
Method
Sum of
structural
NRMSDs
Fit minus
real: a
Fit minus
real: b
Fit minus
real: Other
SELCON3-47 11.05 3.37 4.09 4.75
SSNN-47 10.67 3.68 3.60 4.21
K2d 12.32 2.78 4.65 4.75
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Supplementary information 
 
SI 1 SSNN parameter optimisation 
 
 
 
Figure SI1. Dependence of mean spectral NRMSDs of SSNN-47 as a function of map size in 
SSNN3. “Error bars” are one standard deviation of the variation between proteins. SSNN was 
trained with 47 proteins in a LOOCV for 20,000 iterations, a map size of 7×7 to 100×100, initial 
neighbourhood of 40, initial neighbourhood radius = 10, SSNN2 BMUs = 5, SSNN3 BMUs = 40, 
L0 = 0.1, t1 = 7,000 iterations, and a k1 = 5×10–6. 
 
Table SI1. Dependence of mean structural NRMSDs of SSNN-47 on wavelength range. “Errors” 
are one standard deviation of the variation between proteins. SSNN was trained with 47 proteins in 
a LOOCV for 28,000 iterations, a map size of 20×20, initial neighbourhood size = 10, BMUs = 5, 
L0 = 0.1, t1 = 7,000 iterations, and a k1 = 5×10–6.  
 
Range/nm Wavelengths/nm NRMSD 
41 240–200 0.14±0.08 
46 240–195 0.13±0.08 
51 240–190 0.1±0.1 
 
 
Figure SI2. Dependence of mean structural NRMSDs of SSNN-47 on number of BMUs in SSNN3. 
(a) full range of BMUs tested, (b) small numbers of BMUs.  “Error bars” are one standard deviation 
of the variation between proteins. SSNN was trained with 47 proteins in a LOOCV for 20,000 
iterations, a map size of 13×13 for 1–100 BMUs, 20 for 200–300 BMUs, 22 for 400 BMUs (to 
ensure the map has enough nodes), initial neighbourhood of 10, SSNN2 BMUs = 5, L0 = 0.1, t1 = 
7,000 iterations, and a k1 = 5×10–6.  
 
 
Figure SI3. Dependence of mean structural NRMSDs of SSNN-23 on number of BMUs in SSNN3. 
“Error bars” are one standard deviation of the variation between proteins. This was to see what 
effect changing the size of the reference set had on the optimum number of BMUs. SSNN was 
trained with 23 proteins in a LOOCV for 5,000 iterations, a map size of 40×40, initial 
neighbourhood of 20, SSNN2 BMUs = 5, L0 = 0.1, t1 = 7,000 iterations, and a k1 = 5×10–6.  
 
 
 
Figure SI4. Dependence of mean structural NRMSDs of SSNN-47 on learning rate. “Error bars” 
are one standard deviation of the variation between proteins. SSNN was trained with 47 proteins in 
a LOOCV for 1,000 iterations, a map size of 40×40, initial neighbourhood of 10, BMUs = 5, t1 = 
7,000 iterations, and a k1 = 5×10–6.  
 
 
  
Figure SI5. SSNN mean structural NRMSDs for SSNN-47 as a function of protein concentration 
error. “Error bars” are one standard deviation of the variation between proteins. Position 1 on the x-
axis of this graph is the correct concentration. SSNN was trained with 47 proteins in a LOOCV for 
1,000 iterations, a map size of 40×40, initial neighbourhood of 10, BMUs = 5, L0 = 0.06, t1 = 7,000 
iterations, and a k1 = 5×10–6. 
 
 
Figure SI6. Spectral NRMSD versus wavelength calibration error for SSNN. –10 nm denotes at 10 
nm red (i.e. to shorter wavelength), +10 nm is a 10 nm blue-shift etc. “Error bars” are one standard 
deviation of the variation between proteins. SSNN was trained with 33 proteins in a LOOCV for 
1000 iterations using the leave-one-out method, a map size of 13×13, initial neighbourhood size = 
10, 5 BMUs, an L0 = 0.1, a t1 of 7,000 iterations, and a k1 = 5×10–6. 
 
 
Table SI2. Prediction of secondary structure content in terms of the three categories used by K2d 
by SELCON3-47, SSNN-47, as outlined in the main paper compared, with K2d performed using 
Dichroweb 1 and a training reference set that uses some of the test proteins. The final columns 
contain the difference between the models and the real data together with a sum of the absolute 
values of the differences. 
 Protein 
number Protein name Method ! " Other
Structural 
NRMSD
Fit minus real: 
!
Fit minus real: 
"
Fit minus real: 
other
1 !-Bungarotoxin Real !"!!! !"#!$ !"%$&
K2d 0.11 0.4 0.48 0.806 !"##! !"&$# '!"(#&
SELCON3-47 !"!)* !"(&% !"*() 0.539 !"!)* !")#$ '!")($
SSNN-47 !"!+) !"))& !"*$( 0.128 !"!+) !"&&) '!"&$%
2 Alcohol Dehydrogenase Real !"&*( !"&)* !"*##
K2d 0.33 0.19 0.49 0.175 !"!+, '!"!(* '!"!&#
SELCON3-47 !"&(# !"&!$ !"*&% 0.061 '!"!#) '!"!&, !"!#+
SSNN-47 !"&,! !"&+( !"(,, 0.258 !"!!, !"!)$ '!"!(*
3 Adenylate Kinase Real !"*(, !"#&$ !")&*
K2d 0.54 0.12 0.34 0.025 '!"!!, '!"!!$ !"!#*
SELCON3-47 !"(#$ !"#(& !"(), 0.332 '!"#&+ !"!#) !"###
SSNN-47 !"(!( !"#(* !"(*! 0.039 '!"#(& !"!#, !"#&*
4 Azurin Real !"#!$ !"&*! !",(!
K2d 0.16 0.36 0.48 0.362 !"!*# !"##! '!"#,!
SELCON3-47 !"&)( !"&*$ !"*#% 0.356 !"#&* !"!!$ '!"#&&
SSNN-47 !"&*& !"&)% !"*#! 0.060 !"#() '!"!#& '!"#)!
5 " -lactoglobulin Real !"#,+ !"(#! !"(&)
K2d 0.3 0.15 0.55 0.460 !"#)) '!"&,! !"#&+
SELCON3-47 !"#%& !"&+# !"*)) 0.293 !"!#* '!"#)$ !"##!
SSNN-47 !"&!% !")!, !"(%, 0.134 !"!(# '!"#!( !"!,)
6 Bence Jones Protein Real !"!&% !"($! !"(%#
K2d 0.03 0.5 0.47 0.018 !"!!& !"!#! '!"!##
SELCON3-47 !"!!) !"&%# !"+)$ 0.261 '!"!&* '!"&!$ !"&*%
SSNN-47 !"!*% !"(*! !"($& 0.404 !"!)! '!"!(! !"!##
7 Bovine Pancreatic Trypsin Inhibitor Real !"&!+ !"&(# !"**&
K2d 0.28 0.33 0.39 1.043 !"!+) !"!%$ '!"#,&
SELCON3-47 !"#$& !"&*& !"*)$ 0.038 '!"!#* !"!## '!"!#)
SSNN-47 !"#&) !"&%! !"*$+ 0.115 '!"!%( !"!)$ !"!(*
8 Carbonic Anhydrase Real !"#,& !"&%, !"**&
K2d 0.08 0.44 0.48 0.272 '!"!%& !"#*( '!"!+&
SELCON3-47 !"!+* !"#+( !"+&% 0.200 '!"!%+ '!"##& !"#+,
SSNN-47 !"!,! !"!$% !"%() 0.102 '!"#!& '!"#%% !"&$#
9 CGA Real !"#)* !")&! !"*(*
K2d 0.19 0.3 0.51 0.123 !"!** '!"!&! '!"!)*
SELCON3-47 !"#&# !"#*, !"+&( 0.233 '!"!#( '!"#,( !"#+$
SSNN-47 !"##* !"#&, !"+*$ 0.042 '!"!&! '!"#$( !"&#(
10 !-Chymotrypsin Real !"##( !")#( !"*+#
K2d 0.09 0.35 0.56 0.055 '!"!&( !"!), '!"!##
SELCON3-47 !"!,$ !"&&, !",%, 0.142 '!"!(* '!"!%% !"##*
SSNN-47 !"#!+ !"&+) !",&! 0.100 '!"!!+ '!"!(# !"!($
11 Colicin A Real !"+*( !"!!! !"&(,
K2d 0.78 0 0.21 0.033 !"!&, !"!!! '!"!),
SELCON3-47 !",$( !"!!+ !")#% 0.079 '!"!,! !"!!+ !"!+&
SSNN-47 !"+!! !"!)! !"&+# 0.046 '!"!*( !"!)! !"!&*
12 Concanavalin A Real !"!)% !"(,( !"($%
K2d 0.02 0.51 0.47 0.067 '!"!#% !"!(, '!"!&%
SELCON3-47 !"!%% !")+( !"*&( 0.141 !"!*! '!"!$! !"!&,
SSNN-47 !"!,* !"(*, !"(+$ 0.134 !"!&+ '!"!!% '!"!#$
13 Carboxypepsidase A Real !")%# !"#,) !"(*,
K2d 0.37 0.15 0.48 0.051 '!"!## '!"!#) !"!&(
Cytochrome C SELCON3-47 !"&)) !"),# !"(!& 0.864 '!"#(% !"#$% '!"!*(
SSNN-47 !"#,% !")%! !"(*& 0.171 '!"&#) !"&#+ '!"!!(
14 Real !"(!% !"!!! !"*$&
K2d 0.38 0.05 0.57 0.068 '!"!&% !"!*! '!"!&&
SELCON3-47 !"))( !"#+( !"*!# 0.370 '!"!+( !"#+( '!"!$#
SSNN-47 !"&$* !"#$! !"*#, 0.079 '!"##) !"#$! '!"!+,
15 EcoR1 Endonuclease Real !")#$ !"#+% !"*!)
K2d 0.3 0.15 0.55 0.084 '!"!#$ '!"!&% !"!(+
SELCON3-47 !")&+ !"#+! !"($$ 0.021 !"!!% '!"!!% '!"!!(
SSNN-47 !")+# !"##& !"*#% 0.107 !"!*& '!"!,, !"!#*
16 Elastase Real !"#!% !")(& !"**!
K2d 0.07 0.51 0.42 0.283 '!"!)% !"#,% '!"#)!
SELCON3-47 !"!(( !"##$ !"+$) 0.259 '!"!,( '!"&&) !"&()
SSNN-47 !"!*+ !"#*, !"+%, 0.032 '!"!*# '!"#%, !"&),
17 Flavodoxin Real !")#+ !"&#, !"(,+
K2d 0.36 0.14 0.5 0.150 !"!() '!"!+, !"!))
SELCON3-47 !"&*) !"&() !"*!& 0.173 '!"!,( !"!&+ !"!)*
SSNN-47 !"&%* !"#%& !"*)) 0.124 '!"!)& '!"!)( !"!,,
18 #-Crystalin Real !"!$& !"(,! !"((%
K2d 0.02 0.51 0.47 0.106 '!"!+& !"!*! !"!&&
SELCON3-47 '!"!!) !")*) !",(, 0.217 '!"!$* '!"#!+ !"#$%
SSNN-47 !"!%( !"(&+ !"(%$ 0.278 '!"!!% '!"!)) !"!(#
19 Green Fluorescent Protein Real !"!,% !"((! !"($&
K2d 0.05 0.48 0.47 0.066 '!"!#% !"!(! '!"!&&
SELCON3-47 !"!,+ !"),) !"*)* 0.109 '!"!!# '!"!++ !"!()
SSNN-47 !"!$% !"()% !"(,* 0.169 !"!)! '!"!!& '!"!&+
20 Glyceraldehyde-3-phosphate dehydrogenase Real !"&+( !"&!% !"*#%
K2d 0.3 0.12 0.58 0.139 !"!&, '!"!%% !"!,&
SELCON3-47 !"&$# !"#+* !"*&, 0.062 !"!#+ '!"!)) !"!!%
SSNN-47 !")!* !"#+( !"*&# 0.024 !"!)# '!"!)( !"!!)
21 Glutathione Reductase Real !"))! !"&), !"()(
K2d 0.25 0.16 0.59 0.257 '!"!%! '!"!+, !"#*,
SELCON3-47 !"&+$ !"#%& !"*)+ 0.207 '!"!*# '!"!*( !"#!)
SSNN-47 !"&(& !"&## !"*(+ 0.083 '!"!%% '!"!&* !"##)
22 Hemoglobin Real !"+,! !"!!! !"&(#
K2d 0.73 0.06 0.21 0.064 '!"!)! !"!,! '!"!)#
SELCON3-47 !"+&, !"!!! !")&) 0.071 '!"!)( !"!!! !"!%&
SSNN-47 !",,! !"!)& !")!% 0.068 '!"#!! !"!)& !"!,+
23 Hemerythrin Real !",+* !"!!! !")&,
K2d 0.61 0.07 0.32 0.102 '!"!,* !"!+! '!"!!,
SELCON3-47 !",)$ !"!$* !"&+) 0.122 '!"!), !"!$* '!"!*)
SSNN-47 !",+) !"!,) !"&,) 0.045 '!"!!& !"!,) '!"!,)
24 Rat Intestinal Fatty Acid Binding Protein Real !"##( !"*%( !")!(
K2d 0.35 0.16 0.49 0.909 !"&), '!"(&( !"#%,
SELCON3-47 !"&#! !"&%) !"(%, 0.763 !"!$, '!")!# !"#%&
SSNN-47 !")*# !"#+* !"(+( 0.345 !"&)+ '!"(!$ !"#+!
 Protein 
number Protein name Method ! " Other
Structural 
NRMSD
Fit minus real: 
!
Fit minus real: 
"
Fit minus real: 
other
25 Insulin Real !"#$% !"!&! !"'((
K2d 0.51 0.24 0.25 0.518 )!"!(% !"(*! )!"(&(
SELCON3-47 !"'+! !"(,, !",%' 0.163 )!"!#% !"!+, )!"!(+
SSNN-47 !",&& !"(&& !"'&* 0.252 )!"(&, !"(!& !"!#+
26 Lactate Dehydrogenase Real !"',* !"(&( !"'!(
K2d 0.46 0.23 0.31 0.292 !"!$$ !"!&% )!"!%(
SELCON3-47 !"'#' !"($+ !"'$$ 0.076 !"!(& )!"!,' !"!$(
SSNN-47 !"#$* !"((, !",&! 0.135 !"!%! )!"!'* )!"!'(
27 Lysozyme Real !"'(% !"!&, !"#(%
K2d 0.4 0.16 0.44 0.261 )!"!(% !"!%+ )!"!+%
SELCON3-47 !",*# !"($$ !"'++ 0.130 )!"!,' !"!#% )!"!'$
SSNN-47 !"$%& !"(+! !"#,, 0.184 )!"($, !"(!+ !"!('
28 Myoglobin Real !"*!' !"!!! !"(%&
K2d 0.84 0 0.16 0.035 !"!,& !"!!! )!"!,&
SELCON3-47 !"*+& !"!,& !"($' 0.074 !"!+$ !"!,& )!"!+$
SSNN-47 !"&*! !"!$, !"$%* 0.230 )!"($' !"!$, !"(!$
29 Nuclease Real !"(%# !"(** !"&(+
K2d 0.24 0.15 0.61 0.074 !"!'# )!"!,* )!"!!+
SELCON3-47 !",$# !"(#* !"#$, 0.258 !"(,! )!"!,! )!"!%'
SSNN-47 !",,, !"(%* !"'&% 0.145 !"(,* !"!(! )!"('*
30 Papain Real !"$&! !"(&% !"#+(
K2d 0.26 0.15 0.59 0.035 !"!!! )!"!(% !"!(%
SELCON3-47 !"$!! !"$&+ !"#+$ 0.178 )!"!&! !"!%* !"!!(
SSNN-47 !"(#, !"$,# !"&(( 0.087 )!"(!+ !"!&& !"!'!
31 Parvalbumin Real !"#&# !"!,+ !",%*
K2d 0.62 0.05 0.33 0.090 !"!## !"!(, )!"!&*
SELCON3-47 !"'+* !"!*# !"'&! 0.172 )!"!*+ !"!'* !"!&$
SSNN-47 !",%% !"($# !"'+& 0.148 )!"(&& !"!** !"!+*
32 Phosphoglycerate Kinase Real !",'# !"((! !"#''
K2d 0.7 0.03 0.27 0.393 !",## )!"!*! )!"$+'
SELCON3-47 !"#*% !"!*# !",#( 0.358 !"$'' )!"!$# )!"(%,
SSNN-47 !"'+, !"(,* !",*% 0.229 !"($* !"!$* )!"(##
33 Pepsinogen Real !"$!# !",*& !"'!*
K2d 0.21 0.31 0.48 0.224 !"!!# )!"!+& !"!+$
SELCON3-47 !"!+! !",+% !"#,% 0.232 )!"(,# )!"!!+ !"(,(
SSNN-47 !"!*& !",%% !"#(# 0.048 )!"((% !"!(, !"(!+
34 Prealbumin Real !"!&$ !"''% !"'**
K2d 0.21 0.31 0.48 0.435 !"('* )!"(,% )!"!!*
SELCON3-47 !"!%, !",%' !"'%& 0.091 !"!,( )!"!## !"!!*
SSNN-47 !"(#$ !"'$+ !"'$! 0.214 !"!%! )!"!$$ )!"!&*
35 Rhodanase Real !"$%+ !"(!% !"#%'
K2d 0.36 0.22 0.41 0.680 !"!&, !"((( )!"(*'
SELCON3-47 !",&* !"(&* !"'&% 0.298 !"!+( !"!#% )!"($#
SSNN-47 !",'# !"(#+ !"'%* 0.066 !"!'* !"!'* )!"!%&
36 Ribonuclease A Real !"$(! !",,( !"'&!
K2d 0.23 0.4 0.36 0.418 !"!$! !"!&% )!"(!!
SELCON3-47 !"$$, !"$#& !"#$& 0.192 !"!(, )!"!+# !"!&&
SSNN-47 !"(*' !"$%! !"#$& 0.087 )!"!$& )!"!'( !"!&&
37 Substilin BPN Real !",!$ !"(+* !"#$!
K2d 0.31 0.11 0.58 0.112 !"!!* )!"!&* !"!&!
SELCON3-47 !"(%! !"$'( !"#'* 0.212 )!"(($ !"!&, !"!$*
SSNN-47 !",$# !"(&# !"#!% 0.268 !"!$, )!"!(, )!"!((
38 Substilin novo Real !"$(# !"(,* !"&'*
K2d 0.38 0.09 0.53 0.274 !"(&# )!"!'* )!"((*
SELCON3-47 !",'( !"$!! !"'+' 0.471 !"($& !"!&$ )!"(+'
SSNN-47 !",%! !"(', !"'&+ 0.135 !"(+# !"!!# )!"(*(
39 Superoxide Dismutase Real !"!(* !",&+ !"&('
K2d 0.14 0.33 0.53 0.226 !"($$ )!"!,+ )!"!*'
SELCON3-47 !"(#( !",'& !"'%! 0.312 !"(,, )!"!$( )!"($'
SSNN-47 !"(&' !"$+& !"#&( 0.146 !"('& )!"!%( )!"!#,
40 T4 Lysozyme Real !"&&# !"!*& !"$#!
K2d 0.62 0.08 0.3 0.072 )!"!'# )!"!!& !"!#!
SELCON3-47 !"&&! !"!&( !"$&+ 0.030 )!"!!# )!"!$# !"!(+
SSNN-47 !"&'$ !"!#! !",!* 0.045 )!"!$, )!"!,& !"!#*
41 Thermolysin Real !"'(# !"(&# !"'$(
K2d 0.49 0.18 0.33 0.221 !"!+# !"!(# )!"!%(
SELCON3-47 !"'(' !"(+$ !"'(* 0.018 )!"!!( !"!!+ )!"!!,
SSNN-47 !"'+* !"!%, !"'$% 0.154 !"!&, )!"!+$ !"!!*
42 Tumor Necrosis Factor Real !"!(% !"',, !"#'*
K2d 0.03 0.5 0.47 0.127 !"!(( !"!&+ )!"!+*
SELCON3-47 !"(%+ !"#'$ !"(#' 0.663 !"(+* !"(!% )!",%'
SSNN-47 !"!+$ !"'#$ !"'+& 0.510 !"!#, !"!(% )!"!+$
43 Triose Phosphate Isomerase Real !"''& !"(#' !"'!!
K2d 0.6 0.07 0.33 0.206 !"(#' )!"!*' )!"!+!
K2d 0.03 0.5 0.47 0.894 )!"#+! !"',! !"('!
SSNN-47 !"#(* !"(($ !",+! 0.899 !"!+$ )!"!'$ )!"!,!
44 Apo-cytochrome C (5°C) denatured Real !"!'! !"!'! !"%$!
K2d 0.04 0.33 0.63 0.401 !"!!! !"$%! )!"$%!
SELCON3-47 !"!#' !"!%, !"*(# 0.090 !"!(' !"!#, )!"(!#
SSNN-47 !"!&$ !"!%* !"*,% 0.020 !"!$$ !"!#* )!"!*(
45 Apo-cytochrome C (90°C) denatured Real !"!'! !"!'! !"%$!
K2d 0.08 0.41 0.5 0.771 !"!'! !",+! )!"'$!
SELCON3-47 !"!+$ !"(,# !"+*& 0.135 !"!,$ !"!%# )!"(,'
SSNN-47 !"(!$ !"$+' !"&$# 0.237 !"!&$ !"$,' )!"$%&
46 Ribonuclease (20°C) denatured Real !"!'! !"!'! !"%$!
K2d 0.06 0.23 0.72 0.242 !"!$! !"(%! )!"$!!
SELCON3-47 !"!*! !"($' !"*$% 0.100 !"!'! !"!*' )!"!%(
SSNN-47 !"!#% !"!%' !"*'* 0.030 !"!(% !"!#' )!"!+$
47 Staphyllococcal Nuclease (6°C) denatured Real !"!'! !"!'! !"%$!
K2d 0.02 0.12 0.86 0.070 )!"!$! !"!*! )!"!&!
SELCON3-47 !"!$% !"!+$ !"**+ 0.032 )!"!(( !"!,$ )!"!,,
SSNN-47 !"!&# !"!%* !"*,+ 0.050 !"!$# !"!#* )!"!*,
48 Staphyllococcal Nuclease (70°C) denatured Real !"!'! !"!'! !"%$!
K2d 0.05 0.33 0.62 0.423 !"!(! !"$%! )!",!!
SELCON3-47 !"!*& !"(#, !"+'# 0.187 !"!'& !"((, )!"(+#
SSNN-47 !"!*' !"('( !"++& 0.028 !"!'' !"(!( )!"(''
Sum of absolute values K2d ($",$ $"+* '"&# '"+#
Sum of absolute values SELCON3-47 11.28 3.52 4.18 4.89
Sum of absolute values SSNN 7.43 3.73 3.61 4.26
Table SI3.  Structure vectors and structure NRMSDs, differences from true fit of 
SOMCD, SELCON3-47 and SSNN-47 in 4 structure-type format.  
  
Protein 
number Protein name Method !-regular " -regular Turns Other
Structural 
NRMSD
Fit minus real: 
!-regular
Fit minus real: 
" -regular
Fit minus real: 
turns
Fit minus real: 
other
SOMCD NRMSD – 
SSNN NRMSD
1 Alcohol Real 0.254 0.235 0.214 0.297
Dehydrogenase SOMCD 0.400 0.220 0.120 0.260 0.438 !"#$% &!"!#' &!"!($ &!"!)* &!"+)+
SELCON3-47 0.241 0.209 0.231 0.297 0.191 &!"!#) &!"!+% !"!#* !"!!!
SSNN-47 0.260 0.274 0.224 0.242 0.670 !"!!% !"!)( !"!#! &!"!''
2 Azurin Real 0.109 0.250 0.312 0.328
SOMCD 0.350 0.230 0.110 0.310 0.768 !"+$# &!"!+! &!"+!+ &!"!#, &!"(#*
SELCON3-47 0.234 0.259 0.230 0.288 1.336 !"#+' !"!!( &!"!,+ &!"!$!
SSNN-47 0.252 0.238 0.229 0.280 1.685 !"#$) &!"!#+ &!"!,) &!"!$,
3 " -lactoglobulin Real 0.167 0.410 0.216 0.207
SOMCD 0.220 0.380 0.110 0.290 0.384 !"!') &!"!)! &!"#!% !"!,) &!"+,!
SELCON3-47 0.182 0.271 0.212 0.321 0.649 !"!#' &!"#)( &!"!!$ !"##$
SSNN-47 0.208 0.306 0.212 0.274 0.663 !"!$# &!"#!$ &!"!!$ !"!%*
4 Bence Jones Protein Real 0.028 0.490 0.229 0.252
SOMCD 0.100 0.470 0.090 0.340 0.328 !"!*+ &!"!+! &!"#)( !"!,, !"+)*
SELCON3-47 0.003 0.281 0.200 0.539 0.333 &!"!+' &!"+!( &!"!+( !"+,*
SSNN-47 0.058 0.450 0.199 0.293 0.091 !"!)! &!"!$! &!"!)! !"!$#
5 Carbonic Anhydrase Real 0.162 0.286 0.240 0.312
SOMCD 0.150 0.290 0.170 0.400 0.396 &!"!#+ !"!!$ &!"!*! !"!,, !"!#,
SELCON3-47 0.075 0.174 0.109 0.619 0.333 &!"!,* &!"##+ &!"#)# !")!*
SSNN-47 0.060 0.098 0.059 0.784 0.379 &!"#!+ &!"#,, &!"#,# !"$*+
6 !-Chymotrypsin Real 0.114 0.314 0.200 0.371
SOMCD 0.150 0.330 0.130 0.390 0.289 !"!)% !"!#% &!"!*! !"!#( !"#$!
SELCON3-47 0.069 0.226 0.142 0.544 0.218 &!"!$' &!"!,, &!"!', !"#*)
SSNN-47 0.107 0.273 0.161 0.459 0.149 &!"!!* &!"!$# &!"!)( !"!,,
7 Concanavalin A Real 0.038 0.464 0.236 0.262
SOMCD 0.110 0.430 0.100 0.370 0.389 !"!*+ &!"!)$ &!"#)% !"#!, !"+()
SELCON3-47 0.088 0.374 0.209 0.315 0.208 !"!'! &!"!(! &!"!+* !"!')
SSNN-47 0.065 0.456 0.178 0.301 0.096 !"!+* &!"!!, &!"!', !"!)(
8 Carboxypepsidase A Real 0.381 0.163 0.212 0.244
SOMCD 0.390 0.230 0.110 0.270 0.333 !"!!( !"!%* &!"#!+ !"!+% &!"),'
SELCON3-47 0.233 0.361 0.173 0.229 0.667 &!"#$, !"#(, &!"!)( &!"!#'
SSNN-47 0.168 0.380 0.212 0.239 0.718 &!"+#) !"+#* !"!!! &!"!!'
9 Cytochrome C Real 0.408 0.000 0.233 0.359
SOMCD 0.390 0.240 0.110 0.270 0.618 &!"!#, !"+$! &!"#+) &!"!,( &!"$,)
SELCON3-47 0.334 0.174 0.228 0.273 0.649 &!"!*$ !"#*$ &!"!!' &!"!,%
SSNN-47 0.295 0.190 0.224 0.292 1.101 &!"##) !"#(! &!"!!( &!"!%*
10 EcoR1 Endonuclease Real 0.319 0.178 0.210 0.293
SOMCD 0.460 0.130 0.160 0.260 0.403 !"#$# &!"!$, &!"!'! &!"!)) !"+#)
SELCON3-47 0.327 0.170 0.202 0.297 0.046 !"!!, &!"!!, &!"!!, !"!!$
SSNN-47 0.371 0.112 0.253 0.265 0.190 !"!'+ &!"!%% !"!$) &!"!+,
11 Elastase Real 0.108 0.342 0.208 0.342
SOMCD 0.170 0.310 0.120 0.410 0.346 !"!%+ &!"!)+ &!"!,, !"!%, !"!),
SELCON3-47 0.044 0.119 0.142 0.651 0.323 &!"!%$ &!"++) &!"!%% !")!(
SSNN-47 0.057 0.156 0.148 0.639 0.308 &!"!'# &!"#,% &!"!%! !"+(*
12 Flavodoxin Real 0.317 0.216 0.264 0.203
SOMCD 0.370 0.190 0.120 0.320 0.509 !"!') &!"!+% &!"#$$ !"##* !"!+(
SELCON3-47 0.253 0.243 0.212 0.290 0.788 &!"!%$ !"!+* &!"!'+ !"!,*
SSNN-47 0.285 0.182 0.227 0.306 0.480 &!"!)+ &!"!)$ &!"!)* !"#!)
13 #-Crystalin Real 0.092 0.460 0.109 0.339
SOMCD 0.060 0.450 0.080 0.410 0.187 &!"!)+ &!"!#! &!"!+( !"!*# &!"!!(
SELCON3-47 -0.003 0.353 0.254 0.392 0.266 &!"!(' &!"#!* !"#$' !"!')
SSNN-47 0.084 0.427 0.219 0.270 0.196 &!"!!, &!"!)) !"##! &!"!%(
14 Glyceraldehyde-3 Real 0.274 0.208 0.217 0.301
phosphate SOMCD 0.410 0.160 0.130 0.300 0.431 !"#)% &!"!$, &!"!,* &!"!!# &!"%*#
-./01.234/567/ SELCON3-47 0.291 0.175 0.226 0.300 0.153 !"!#* &!"!)) !"!!( &!"!!#
SSNN-47 0.295 0.190 0.224 0.292 1.101 &!"##) !"#(! &!"!!( &!"!%*
15 Glutathione Reductase Real 0.330 0.236 0.172 0.262
SOMCD 0.340 0.260 0.120 0.270 0.253 !"!#! !"!+$ &!"!'+ !"!!, &!"$$(
SELCON3-47 0.279 0.182 0.221 0.316 0.388 &!"!'# &!"!'$ !"!$( !"!'$
SSNN-47 0.242 0.211 0.247 0.300 0.702 &!"!,, &!"!+' !"!*' !"!),
16 Hemoglobin Real 0.760 0.000 0.105 0.136
SOMCD 0.800 0.030 0.060 0.120 0.105 !"!$! !"!)! &!"!$' &!"!#% !"!!$
SELCON3-47 0.726 0.000 0.167 0.156 0.051 &!"!)$ !"!!! !"!%+ !"!+!
SSNN-47 0.660 0.032 0.102 0.206 0.100 &!"#!! !"!)+ &!"!!) !"!*!
17 Hemerythrin Real 0.675 0.000 0.111 0.215
SOMCD 0.750 0.080 0.060 0.120 0.171 !"!*' !"!,! &!"!'# &!"!(' !"#!,
SELCON3-47 0.639 0.095 0.064 0.209 0.097 &!"!)% !"!(' &!"!$* &!"!!%
SSNN-47 0.673 0.063 0.084 0.180 0.064 &!"!!+ !"!%) &!"!+* &!"!)'
18 Lactate Dehydrogenase Real 0.438 0.161 0.155 0.246
SOMCD 0.510 0.150 0.070 0.270 0.200 !"!*+ &!"!## &!"!,' !"!+$ !"!%)
SELCON3-47 0.454 0.127 0.158 0.264 0.064 !"!#% &!"!)$ !"!!) !"!#,
SSNN-47 0.528 0.113 0.098 0.262 0.137 !"!(! &!"!$, &!"!'* !"!#%
19 Lysozyme Real 0.419 0.063 0.298 0.221
SOMCD 0.380 0.200 0.120 0.300 0.584 &!"!)( !"#)* &!"#*, !"!*( &!"#+!
SELCON3-47 0.385 0.122 0.152 0.325 0.365 &!"!)$ !"!'( &!"#$% !"#!$
SSNN-47 0.296 0.170 0.218 0.315 0.704 &!"#+) !"#!* &!"!,! !"!($
20 Myoglobin Real 0.804 0.000 0.052 0.144
SOMCD 0.860 0.010 0.040 0.090 0.087 !"!'% !"!#! &!"!#+ &!"!'$ &!"!+(
SELCON3-47 0.876 0.036 -0.018 0.142 0.060 !"!*+ !"!)% &!"!*! &!"!!+
SSNN-47 0.680 0.023 0.070 0.227 0.116 &!"#+$ !"!+) !"!#, !"!,)
21 Papain Real 0.260 0.169 0.175 0.396
SOMCD 0.190 0.350 0.110 0.340 0.552 &!"!*! !"#,# &!"!%' &!"!'% !")+!
SELCON3-47 0.200 0.267 0.229 0.343 0.481 &!"!%! !"!(, !"!'$ &!"!')
SSNN-47 0.153 0.235 0.167 0.444 0.232 &!"#!* !"!%% &!"!!, !"!$,
22 Phosphoglycerate Kinase Real 0.345 0.110 0.231 0.313
SOMCD 0.590 0.130 0.060 0.220 0.356 !"+$' !"!+! &!"#*# &!"!() !")!#
SELCON3-47 0.589 0.085 0.107 0.244 0.281 !"+$$ &!"!+' &!"#+$ &!"!%(
SSNN-47 0.714 0.022 0.078 0.185 0.055 &!"!$% !"!++ &!"!+* !"!$(
23 Pepsinogen Real 0.205 0.386 0.165 0.243
SOMCD 0.160 0.420 0.100 0.310 0.270 &!"!$' !"!)$ &!"!%' !"!%* !"!$$
SELCON3-47 0.070 0.379 0.223 0.316 0.266 &!"#)' &!"!!* !"!', !"!*)
SSNN-47 0.086 0.399 0.228 0.286 0.227 &!"##( !"!#) !"!%) !"!$)
24 Prealbumin Real 0.062 0.449 0.165 0.323
SOMCD 0.210 0.390 0.090 0.320 0.384 !"#$, &!"!'( &!"!*' &!"!!) !"#),
SELCON3-47 0.093 0.394 0.214 0.282 0.149 !"!)# &!"!'' !"!$( &!"!$#
SSNN-47 0.152 0.427 0.192 0.229 0.245 !"!(! &!"!++ !"!+* &!"!($
25 Rhodanase Real 0.297 0.109 0.235 0.359
SOMCD 0.400 0.160 0.150 0.290 0.467 !"#!) !"!'# &!"!,' &!"!%( !"+!,
SELCON3-47 0.368 0.168 0.185 0.284 0.323 !"!*# !"!'( &!"!'! &!"!*'
SSNN-47 0.345 0.157 0.198 0.301 0.259 !"!$, !"!$, &!"!)* &!"!',
26 Ribonuclease A Real 0.210 0.331 0.218 0.242
SOMCD 0.270 0.370 0.090 0.270 0.357 !"!%! !"!)( &!"#+, !"!+, !"!+,
SELCON3-47 0.223 0.256 0.220 0.306 0.578 !"!#) &!"!*' !"!!+ !"!%$
SSNN-47 0.184 0.290 0.228 0.297 0.329 &!"!+% &!"!$# !"!#! !"!''
27 Substilin BPN Real 0.302 0.178 0.225 0.295
SOMCD 0.380 0.260 0.100 0.260 0.408 !"!*, !"!,+ &!"#+' &!"!)' !")!'
SELCON3-47 0.190 0.241 0.223 0.325 0.489 &!"##+ !"!%) &!"!!+ !"!)!
SSNN-47 0.325 0.165 0.207 0.302 0.103 !"!+) &!"!#) &!"!#, !"!!*
28 Substilin novo Real 0.215 0.138 0.295 0.353
SOMCD 0.390 0.190 0.110 0.310 0.580 !"#*' !"!'+ &!"#,' &!"!$) !"#+*
SELCON3-47 0.341 0.200 0.199 0.275 0.659 !"#+% !"!%+ &!"!(% &!"!*,
SSNN-47 0.390 0.143 0.165 0.302 0.453 !"#*' !"!!' &!"#)! &!"!'#
29 Superoxide Dismutase Real 0.018 0.367 0.298 0.316
SOMCD 0.210 0.310 0.110 0.370 0.648 !"#(+ &!"!'* &!"#,, !"!'$ !"#$'
SELCON3-47 0.151 0.346 0.210 0.280 0.423 !"#)) &!"!+# &!"!,, &!"!)%
SSNN-47 0.164 0.276 0.183 0.378 0.504 !"#$% &!"!(# &!"##' !"!%+
30 T4 Lysozyme Real 0.665 0.086 0.116 0.134
SOMCD 0.690 0.060 0.050 0.190 0.123 !"!+' &!"!+% &!"!%% !"!'% !"!$+
SELCON3-47 0.660 0.061 0.092 0.175 0.045 &!"!!' &!"!+' &!"!+$ !"!$#
SSNN-47 0.642 0.050 0.091 0.217 0.082 &!"!+) &!"!)% &!"!+' !"!,)
31 Thermolysin Real 0.415 0.165 0.215 0.206
SOMCD 0.470 0.160 0.070 0.300 0.297 !"!'' &!"!!' &!"#$' !"!($ !"!%*
SELCON3-47 0.414 0.172 0.148 0.270 0.175 &!"!!# !"!!* &!"!%* !"!%$
SSNN-47 0.478 0.093 0.114 0.315 0.230 !"!%) &!"!*+ &!"#!# !"#!(
32 Tumor Real 0.019 0.433 0.219 0.329
Necrosis SOMCD 0.100 0.480 0.100 0.320 0.300 !"!,# !"!$* &!"##( &!"!!( !"#(,
Factor SELCON3-47 0.197 0.542 0.091 0.063 0.377 !"#*, !"#!( &!"#+, &!"+%%
SSNN-47 0.072 0.452 0.189 0.287 0.101 !"!') !"!#( &!"!)! &!"!$+
33 Triose Real 0.446 0.154 0.124 0.276
Phosphate SOMCD 0.620 0.130 0.060 0.190 0.244 !"#*$ &!"!+$ &!"!%$ &!"!,% !"#+,
Isomerase SELCON3-47 0.520 0.109 0.150 0.230 0.123 !"!*$ &!"!$' !"!+% &!"!$%
SSNN-47 0.518 0.112 0.136 0.234 0.116 !"!*+ &!"!$+ !"!#+ &!"!$+
mean Real
SOMCD 0.370
SELCON3-47 0.350
SSNN-47 0.381
standard Real
deviation SOMCD 0.162
SELCON3-47 0.273
SSNN-47 0.370
 
 
 
 
 
 
 
 
Figures SI7 to SI54 show the 4 output plots of SSNN for the 48 proteins in the CDDATA.48 
performed in LOOCV mode using the other 47 members of the reference set as the training set in 
each case. The parameters for all runs were: 28,000 iterations, a map size of 40×40, initial 
neighbourhood of 20, BMUs = 5, L0 = 0.1, t1 = 7,000 iterations, and a k1 = 5×10–6. 
 
 
Figure SI7. Protein 1, α-Bungarotoxin SSNN-47 run as described in the text. 
    
	  
 
Figure SI8. Protein 2, Alcohol Dehydrogenase SSNN-47 run as described in the text. 
 
 
Figure SI9. Protein 3, Adenylate Kinase. SSNN-47 run as described in the text. 
    
  	  	  
  	  
Figure SI10. Protein 4, Azurin. SSNN-47 run as described in the text. 
    
  	  	  
  	  	  
Figure SI11. Protein 5, β-lactoglobulin. SSNN-47 run as described in the text. 
    
  	  	  
  	   	  
Figure SI12. Protein 6, Bence Jones Protein. SSNN-47 run as described in the text. 
    
  	  	  
  	   	  
Figure SI13. Protein 7, Bovine Pancreatic Trypsin Inhibitor. SSNN-47 run as described in the text. 
    
  	  	  
  	  	  
Figure SI14. Protein 8, Carbonic Anhydrase. SSNN-47 run as described in the text. 
    
  	  	  
  	  	  
Figure SI15. Protein 9, CGA. SSNN-47 run as described in the text. 
    
  	  	  
  	  	  
Figure SI16. Protein 10, α-Chymotrypsin. SSNN-47 run as described in the text. 
    
  	  	  
  	  	  
Figure SI17. Protein 11, Colicin A. SSNN-47 run as described in the text. 
    
  	  	  
  	   	  
Figure SI18. Protein 12, Concanavalin A. SSNN-47 run as described in the text. 
    
  	  	  
 	  
Figure SI19. Protein 13, Carboxypepsidase A. SSNN-47 run as described in the text. 
    
 
 
Figure SI20. Protein 14, Cytochrome C. SSNN-47 run as described in the text. 
  	  	  
  	  	  
  	  	  
Figure SI21. Protein 15, EcoR1 Endonuclease. SSNN-47 run as described in  the text. 
    
  	  	  
  	  	  
Figure SI22. Protein 16, Elastase. SSNN-47 run as described in the text. 
    
  	  	  
  	   	  
Figure SI23. Protein 17, Flavodoxin. SSNN-47 run as described in the text. 
    
  	  	  
  	  	  
Figure SI24. Protein 18, γ-Crystalin. SSNN-47 run as described in the text. 
    
  	  	  
  	  	  
Figure SI25. Protein 19, Green Fluorescent Protein. SSNN-47 run as described in the text. 
    
  	  	  
  	  	  
Figure SI26. Protein 20, Glyceraldehyde-3-phosphate dehydrogenase. SSNN-47 run as described in 
the text. 
    
  	  	  
  	  	  
Figure SI27. Protein 21, Glutathione Reductase. SSNN-47 run as described in the text. 
    
 
 
 
 
  	  	  
	  
   	  	  
	  
	  
	  
	  
Figure SI28. Protein 22, Hemoglobin SSNN-47. run as described in the text. 
    
  	  	  
  	  	  
Figure SI29. Protein 23, Hemerythrin. SSNN-47 run as described in the text. 
    
  	  	  
  	   	  
Figure SI30. Protein 24, Rat Intestinal Fatty Acid Binding Protein. SSNN-47 run as described in 
the text. 
    
  	  	  
 
Figure SI31. Protein 25, Insulin. SSNN-47 run as described in the text. 
    
    
    
Figure SI32. Protein 26, Lactate Dehydrogenase SSNN-47 run as described in the text. 
    
    
    
Figure SI33. Protein 27, Lysozyme SSNN-47 run as described in the text. 
    
    
    
Figure SI34. Protein 28, Myoglobin SSNN-47 run as described in the text. 
    
    
    
Figure SI35. Protein 29, Nuclease SSNN-47 run as described in the text. 
    
    
    
Figure SI36. Protein 30, Papain SSNN-47 run as described in the text. 
    
    
    
Figure SI37. Protein 31, Parvalbumin SSNN-47 run as described in the text. 
    
    
    
Figure SI38. Protein 32, Phosphoglycerate Kinase SSNN-47 run as described in the text. 
    
    
    
Figure SI39. Protein 33, Pepsinogen SSNN-47 run as described in the text. 
    
    
    
Figure SI40. Protein 34, Prealbumin SSNN-47 run as described in the text. 
    
    
    
Figure SI41. Protein 35, Rhodanase SSNN-47 run as described in the text. 
    
    
    
Figure SI42. Protein 36, Ribonuclease A SSNN-47 run as described in the text. 
    
    
    
Figure SI43. Protein 37, Substilin BPN SSNN-47 run as described in the text. 
    
    
    
Figure SI44. Protein 38, Substilin novo SSNN-47 run as described in the text. 
    
    
    
Figure SI45. Protein 39, Superoxide Dismutase SSNN-47 run as described in the text. 
    
    
    
Figure SI46. Protein 40, T4 Lysozyme SSNN-47 run as described in the text. 
    
    
    
Figure SI47. Protein 41, Thermolysin SSNN-47 run as described in thetext. 
    
    
    
Figure SI48. Protein 42, Tumor Necrosis Factor SSNN-47 run as described in the text. 
    
    
    
Figure SI49. Protein 43, Triose Phosphate Isomerase SSNN-47 run as described in the text. 
    
    
    
Figure SI50. Protein 44, Apo-cytochrome C (5°C) denatured SSNN-47 run as described in the text. 
    
    
    
Figure SI51. Protein 45, Apo-cytochrome C (90°C) denatured e SSNN-47 run as described in the 
text. 
    
    
    
Figure SI52. Protein 46, Ribonuclease (20°C) denatured SSNN-47 run as described in the text. 
    
    
    
Figure SI53. Protein 47, Staphyllococcal Nuclease (6°C) denatured SSNN-47 run as described in 
the text. 
    
    
    
Figure SI54. Protein 48, Staphyllococcal Nuclease (70°C) denatured SSNN-47 run as described in 
the text. 
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ABSTRACT Collecting circular dichroism (CD) spectra for protein solutions is a simple 
experiment, yet reliable extraction of secondary structure content is dependent on knowledge of 
the concentration of the protein—which is not always available with accuracy. We previously 
developed a self-organising map (SOM), called Secondary Structure Neural Network (SSNN), 
to cluster a database of CD spectra and use that map to assign the secondary structure content of 
new proteins from CD spectra. The performance of SSNN is at least as good as other available 
protein CD structure fitting algorithms. In this work we apply SSNN to a collection of spectra 
of experimental samples where there was suspicion that the nominal protein concentration was 
incorrect. We show that by plotting the normalized root mean square deviation of the SSNN 
predicted spectrum from the experimental one versus a concentration scaling-factor it is 
possible to improve the estimate of the protein concentration while providing an estimate of the 
secondary structure. For our implementation (51 data points 240 – 190 nm in nm increments) 
good fits and structure estimates are obtained if the NRMSD (normalised root mean square 
displacement, RMSE/data range) is < 0.03; reasonable for NRMSD < 0.05; and variable above 
this. We have also augmented the reference database with 100% helical spectra and truly 
random coil spectra. 
INTRODUCTION 
To extract secondary structure information for globular proteins from circular dichroism (CD) 
spectra, expert opinion must be sought; this is usually from either a person who has worked in 
the field for a long time, or a software methodology. A number of such methodologies are 
available in Dichroweb 1,2 and at the CDPro website.3,4 However, all such available 
methodologies are dependent on the accuracy of the protein concentration. In other papers 5,6 we 
reported the development of SSNN, “Secondary Structure Neural Network”, which is a software 
package to assign secondary structures using a self-organising map (SOM) methodology. Our 
approach is similar in intent to the family of K2d programs 7 but more flexible in terms of 
reference data set and wavelength range. It has also been validated by testing it in a leave-one-
out methodology using the CDDATA.48 reference set from CDPro 3,4 as a 47-member training 
set with one test protein, repeating the test 48 times and comparing with CDSSTR, SELCON3, 
and K2d.5,6 CDDATA.48 has structure vectors associated with it and may be found on the 
CDPro website (http://lamar.colostate.edu/~sreeram/CDPro/main.html), which is maintained by 
Sreerama et al. at Colorado State University.8 The structure labels used are written as a vector 
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throughout this work and refer to: (α-helix, distorted α-helix, β-sheet, distorted β-sheet, turn, 
other) as in references.8,9,10 The assignments come from DSSP annotation with the 2 residues at 
each end of helices and 1 residue at each end of β-strands being taken as distorted.11 In this 
work the structure vectors are quoted as fractions of 1 in this order. Total α-helix content is thus 
the sum of the first two components and total β-sheet content is the sum of the third and fourth 
components. Pure CD structure types produce spectra similar to those seen in Figure 1.  
 
Figure 1: The CD spectra of the proteins of reference set CDDATA.(48+5) with the most 
extreme structure types: an extrapolation of the CD of peptide Aurein 2.5 to model 100% α-
helix; rat intestinal fatty acid binding protein is the highest β-sheet content in the reference set 
(58.4%); Azurin has the largest turn content in the reference set (31.2 %); N-formyl acetic acid is 
100% random coil protein.  
 
SSNN proceeds in three distinct units. In the first unit, SSNN1, the spectra of a reference 
set of known proteins (with known structures) is organised on a map of chosen size so that 
similar spectral shapes are neighbours. All nodes on the map are given spectra interpolated 
between those of the original reference set. In SSNN2, secondary structure vectors 
corresponding to the spectrum of that node are assigned to all nodes. In SSNN3, the best 
position on the map for the spectrum of an unknown protein is found and its structure vector 
determined from its position. For a given reference set, SSNN1 and SSNN2 need only be run 
once. 
SSNN performed at least as well as other available fitting methodologies in our earlier 
work.5,6 Its worst structure suggestions were where the unknown protein was on the edge of the 
structures map or where the intensity in the 208–222 nm region gave a relatively small spectral 
NMRSD (normalised root mean square displacement, see below) but the shape of the 
experimental spectrum was reminiscent of an α-helix and that of the predicted model spectrum 
β-sheet (or conversely). Our motivation in developing a new structure fitting method was to 
have an approach that could be used in a wide variety of situations. Our first attempts to apply 
SSNN ‘in the real world’ were not entirely successful for two completely different reasons. The 
first reason was that some proteins and peptides (particularly the latter) ended up on the very 
edge of the spectral map because our reference set did not include very high helical or 
completely unfolded spectra. The second was that despite our best efforts and those of our 
colleagues, estimates of protein concentration were never as accurate as we thought. This has 
the automatic consequence for any fitting methodology of introducing an error into the 
estimates of secondary structure. 
In this work we have therefore augmented the SSNN reference set with 5 spectra created to 
represent 100% α-helical proteins and 100% ‘random coil’, bringing the reference set up to 53 
proteins. Here random coil refers to the spectrum observed for an unfolded peptide. Its structure 
vector is 100% ‘other’, i.e. (0,0,0,0,0,1). We have also developed a way of using SSNN to 
improve the estimates of protein concentration. 
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METHODS 
A SOM is a type of unsupervised neural network that takes high-dimensional data (in our 
case CD spectra) and clusters them, then visualises it in a manner that is much easier to 
understand than the high-dimensional data set. SSNN is described in reference 5 and the details 
of how to implement the code are given in 6. The process of training the SOM with a reference 
data set (SSNN1) is first to make a matrix of n×n (in this case 40×40) vectors containing 
pseudo-random numbers. Then one selects, at random, a protein spectrum from the reference set 
and compares it with all of the random spectra in the matrix. The random vector in the ‘spectra 
map’ that has the smallest Euclidean distance from the selected protein spectrum is called the 
best matching unit (BMU) and is the ‘winner’. Next this BMU is made more similar to the 
selected spectrum using a learning rule, which makes the numbers in the random vector more 
similar to the protein spectrum. At the same time the vectors in the map near the BMU, the 
neighbourhood, are made more similar to the protein spectrum as well, but to a lesser degree in 
a distance (map coordinate)-dependent way. This is done for thousands of iterations, 28000 in 
our case. Once this is finished, the spectra map is trained, and ready for the next stage. Due to 
the random selection, the physical appearance of the maps change each time SSNN1 is run, 
though the clustering will be the same and thus ultimate fits should not change. One layer of a 
trained SOM can be seen in Figure 2a for our augmented version of CDDATA.48 which we 
denote CDDATA.(48+5). The figure shows the clustered CD spectra in a 40×40 spectra map for 
the 222 nm data point. This only shows one of the stack of 51 data points for each spectrum, so 
there are 50 other nm points for each spectrum, and thus a stack of 50 other maps could be 
produced. The map shows the 53 reference set spectra, and also virtual interpolated spectra 
filling in the gaps to make up the 1600 spectra.  
The second module, SSNN2 takes the clustered spectra and constructs a structures map by 
finding the coordinates of the BMUs of the 53 proteins in the spectra map and placing their 
structures at the same coordinates in the structures map. For the virtual structures, SSNN2 takes 
a distance-weighted sum of 5 of the structures of neighbouring spectra from the reference set. A 
typical result is shown in Figure 2b for the α-helix. There is a structures map for each of the 6 
structure types used in this work. The two peaks in Figure 2b in this map show that not all α-
helix-rich proteins have the same spectra and hence structure vectors. 
In SSNN3, a model of a test spectrum is determined (see Results for examples) as a 
weighted sum of its 5 BMUs (positions of BMUs on the SOM are also given in the output files). 
The structures then follow from the same weighted sum as in the structures map. The model or 
predicted (fitted) spectrum has an NRMSD (normalised root mean squared deviation) associated 
with it, and this is used to indicate how much the structures prediction can be trusted. We use 
these definitions of RMSD and NRMSD,  
 
         (1) 
 
                (2) 
 
where Si are the elements of the real spectrum, and Mi are elements of the model spectrum, N is 
the number of data points in a spectrum (51 in this case). Mmax and Mmin are the largest and 
smallest observed values, in this case the largest and smallest values in the model spectrum 
being evaluated.  
 
 
RMSD =
Si − Mi( )
2
i=1
N
∑
N
 
NRMSD = RMSD
Mmax − Mmin
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Figure 2: (a) Spectral intensity map for 222 nm CD signals. (b) Structures map for α-helix 
structure vector component after optimisation starting from a reference set of 53 proteins which 
includes CDDATA.48 from CDPro and an additional 5 spectra (see text).  
 
In this implementation of SSNN we have chosen to represent CD spectra as vectors of 57 
numbers, the first 51 being the Δε intensities (where the concentration is that of amino acid 
residues not protein molecules) for 240–190 nm in 1 nm steps and the last 6 being the structure 
vector components. In our previous work 5 we showed that with a reference set of 48 spectra, 
the SOM size of 40×40 nodes or spectra was optimal. The same will be true for 53 spectra, 
though a large increase or decrease would require a larger or smaller map. A version of SSNN 
(SSNNGUI) is available pre-trained with CDDATA.(48+5) at 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/arodgergroup/research_intro/inst
rumentation/ssnn/ and the instructions for its use are given in details in reference 6. The test 
spectra must then be matching 51-number column vectors. Alternatively SSNN1_2.app may be 
trained on reference sets for any wavelength range or set of proteins, as also described in 
reference 6. The key innovation of this work is to have made both SSNNGUI and SSNN1_2.app 
useable when one only has an estimate of the protein concentration. In this case a concentration 
scaling factor range should be entered on the GUI (graphical user interface) and also a step size. 
Bearing in mind that more calculations take longer to perform, it is preferable to do a coarse-
grained calculations first then refine the step size for a smaller range. A spectral NRMSD 
against concentration scaling factor plot will be additional output if these parameters are entered 
on the GUIs. 
Insulin and polylysine sample preparation and data collection 
Insulin and polylysine were obtained from Sigma–Aldrich (insulin from bovine pancreas I6634, 
polylysine P 4707 MW 70000–150000). For the pH 2.3 insulin, 0.44 mg of insulin was dissolved 
in NaOH (0.1 M). Sodium phosphate buffer (to final concentration 4 mM) was added, resulting 
in an insulin solution of ~0.3 mg/ml (concentration calculated by measuring the UV absorbance 
at 278 nm and using the Sigma–Aldrich extinction coefficient of 6080 mol–1cm–1dm3). The pH 
was adjusted to 2.3 with HClO4 0.1M and it was diluted by factor of 4. Polylysine was made to 
nominal 0.10 mg/mL in water and adjusted to pH 11.2 with NaOH resulting in a nominal 0.094 
mg/mL solution. 
For the UV absorbance measurements, a Jasco V-660 spectrophotometer was used. All the 
CD spectra were taken in a Jasco J-815 or J-715 CD spectropolarimeter. The balance used was a 
Mettler Toledo XP2U and the pH meter Mettler Toledo Seven Compact pH/Ion S220 InLab 
Nano Sensors. 
RESULTS AND DISCUSSION 
Applying SSNN3 to real data 
Following our successful leave-one-out validation of SSNN using spectra from the CDPro 
website,4 we embarked on applying SSNN to real data. This project had mixed success until we 
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considered the fact that although the proteins all had a nominal value of 0.1 mg/mL, this 
concentration was unlikely to be correct. We therefore wrote a version of SSNN3 that processes 
an input spectrum through SSNN several times, each time multiplying the spectrum vector by 
different factors, which we call the ‘concentration scaling factors’. As illustrated in the 
examples below, we found that the plot of NRMSD versus scaling factor often has a single 
minimum. If the value of the minimum NRMSD is small (<0.03) we are confident this scaling 
factor gives a reasonable estimate of the true concentration and secondary structure estimate. It 
is advisable to view the output for a number of scaling factors near the minimum if the structure 
estimates differ significantly—this is particularly true if e.g. the low wavelength data quality is 
poor. For larger NRMSDs, visual inspection of the overlay of model and experimental spectra is 
advisable as discussed below. Better fits also correlate with the BMUs not jumping around the 
SOM.  
For ease of use we have made a single GUI option for using SSNN3 pre-trained with 
reference set CDDATA.(48+5). We previously used it with one single concentration but have 
added the option to scale the concentration automatically. This application is denoted 
SSNNGUI.app. More advanced users can use a re-trainable version, which includes SSNN1 and 
SSNN2 as well as SSNN3, called SSNN1_2.app. SSNN is written in MATLAB, and for the 
GUI, MATLAB’s GUIDE (graphical user interface development environment) was used. 
SSNN3-single, runs SSNN once for each unknown protein in the test set to determine the 
secondary structures of the proteins in question at the stated concentration. SSNN3-multiple 
allows the user to select a range of concentration scaling factors and gives secondary structure 
analyses and NRMSD values for each scaling factor each as part of the output. The GUI of 
SSNN3 takes less than 2 seconds to run (per spectrum) on a 2009 MacBook Pro laptop with 8 
GB RAM, and a 2.26 GHz processor once the MATLAB Compiler Runtime is installed (for 
details see reference 6). The training process of SSNN1 and SSNN2 running for 28,000 
iterations takes about 20 minutes to run. SSNNGUI is available for Mac and Windows at 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/arodgergroup/research_intro/inst
rumentation/ssnn/. 
Guide lines for the formatting of the input files can be found in the instructions text file on 
the SSNN website. The output is plots to show where the BMUs making the model spectrum 
are relative to the reference set members, an overlay of the model (or predicted) spectrum and 
the original experimental spectrum, along with the spectral NRMSD value. When SSNNGUI is 
run in multiple mode, a plot of NRMSD versus scaling factor is also produced. The results 
reported in this paper have been determined using the SSNNGUI. 
Applications 
The remainder of this paper is structured around particular examples that illustrate aspects 
of the performance of SSNN. The first two examples are for highly helical and highly sheet 
proteins followed by the mixed structure insulin at low pH as a function of temperature to 
illustrate the strengths and weaknesses of applications of SSNN to solution-phase protein 
structure and concentration determination. Insulin was chosen as a worst-case scenario as 
discussed below. The examples are followed by illustrations with unknown lipoproteins, ZapA 
mutants (the protein that bundles FtsZ fibres), some related toxins, and concludes with a peptide 
in different solvents. 
Membrane peptide: α-helix 
The experimental CD, scaling factor 1.0 model spectrum, SOM and plot of spectral NRMSD vs 
scaling factor for an α-helical peptide whose concentration was known fairly accurately are 
shown in Figure 3. The suggests 0.95 (83% helix) and 1.0 (84% helix) are best fits, with 0.9 
(81%) and 1.05 (85%) still having very good fits. All have 0% β-sheet content (Table 1). We 
therefore conclude this peptide has 83±2% helix, 0% sheet, 5±1% turn and 12±1% Other. As 
discussed below for mixed structure systems it may be appropriate to declare a bigger 
uncertainty.  
  
Table 1: Secondary structure estimates for an α-helical peptide as a function of scaling factor.  
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Concentration 
scaling factor 
α-Regular α-
Distorted 
β-Regular β-
Distorted 
Turn Other 
0.9 0.624 0.184 0.003 0.002 0.052 0.136 
0.95 0.655 0.176 0 0 0.048 0.121 
1 0.67312 0.16736 0 0 0.045 0.114 
1.05 0.69919 0.15312 0 0 0.043 0.105 
(a)       (b) 
 
Figure 3: SSNN results for a highly helical peptide in a lipid environment. (a) The SOM with 
BMUs indicated clustered on the top left of the map (spectra numbers are in the order provided 
by CDDATA.48), the experimental spectrum (assuming 0.1 mg/mL concentration) and model 
spectrum for scaling factor 1.0. (b) SSNN spectral NRMSD.  
 
Polylysine: β-sheet 
Polylysine (~1.1 mg/mL) was dissolved in H20 and the pH was adjusted to 11.4 with NaOH 
then heated at 55°C for 30 min to produce a β-sheet (Figure 4).12,13 The spectral NRMSD 
(Figure 4b) is a minimum for scaling factor 0.9 where the structure vector is 
(0.020,0.052,0.29,0.14,0.20,0.29). With this highly sheet protein (and others we tested, data not 
shown), the accuracy of the concentration is not a great concern as the α-helical percentage was 
7% and β-sheet percentage was 44% for concentration scaling factors ranging from 0.65–1.2. 
The local minima in the NRMSD plots at higher scaling factors (~1.85) are clearly bad fits 
when inspected as they look helical. 
 We chose to analyse polylysine because it is a simple system which is deemed to give 
the archetypical α-helix, β-sheet, and random coil spectra under different conditions. After 
extensive work (data not shown) we remain unconvinced that the pH 11.2 room temperature 
polylysine structure is a pure α-helix, at least in our laboratory. 
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Figure 4: SSNN results for a highly sheet protein. (a) The SOM with BMUs indicated clustered 
towards the bottom right of the map (spectra numbers are in the order provided by CDDATA.48), 
the experimental spectrum (assuming 0.1 mg/mL concentration), and model spectrum for 
scaling factor 1.0. (b) SSNN spectral NRMSD.  
Insulin 
Insulin is a small 2-peptide protein whose crystal structure for the neutral pH zinc containing 
protein (PDB entry 4INS) was annotated to have structure vector (0.29, 0.23, 0.02, 0.04, 0.05, 
0.36) for Woody and Sreerama’s data base.3  Insulin is a challenging protein to get and keep in 
solution, and its structure varies with pH and whether it has zinc present or not. Despite being 
extensively studied, its structural details remain unclear in some environments, so resulting data 
will be useful. In addition, in leave-one-out testing with SSNN and SELCON3 this fairly helical 
protein was the third worst structure analysis.5 The results shown below are for insulin at pH 2.4, 
which is a zinc-free structure as it illustrates the limitations of SSNN effectively. The spectral 
shape is sufficiently different from the neutral pH zinc containing structure so the data base not 
to be modified. 
CD spectra for pH 2.4 insulin are shown in Figure 5a as a function of temperature 
(assuming nominal 0.1 mg/mL concentration). Our aim here was to have a constant 
concentration for a series of spectra. In practice, a small degree of evaporation did increase the 
concentration for the last few spectra. The SSNN spectral NRMSDs are plotted in Figure 4b on 
a displaced vertical scale and the predicted helical and sheet content are plotted in Figure 4c as a 
function of temperature using scaling factor 2.0 for the first 11 spectra and 1.8 for the last 4 
(some evaporation occurred during the experiment as seem by the absorbance signals). The 
room temperature structure predictions are ~9% less helical than both the crystal and the zinc-
free pH 7.3 solution data (not shown) which is in accord with the available low pH NMR data 
(PDB 2HIU,14 for insulin with the B chain carboxy-terminus native alanine mutated to 
threonine) which is 39% helix (according to DSSP annotation).  
The peculiar step in Figure 5c between 25°C and 30°C provides an interesting illustration 
of another value of the variable concentration methodology as a means of estimating reliability 
of structure predictions. As shown in Figure 5b, none of the spectral NRMSDs are below the 
somewhat arbitrary quality threshold of 0.03. The factor 2.0 BMUs and fits are illustrated in 
Figures 5d and e for 25°C and 30°C and the factor 2.1 for 30°C. The BMUs for the two 2.0 fits 
are in slightly different parts of the map and that for 2.1 spans both parts. This instability 
reflects the fact that the reference set does not contain the ‘right’ type of helical spectra which 
also raises difficulty for the peptide in trifluoroethanol (TFE) discussed below. It is also 
interesting to note that the α-helical structure gradually decreases from 45° to 75°, whereas the 
β-sheet structure increases over a much small temperature range (45–55°). 
 
(a)       (b) 
0.5 1 1.5 2 2.5
0
0.02
0.04
0.06
0.08
0.1
0.12
S
pe
ct
ra
l N
R
M
S
D
 
Scaling factor
 8 
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Figure 5: (a) CD spectra of insulin (pH 2.4 ) as a function of temperature (assuming nominal 
concentration 0.1 mg/mL in 1 mm path length cuvette). (b) NRMSD for SSNN output. Plots are 
vertically displaced by 0.01 for each temperature increment, with 20°C at the bottom. (c) SSNN 
α-helix and β-sheet as a function of temperature, using scaling factor 2 for 20–70° and 1.8 for 
the remainder. SSNN	  output	  for	  (d) 25°	  C	  with	  concentration	  scaling	  factor	  2.0	  (36%	  helix),	  (e)	  
30°	  C	  with	  concentration	  scaling	  factor	  2.0	  (34%	  helix),	  and	  (f)	  30°	  C	  with	  concentration	  scaling	  
factor	  2.1	  (41%	  helix).	   
Lipoproteins 
CD spectroscopists frequently use protein concentrations of ~0.1 mg/mL, which for a pure 
protein corresponds to ~ 910–950 µM amino acid residue concentration which gives a good far 
UV (i.e. amide chromophore) CD spectrum in a 1 mm cuvette (as long as the buffer does not 
absorb light significantly). However, by definition, lipoproteins include lipids which are 
invisible in the spectrum but contribute to the mass and often affect protein concentration 
determination methods. Figure 6a shows the overlay of the CD spectra of 4 high density 
lipoproteins (L1–L4), which were all thought to be 0.1 mg/mL in concentration. Literature (e.g. 
10) led us to expect helical content when folded of between 50% and 80%. Some of our spectra 
are almost identical in spectral shape, but differ in magnitude. These spectra had been collected 
in our laboratory and abandoned, as the results could not be interpreted with available structure 
fitting methodologies. 
Plots of spectral NRMSDs versus concentration scaling factor for L1–L4 are shown in 
Figure 6b. The NRMSD minima are for scaling factors: 1.05, 1.05, 1.35, and 1.2 for L1 to L4 
respectively. The different predictions for neighbouring scaling factors give an indication of the 
percentage errors in the fits. Thus we conclude that the original protein concentrations were 
respectively 0.093, 0.095, 0.074, 0.083 mg/mL (within ±5%). Figure 6c illustrates the quality of 
the model spectrum overlaid with the original for L4 (the worst fit of the 4 proteins). L1 and L3 
are 63% helix, 6–7% sheet and L2 and L4 are 65% helix, 6% sheet with errors (as determined 
by nearest scaling factor fits) of ~3% for the helices and 2% for the sheets. 
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(a)       (b) 
 
  
 
(c)        
 
Figure 6: (a) CD spectra of 4 lipoproteins, L1–L4, converted to Δε assuming original protein 
concentration was 0.1 mg/mL in a 1 mm path length cuvette and the average amino acid 
molecular mass was 105 u. (b) SSNN3-multiple NRMSD for the 4 proteins versus concentration 
scaling factor. (c) SSNN3 output for L4 with concentration scaling factor 1.2.  
ZapA: wild type and mutants 
Escherichia Coli ZapA is a 104-residue protein which binds to the cell division protein 
FtsZ.15,16,17 We had been interested in whether the wild type (WT) protein’s structure changed 
when key residues (denoted e.g. I83E) were mutated. Although we had collected CD data 
(Figure 7a), our analysis had been hindered by very inaccurate concentration determinations. 
We therefore implemented SSNN and plotted the NRMSD versus concentration scaling factor. 
The answer is perhaps less clear than in the previous example with the NRMSD curves 
oscillating. However, this is partly the illusion of a different scale and partly that different local 
spectral NRMSD minima optimize different parts of the spectrum. Minima are at respectively 9 
or 9.8, 3.6, and 4.4 for WT, I83E and V17E mutants. The last of these is illustrated in Figure 7c. 
The structure vectors for the two WT factors are (0.42,0.20,0.028,0.023,0.12,0.21) and 
0.45,0.21,0.013591,0.017,0.11,0.20) with factor 9.8 being perhaps a slightly better visual fit 
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than 9 for the WT. We take the WT α-helical content to be (64±2)%. By way of contrast I83E 
has structure vector (0.33,0.19,0.047,0.043,0.14,0.25) so only 52% helix and V17E has vector 
(0.45,0.21,0.013,0.017,0.10,0.21) so 66% helix. 
Even allowing for the uncertainties suggested in the predictions, I83E is significantly less 
helical than the other two proteins. According to the Pseudomonas aeruginosa crystal structure 
17 we would expect ~ 64% helix and ~10% sheet for the WT ZapA. This helical content 
compares very well with the above SSNN results for WT and V17E (though the sheet 
predictions are low suggesting solution flexibility at the ends). However, I83E has significantly 
less helix predicted. Even allowing for errors predictions, we conclude that the I83E mutation 
disrupts some of the helical character of ZapA but the V17E mutant does not. Consistent with 
this is the fact that position 83 is in the coiled-coil region of the protein whereas position 17 is at 
the end of strand 2.16, 17 
  
 
(a)       (b) 
  
(c)        
 
Figure 7: CD spectra of ZapA. (a) WT, I83E and V17E with Δε determined assuming nominal 
concentration 0.1 mg/mL in 1 mm pathlength cuvette and the average amino acid molecular 
mass 116 u. (b) SSNN3-multiple NRMSD for the 3 proteins versus concentration scaling factor 
with 0.03 quality indicator shown. (c) Overlay of experiment and model spectra for scaling 
factors = 4.4 for V17E. 
Toxins 
CD data were collected for a series of related bacterial proteins (toxins) as shown in Figure 8a. 
All samples had been dialysed to remove high concentrations of salt that interfered with CD 
data collection resulting in unknown concentrations. SSNNGUI was implemented with a range 
of scaling factors. Toxins 2 and 3 have spectra of almost the same shape, but the poor quality of 
the spectra at low wavelength result in different structure predictions, respectively 29% helix 
and 20% sheet for toxin 2 with scaling factor 0.6 and 32% helix and 12% sheet for toxin 3 with 
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scaling factor 1.1. No reasonable fit emerged for Toxin 1 which led us to re-examine the raw 
CD data files, which showed HT voltages above 600 V below 200 nm for Toxin 1 and below 
196 nm for the others. So the short wavelength data were at fault not the fitting methodology. 
We therefore prepared new protein samples, which showed that the original spectra were 
attenuation at low wavelength. The typical minimum NRMSD was 0.016 with 35% α-helix and 
12% β-sheet. 
(a) 
 (b) 
(c) 
Figure 8: (a) Toxin CD spectra with Δε determined assuming nominal concentration 0.1 mg/mL 
in 1 mm pathlength cuvette and the average amino acid molecular mass 105 u. (b) SSNN3-
multiple NRMSD for the 3 proteins versus concentration scaling factor with 0.03 quality indicator 
shown. (c) Overlay of experiment and “best fit” (see text for comment) model spectra for Toxin 1, 
scaling factor = 0.2.) 
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Peptide structure fitting   
Peptides are a challenge to structure fitting programs as they tend to adopt a single secondary 
structure motif with frayed ends. Further, any sample may be a mixture of populations. We 
wished to see whether SSNN could at least be used to rank relative amounts of folding for 
peptides. Initial attempts to use SSNN with CDDATA.48 resulted in BMUs at the very edge of 
the maps and poor fits for unfolded peptides and for peptides suspected to be well-folded 
helices. With hindsight this should not have been surprising given CDDATA.48 contained data 
only from globular proteins which all have a mix of secondary structure motifs. To produce 
better peptide structure estimates we enhanced CDDATA.48 with 5 more spectra. Three spectra 
to mimic unfolded peptides were included: MSLSRRQAAQASGIALCAGAVPLKASA in 
water taken from reference,18 and the spectra for N-formyl acetic acid and N-acetyl valine,19 
which have 100% ‘random coil’ structure. Two more reference spectra were constructed by 
taking the spectrum for myoglobin (from CDDATA.48) and for a helical aurein peptide 20 and 
scaling them to have the accepted maximum magnitude value of –13 mol–1cm–1dm3 21 at 222 or 
208 nm. Scaled-myoglobin and the aurein were taken to have 100 % α-helix structure. 
To test the usefulness of SSNN with the enhanced reference set for assessing secondary 
structures of peptides we used the data from a systematic study of a 27-mer SufI signal peptide 
from the Escherichia coli Tat system 15 with sequence: 
MSLSRRQFIQASGIALCAGAVPLKASA. Here we consider the peptide structure in water, 
methanol, 0.05% SDS, TFE, and TFE:water (Figure 9a). The overlay of the NRMSD plots 
versus concentration factor in Figure 9b suggest that the nominal concentration of 0.1 mg/mL is 
fairly close to the true value for all solvents except TFE (see below). The water model spectrum 
for scaling factor 1.05 (Figure 9c), gives a good fit to experiment letting us conclude that the 
prediction of only a small amount of secondary structure (5% helix, 9% sheet) is correct. One of 
the BMUs for this fit is spectrum 49, one of our additions to the training set. The structure 
predictions for the neighbouring scaling factors suggest ~ 2% error.  
The methanol NRMSD plot (Figure 9b) is fairly flat, with multiple minima. The factor 1.25 
fit looks best (Figure 9d) suggesting methanol induces ~51% helix and ~10% sheet. The factor 
1.0 vector (0.30,0.18,0.070,0.055,0.12,0.29) leads us to conclude that in this case error is of the 
order of 5%. The other three solvents all have reasonable, but not good, fits at their NRMSD 
minima with helix/sheet percentages being 32%/17% for SDS (factor 1.2), 36%/16% for TFE 
factor (factor 0.65), and 33%/16% for TFE:water (factor 0.85). To confirm these values we 
would suggest some titration experiments with different mixed solvents. It is hard to imagine 
how the TFE concentration has been underestimated by 35% since the sample was prepared 
using a micro-balance. The local minimum near scaling factor 1.0 suggests 54% helix and 10% 
sheet. We would expect TFE to be at least as effective as MeOH in inducing helical structure, so 
we conclude that the quality of the fit is suffering from a lack of reference spectra where 208 
nm is significantly larger in magnitude than 222 nm as was discussed above for insulin.  
 
 (a)                                (b) 
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(c) (d)
 
  
 
Figure 9: (a) CD spectra (with conversion to Δε per amino acid performed by assuming a 
concentration of 0.1 mg/mL in a 1 mm path length cuvette) of SufI peptide in different solvents. 
Data taken from reference 18. (b) SSNN3-multiple NRMSD for SufI in different solvents versus 
concentration scaling factor with 0.03 quality indicator shown. (c) Overlay of experiment and 
best fit model spectrum for Sufl in water [scaling factor = 1.05, structure vector 
(0.02,0.03,0.056,0.036,0.06,0.80)]. (d) Overlay of experiment and best fit model spectrum for 
Sufl in methanol [scaling factor = 1.25, structure vector: (0.32,0.19,0.051,0.046,0.15,0.25)].   
 
On the basis of this peptide example, we can conclude that when used with care, inspecting 
the fits, and considering the location of the BMUs on the map, SSNN can be a useful tool for 
peptides. In the original analyses of reference 18 it was assumed that the peptide could only 
adopt a helical or a random coil structure and percentages were determined using the CD 
magnitude at 222 nm. The results of using SSNN indicate a more complicated structural 
landscape for this 27-mer, which is in accord with the small size (or lack of with TFE) of the dip 
in CD intensity at ~216 nm expected between the 208 nm and 222 nm negative maxima for a 
helical protein. 
Conclusion 
In this paper we have shown how SSNN can be used to provide fairly reliable secondary 
structure estimates for proteins, even when the concentration of the sample is not known, as 
long as the spectral NRMSD versus concentration scaling factor plots have a clear minimum. 
Our experiences as summarized in the results section suggests that for the size of spectrum 
vector used in this work (51 data points spaced at 1 nm intervals), an NRMSD<0.03 gives a 
reasonable structure prediction. Where an oscillating NRMSD versus concentration scaling 
factor is observed, this is usually due to the set of BMUs changing as a function of 
concentration scaling factor. SSNN-multiple can be useful in making it clear when 
neighbouring scaling factors have BMUs in different parts of the map, which indicates a larger 
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error in the structure estimates. In such a situation an educated eye may be able to discern the 
best fit. Sometimes a poor fit reflects inadequacies in the reference set used to train SSNN, other 
times it reflects deficiencies in the experimental data such short wavelength data being 
significantly attenuated due to low photon count. Secondary structure estimates for both insulin 
and peptides dissolved in TFE would benefit from additions to the reference set. In some cases 
the results may suggest one of a small number of possibilities and an alternative technique such 
as infrared absorbance, Raman or Raman optical activity may be required to select between 
them. A series of spectra as a function of temperature or solvent competition may help clarify 
the appropriate scaling factor. 
Most of the work reported in this paper has been performed with a GUI for the final 
module SSNN3-multiple. It takes as input the spectral SOM from SSNN1 and the structure map 
from SSNN2 as well as the experimental spectrum as a vector of 51 data points from 240 nm to 
190 nm in 1 nm intervals. If a different wavelength range is required or a change in the 
reference data set is proposed, SSNN1 and SSNN2 will need to be rerun using the 
SSNN1_2.app. With the hindsight of the peptide work reported above, we have augmented 
CDDATA.48 reference set from CDPro to include 100% helical structures and 100% random 
coil structures thus extending the parameter space. The SSNNGUI that is now available at 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/arodgergroup/research_intro/inst
rumentation/ssnn/ was trained with this larger reference set of 53 protein spectra. The fitting 
could be improved further by e.g. adding TFE-induced structures to a reference set. The lack of 
appropriate spectra in a reference set is usually apparent because the BMUs for a protein are 
very near the edge of the SOM rather than surrounded by other BMUs.  
In looking for examples on which to test this concentration-optimising version of SSNN, 
we had many old data sets that had never been analysed once it had become apparent that we 
did not know the concentration. We are now able to proceed further with such data sets. A key 
to further progress will be enhancement of the training sets with particular classes of proteins, 
e.g. membrane proteins. Collecting the data for new spectra is one aspect of this, however, 
equally important is determination of the structure vector. In general, SSNN-multiple structures 
estimates for highly α-helical proteins are within about 3% and for highly β-sheet proteins have 
a low error despite the fact that concentration estimates may have high error. SSNN errors for 
mixed helix/sheet proteins may be of the order of 10% if the spectra NRMSD magnitudes are 
high (above 0.03). 
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Table S I:  The predicted structures of the lipoproteins tested with SSNN GUI for all 
concentration scaling factors.  !
Concentration 
0.1
Alpha-
regular
 Alpha-
disorted     Beta-regular
  Beta-
disorted    Turns   Other
lipoprotein 1 0.014262 0.048501 0.26341 0.14546 0.21261 0.31576
lipoprotein 2 0.014951 0.050093 0.27105 0.1451 0.21012 0.30869
lipoprotein 3 0.011942 0.044572 0.24141 0.14452 0.22426 0.3333
lipoprotein 4 0.013403 0.047352 0.25117 0.14488 0.21848 0.32471
0.2
lipoprotein 1 0.020358 0.051455 0.29918 0.13834 0.19897 0.2917
lipoprotein 2 0.019757 0.049894 0.30153 0.13744 0.19732 0.29406
lipoprotein 3 0.017688 0.050781 0.2927 0.14634 0.204 0.28848
lipoprotein 4 0.021252 0.054455 0.2926 0.14385 0.20159 0.28625
0.3
lipoprotein 1 0.067308 0.065269 0.23626 0.11614 0.22545 0.28957
lipoprotein 2 0.06796 0.065562 0.23521 0.11595 0.22564 0.28968
lipoprotein 3 0.021811 0.053098 0.30036 0.13664 0.19378 0.29431
lipoprotein 4 0.055284 0.058422 0.25864 0.12144 0.21613 0.29009
0.4
lipoprotein 1 0.14383 0.1069 0.14308 0.094367 0.2336 0.27822
lipoprotein 2 0.14897 0.11058 0.1327 0.090714 0.23452 0.28252
lipoprotein 3 0.073032 0.068205 0.23091 0.11618 0.22537 0.28631
lipoprotein 4 0.09858 0.080816 0.19593 0.11053 0.23107 0.28307
0.5
lipoprotein 1 0.17428 0.12475 0.092071 0.070912 0.24241 0.29557
lipoprotein 2 0.17184 0.1237 0.088547 0.06962 0.24655 0.29974
lipoprotein 3 0.14389 0.10694 0.14298 0.094328 0.23361 0.27826
lipoprotein 4 0.16013 0.11593 0.11677 0.083078 0.23597 0.28813
0.6
lipoprotein 1 0.22546 0.14977 0.061583 0.06964 0.20377 0.28978
lipoprotein 2 0.25156 0.1591 0.060937 0.069562 0.18645 0.27239
lipoprotein 3 0.17002 0.12097 0.098439 0.074612 0.24233 0.29363
lipoprotein 4 0.18171 0.13431 0.072547 0.064502 0.23659 0.31035
0.7
lipoprotein 1 0.27571 0.16441 0.062926 0.070872 0.17986 0.24623
lipoprotein 2 0.27677 0.16361 0.065516 0.071978 0.18355 0.23857
lipoprotein 3 0.21 0.14557 0.059672 0.066078 0.21518 0.3035
lipoprotein 4 0.25187 0.16064 0.060977 0.066953 0.18579 0.27377
0.8
lipoprotein 1 0.29202 0.16921 0.067138 0.069558 0.17149 0.23059
lipoprotein 2 0.28679 0.16378 0.065518 0.069931 0.17914 0.23484
lipoprotein 3 0.25293 0.16077 0.061063 0.067187 0.18546 0.27258
lipoprotein 4 0.27606 0.16352 0.065724 0.071843 0.18382 0.23903
0.9
lipoprotein 1 0.30118 0.16981 0.064452 0.063092 0.16517 0.2363
lipoprotein 2 0.32963 0.18861 0.062708 0.055574 0.14049 0.22298
lipoprotein 3 0.27829 0.16544 0.064438 0.071135 0.17962 0.24108
lipoprotein 4 0.29155 0.16886 0.067225 0.069332 0.17122 0.23182
1
lipoprotein 1 0.37307 0.20784 0.050736 0.038988 0.11205 0.21731
lipoprotein 2 0.42532 0.20314 0.037853 0.029121 0.11487 0.18968
lipoprotein 3 0.28681 0.16608 0.066914 0.070533 0.17891 0.23075
lipoprotein 4 0.30434 0.17227 0.064316 0.062091 0.16184 0.23514
1.2
lipoprotein 1 0.53908 0.1739 0.018855 0.01366 0.0926 0.16191
lipoprotein 2 0.56027 0.1685 0.018697 0.013503 0.08762 0.15142
lipoprotein 3 0.35701 0.20381 0.056729 0.044064 0.11459 0.2238
lipoprotein 4 0.45056 0.19774 0.032536 0.025746 0.11188 0.18154
1.4
lipoprotein 1 0.69528 0.12997 0.01162 0.0082634 0.051245 0.10361
lipoprotein 2 0.69609 0.13325 0.0094157 0.0066956 0.052767 0.10179
lipoprotein 3 0.47503 0.19334 0.027007 0.020731 0.10624 0.17765
lipoprotein 4 0.56242 0.16799 0.018627 0.013447 0.08708 0.15044
1.6
lipoprotein 1 0.71046 0.14234 0 0 0.048521 0.098677
lipoprotein 2 0.70119 0.14387 0.0022733 0.0016166 0.047171 0.10388
lipoprotein 3 0.56202 0.16808 0.01864 0.013458 0.087182 0.15062
lipoprotein 4 0.69506 0.13455 0.0090069 0.0064049 0.052756 0.10222
1.8
lipoprotein 1 0.73716 0.12163 0.0019883 0.0014139 0.047229 0.090583
lipoprotein 2 0.73841 0.12306 0.0020441 0.0014536 0.044092 0.090949
lipoprotein 3 0.69527 0.13011 0.011552 0.0082145 0.051245 0.10361
lipoprotein 4 0.70953 0.14551 0 0 0.044822 0.10014
2
lipoprotein 1 0.76651 0.11466 0 0 0.036096 0.082733
lipoprotein 2 0.7819 0.10675 0 0 0.03419 0.077159
lipoprotein 3 0.71128 0.14155 0 0 0.049089 0.098082
lipoprotein 4 0.73838 0.12351 0.0019197 0.0013651 0.043868 0.090954
2.2
lipoprotein 1 0.80901 0.090747 0 0 0.034375 0.065865
lipoprotein 2 0.82031 0.081754 0.0013303 0.00094597 0.033014 0.062647
lipoprotein 3 0.71537 0.13386 0.0023665 0.0016829 0.048638 0.098091
lipoprotein 4 0.76394 0.11741 0 0 0.034759 0.083887
2.4
lipoprotein 1 0.83315 0.076987 0.0013513 0.0009609 0.029141 0.058407
lipoprotein 2 0.83846 0.075507 0.0013335 0.00094826 0.026992 0.05676
lipoprotein 3 0.74384 0.12174 0.0020509 0.0014584 0.040589 0.090327
lipoprotein 4 0.79663 0.098363 0 0 0.034764 0.070247
2.6
lipoprotein 1 0.85301 0.067532 0.0013188 0.00093783 0.025482 0.051721
lipoprotein 2 0.85318 0.067473 0.001308 0.00093009 0.025454 0.051656
lipoprotein 3 0.78187 0.10675 0 0 0.034163 0.077215
lipoprotein 4 0.83316 0.076954 0.0013626 0.00096897 0.029145 0.058413
2.8
lipoprotein 1 0.85089 0.069717 0.001305 0.00092801 0.02467 0.052495
lipoprotein 2 0.85089 0.069721 0.001302 0.00092585 0.024668 0.052491
lipoprotein 3 0.81962 0.0822 0.0012645 0.0008992 0.033181 0.062834
lipoprotein 4 0.85301 0.06753 0.0013192 0.00093808 0.025481 0.05172
3
lipoprotein 1 0.85088 0.069729 0.0013023 0.00092604 0.02467 0.052496
lipoprotein 2 0.85086 0.069741 0.0013019 0.00092578 0.024671 0.052503
lipoprotein 3 0.83314 0.076984 0.001354 0.00096281 0.029145 0.058412
lipoprotein 4 0.85099 0.069674 0.0012994 0.00092402 0.02466 0.052457
3.2
lipoprotein 1 0.85084 0.06975 0.0013027 0.00092633 0.024673 0.05251
lipoprotein 2 0.85081 0.069762 0.0013031 0.00092661 0.024675 0.052519
!!
    Table S II: Spectral NRMSD of lipoproteins for each concentration scaling factor 
(denoted ‘Co ncentration’) examined. 
!
lipoprotein 3 0.8529 0.067571 0.0013251 0.0009423 0.025499 0.051761
lipoprotein 4 0.85097 0.069691 0.0012971 0.00092235 0.02466 0.052462
3.4
lipoprotein 1 0.8508 0.069769 0.0013038 0.00092713 0.024677 0.052524
lipoprotein 2 0.85078 0.06978 0.0013044 0.00092755 0.024679 0.052532
lipoprotein 3 0.85089 0.069709 0.0013064 0.000929 0.024671 0.052493
lipoprotein 4 0.85091 0.06972 0.0012984 0.00092331 0.024665 0.052482
3.6
lipoprotein 1 0.85077 0.069784 0.001305 0.00092797 0.02468 0.052536
lipoprotein 2 0.85075 0.069794 0.0013056 0.00092841 0.024682 0.052544
lipoprotein 3 0.85092 0.069705 0.001301 0.00092512 0.024665 0.052479
lipoprotein 4 0.85086 0.069745 0.0013003 0.00092465 0.02467 0.052502
3.8
lipoprotein 1 0.85074 0.069797 0.0013061 0.00092873 0.024683 0.052547
lipoprotein 2 0.85072 0.069805 0.0013067 0.00092916 0.024685 0.052553
lipoprotein 3 0.8509 0.069722 0.0013004 0.00092472 0.024667 0.052488
lipoprotein 4 0.85082 0.069764 0.0013021 0.0009259 0.024675 0.052518
4
lipoprotein 1 0.85072 0.069808 0.001307 0.00092941 0.024685 0.052555
lipoprotein 2 0.8507 0.069815 0.0013076 0.00092981 0.024687 0.052561
lipoprotein 3 0.85086 0.069741 0.0013012 0.00092531 0.024671 0.052502
lipoprotein 4 0.85078 0.06978 0.0013036 0.00092698 0.024679 0.052531
Conc. Lipoprotein 1 Lipoprotein 2 Lipoprotein 3 Lipoprotein 4
0.1 0.17373 0.16101 0.19559 0.18199
0.2 0.078179 0.075448 0.11093 0.094671
0.3 0.061069 0.06393 0.070452 0.066127
0.4 0.04708 0.044042 0.064299 0.054296
0.5 0.052831 0.051135 0.047451 0.044787
0.6 0.039238 0.035442 0.045115 0.047038
0.7 0.025232 0.024039 0.045917 0.029046
0.8 0.01982 0.019678 0.029543 0.018716
0.9 0.019099 0.02085 0.021897 0.014965
1 0.01606 0.011649 0.01752 0.016609
!
!
!
!
!
!
!
!
!
!
!
!
ZapA!
1.2 0.021886 0.027913 0.017271 0.010366
1.4 0.030681 0.031658 0.012088 0.026781
1.6 0.035815 0.03795 0.028181 0.02395
1.8 0.035241 0.03721 0.027439 0.029177
2 0.036921 0.037531 0.032832 0.027642
2.2 0.03666 0.037839 0.033985 0.029618
2.4 0.041127 0.048554 0.033851 0.028793
2.6 0.057096 0.069767 0.033743 0.030886
2.8 0.080572 0.095972 0.034215 0.044315
3 0.10673 0.12403 0.037175 0.065682
3.2 0.13404 0.15289 0.048506 0.089628
3.4 0.16193 0.18217 0.066051 0.11459
3.6 0.19013 0.21171 0.086106 0.14002
3.8 0.21852 0.24139 0.10734 0.16571
4 0.24705 0.27119 0.12916 0.19155
!  
Figure S1: ZapA 3, wild type: locations of BMUs, black ones marked with ‘R’ are 
training set proteins, red ones marked with ‘U’ are the 5 BMUs that make up the 
model spectrum and the structure estimation. Here ZapA WT has a concentration 
scaling factor of 8.8 (see Figure S8 for further details). 
See main text to see if this should be deleted, or replaced by new, correct stuff. 
!  
Figure S2: ZapA comparisons of SSNN model spectra with their respective original 
spectra scaled with best scaling factors (denoted ‘Concentration’). The scaled 
experimental spectra are in black, the models are in dashed blue. (a) ZapA wild type 
scaled by 8.8, indicating an original concentration of 0.011 mg/mL. (b) ZapA I83E 
mutant scaled by 2.5 indicating an original concentration of 0.04 mg/mL. (c) ZapA 
V17E scaled by 4.1 indicating an original concentration of 0.024 mg/mL. (d) V17E 
scaled at 2.0 times original concentration, note the very large NRMSD.
Analytical Methods             RSCPublishing 
ARTICLE 
 
This journal is © The Royal Society of Chemistry 2013    Analytical Methods, 2013, 00, 1-3 | 1 
SSNN, a method for neural network protein secondary 
structure fitting using circular dichroism data 
Cite	  this:	  DOI:	  10.1039/x0xx00000x	  VINCENT HALL,a,b ANTHONY NASH, a,b,c ALISON 
RODGER*b,d	  
Received (in XXX, XXX) Xth XXXXXXXXX 2013, Accepted Xth XXXXXXXXX 20XX 5 
 
Circular dichroism (CD) spectroscopy is a quick method for measuring data which can be used to determine the 
average secondary structures of proteins, probe their interactions with their environment, and aid in drug discovery. 
This paper describes the operation and testing of a self-organising map (SOM) structure-fitting methodology named 
Secondary Structure Neural Network (SSNN), which is a methodology for estimating protein secondary structure 10 
from CD spectra of unknown proteins using CD spectra of proteins with known X-ray structures. SSNN comes in two 
standalone MATLAB applications for estimating unknown proteins’ structures, one that uses a pre-trained map and 
one that begins by training the SOM with a reference set of the user’s choice. These are available at 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/arodgergroup/research_intro/instrumentation/ssnn/ as 
SSNNGUI and SSNN1_2 respectively. They are available for both Macintosh and Windows formats with two 15 
reference sets: one obtained from the CDPro website, referred to as CDDATA.48 which has 48 protein spectra and 
structures, and one with 53 proteins (CDDATA.48 with 5 additional spectra). Here we compare SSNN with 
CDSSTR, a widely-used secondary structure methodology, and describe how to use the standalone SSNN 
applications. Current input format is Δε per amino acid residue from 240 nm to 190 nm in 1 nm steps for the known 
and unknown proteins and a vector summarising the secondary structure elements of the known proteins. The format 20 
is readily modified to include input data with e.g. extended wavelength ranges or different assignment of secondary 
structures.  
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Introduction 
Circular dichroism spectroscopy is the difference in absorbance 
of left and right circularly polarized light. It is probably most 
often used to estimate the percentages of different secondary 30 
structures that are present in proteins. Assuming that high quality 
data have been collected for the sample of interest and the 
concentration is accurately known, then the question arises as to 
what method is best used to assign secondary structure motifs 
quantitatively. It is now generally recognised that the best 35 
approach is to use spectral data and secondary structures for an 
extensive reference set of proteins and then implement a process 
to estimate the secondary structure content of the unknown 
protein.1-6  
 Some CD spectral features are readily apparent, for example, 40 
an α-helix is characterised by a large positive band at 190 nm 
(part of a π→π* exciton couplet), and two smaller negative bands 
at 208 nm (the other π→π* component) and 222 nm (n→π*). β-
sheets usually show a positive peak between 195 nm and 202 nm, 
and a negative signal between 215 nm and 220 nm, though 45 
sometimes resemble the ‘random coil’ and poly-proline II spectra 
which have a negative signal at 200 nm.4 It is now widely 
accepted that this 200 nm negative band is dominated by 
contributions from residues with poly(proline) type-II 
conformations.7 β-turns have a large negative band at 180 nm–50 
190 nm, a positive signal in the 200 nm–205 nm range (π→π*), 
and a negative signal at 225 nm (n→π*).  
 A number of secondary structure analysis programs, based 
either in statistical methods or intelligent systems, exist that make 
quantitative assignments of percentages of structure type.e.g. 1, 8-11 55 
It is possible to make use of some of these on Dichroweb, an 
online server hosted at Birkbeck, University of London.12 The 
commonly used statistical packages which are available on 
Dichroweb include: CONTIN which is a ridge regression 
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technique; CDSSTR (an update of ‘VARSLC’) which is a 
variable selection, or feature selection, method; and SELCON 
(now SELCON3) which is a self-consistent method together with 
a singular value decomposition, SVD, algorithm. Dichroweb 
includes one intelligent system approach, called K2d,10 which is a 5 
self organizing map (SOM) neural network approach. Although 
the intelligent systems approach appears to have many 
advantages, K2d and its successors including K2D2/3 13-15 and 
SOMCD,16 have not been widely adopted by the CD community. 
As these methods are only available as pre-trained SOMs where 10 
the reference set and structural categories have been defined by 
the original authors, we chose to develop our own CD structure 
fitting SOM: Secondary Structure Neural Network (SSNN) so we 
could test it back-to-back with statistical methods and enable any 
user to train it with new spectral reference sets and different 15 
structure assignment methodologies if the researcher wished to do 
so. This is timely as new data bases are currently being 
developed, greatly facilitated by the recently established Protein 
Circular Dichroism Data Bank.17 
 In summary, SSNN has three independent modules that 20 
operate in sequence.  
SSNN1: takes spectra for a set of proteins of known secondary 
structure content (the reference set) and trains (organises) them so 
that related spectra are put near each other on the map. The map 
has many more nodes to put spectra in than there are spectra, so 25 
the gaps are filled-in with intermediate, virtual spectra. These 
virtual spectra are made by taking weighted sums of the nearby 
experimentally-obtained spectra. 
SSNN2: puts vectors of the secondary structure contents of the 
reference proteins onto a structures map that matches the output 30 
of SSNN1, with structure vectors created for the virtual spectra 
by using the same weighting for the virtual nodes as used for the 
spectra.  
SSNN3: takes as input a CD spectrum of a structurally unknown 
protein (currently in units of Δε/(mol–1dm3cm–1), where the 35 
concentration is that of amino acid residues rather than molecules 
of protein) and produces as output an estimate of its secondary 
structure, a model spectrum, and the spectral NRMSD 
(normalised root mean squared deviation) defined as 
  40 
 
 
 
 
 45 
 
where xi is the value at each wavelength (or structure), N is the 
number of data points, M is the largest intensity, and m is the 
smallest, so (M–m) is the range. SSNN1 and SSNN2 need only be 
performed once for a given reference set. 50 
 In a previous paper 11 we determined the parameters required 
to optimize the performance of SSNN and showed that it 
compared well with SELCON3, K2d, and SOMCD in a leave-
one-out comparison using CDDATA.48 from the CDPro web site 
(http://lamar.colostate.edu/~sreeram/CDPro/). At this time we 55 
made SSNN3 available pre-trained but without detailed 
instructions for use. The overall performance of SSNN-47 and 
SELCON3-47 is similar: SELCON3-47 “won” for 23 out of 48 
spectra, being slightly better on average for α-helix and Other 
structure estimates. Whereas SSNN-47 “won” for 25 out of 48 60 
spectra and on average was slightly better for mixed α-helix/β-
sheets, and β-sheets and turns. Comparisons between SSNN and 
K2d and SOMCD were hampered by lack of re-trainable 
executable versions of K2D and SOMCD so we worked with 
what was available in Dichroweb 4 and the literature 16 creating a 65 
comparison methodology that dis-favoured SSNN. In summary, 
SSNN out-performed K2d and performed better than SOMCD for 
22 of the 33 proteins for which results were available in reference 
16. 
 The aim of this paper is to provide other CD users, including 70 
those in the biopharmaceutical industry, with the tools required to 
use all three modules of SSNN, thus enabling them to work with 
new reference sets and structure definitions should they so desire. 
We also show that SSNN has a firm place in the tool-kit for CD 
structure analysis by showing that it compares very well with 75 
CDSSTR, which Woody and Sreerama previously showed was 
better than SELCON3 for β-distorted structures.3 
Methods 
Reference data set 
The reference data sets used by us to train SSNN in this work are 80 
CDDATA.48 (with data from 240 nm–190 nm taken from the 
CDPro website: http://lamar.colostate.edu/~sreeram/CDPro/) and 
CDDATA.48+5 which is CDDATA.48 augmented with 5 
additional spectra, 2 representing 100% α-helix and 3 100% 
Other structures (some of these are extrapolations). The spectra 85 
are given in per residue molar absorbance units (Δε= mol–1 dm3 
cm–1) and the structures are assigned to 6 structure categories. 
This is the largest available CD reference set that has been 
consistently annotated with secondary structures. Each member 
of the input reference set has 57 numbers. In order they are: 51 90 
for the spectral intensity at each wavelength from 240 nm to 190 
nm, and 6 for the structure values in the order: (α-helix regular, 
α-helix distorted, β-sheet regular, β-sheet distorted, turns, Other 
structures). The CDPro website and its references explain the 
structure types which are summarised in reference 3. In summary 95 
the ‘regular’ structures are the middle of helices and sheets and 
the ‘distorted’ structures at the ends. In the leave-one-out tests 
reported in this paper, each spectrum was removed from the 
reference set in turn and used as the test spectrum. CDSSTR or 
SSNN1 and SSNN2 was/were run with the resulting 47-member 100 
reference set. This was repeated for each member of the reference 
set, this is called leave-one-out cross-validation.  
SSNNGUI 
To run SSNN3, or “SSNNGUI”, pretrained with CDDATA.48+5 
file, the correct version for the computer being used should be 105 
downloaded from 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/ar
odgergroup/research_intro/instrumentation/ssnn/.  
 The details of how to install and run SSNNGUI are in the 
supplementary information. What follows below is an outline of 110 
how to proceed and the results that will be obtained. Table 1 
summarises the steps once the program has been installed on your 
computer. Figure 1 shows SSNNGUI_versA, the version of 
SSNN3 that does not need SSNN1 and SSNN2 to be trained 
before it is used as it already includes the results of training with 115 
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CADATA.48+5. 
 
Figure 1: Screenshot of SSNNGUI 2013a. 
 
Table 1. Protocol to run SSNN3 for test proteins of known 5 
concentration once the application has been installed (see 
Methods and Supplementary Information for details). 
1. Navigate to the folder containing SSNNGUI_2013a.  
2. Click the SSNNGUI.app icon or run the .sh file using Terminal 
as described in the Supplementary Information. 
3. Click on the browse button beside the field that says <Input a 
folder name to save the outputs...>. Navigate to the folder 
containing < SSNNGUI_2013a>, and select any file in it (you 
may need to change the selection criterion to <All files>), as long 
as the folder is correct. The text in the SSNNGUI box will not 
change. 
4. In the field called <Input a test data set> type the name of the 
test file, for example <toxins experiment 1 Friday>. The file type 
should be .txt, but do not include <.txt> in the file name.  
The test file should have columns of 51 data points representing 
the CD spectra from 240 nm to 190 nm. Multiple spectra can be 
in the same .txt file as tab or comma delimited columns. No other 
text should be present. See the example file included in the 
package. 
5. In the field <How many spectra being tested?> put the number 
of spectra in that test file. 
6. Hit the <Run SSNN one dataset> button (“one dataset” means 
one file with, perhaps, multiple spectra). In a few seconds one 
should be presented with the same number of windows as the 
number entered in step 5. These windows will contain two plots. 
The top plot will be the locations of all of the best matching units 
(BMUs), the bottom plot will be the experimental spectrum of a 
protein compared with the model of it that SSNN made, and a 
residual (the difference between the original spectrum and the 
model spectrum). The txt output files should also appear in an 
output folder labelled with the input data file name. 
 
 
 10 
SSNN1_2 
To make SSNN future compatible we have made SSNN available 
as a re-trainable package. The user will be able to use SSNN with 
different data sets as they become available. In the supplementary 
information is a guide on how to use the incarnation of SSNN 15 
that can be retrained. 
RESULTS AND DISCUSSION 
The main result of this paper is the production of a stand-alone 
pretrained GUI for SSNN, called SSNNGUI. We have also made 
versions of SSNN1, 2, and 3 all together in one application 20 
denoted SSNN1_2. They are available at 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/ar
odgergroup/research_intro/instrumentation/ssnn/.  
 SSNN1_2 will allow CD practitioners to train the methodology 
with their own desired reference sets. They may then estimate CD 25 
secondary structures, with the confidence of having used their 
own reference spectra of the test proteins. Preferred reference sets 
might include additional proteins, different methods of structural 
annotation (including number of structure types), different 
wavelength ranges etc. This is particularly attractive as more 30 
good spectra and structures become available from CD, X-ray 
crystallography, NMR and other sources.  
 The SSNN application has various parameters that can be 
varied to train the program in a way tailored to the reference set 
used. For example, practitioners might like to change the number 35 
of iterations, as SSNN may take longer to learn a larger reference 
set than the 28,000 iterations that we found was best for about 50 
spectra.11 
 Care should be taken in changing parameters. For example, the 
initial learning rate follows a negative exponential curve 40 
throughout the training process. Changing this rate will have an 
impact on the whole training. Making the initial learning rate too 
low will cause spectra map spectra to approximate the reference 
set (experimental) spectra too slowly. Making it too high will 
move spectra into position too quickly, which might not produce 45 
a broad enough region for each type of structure. Our 
experiments showed us learning too quickly can be a bad thing.11 
This may also depend on the size of the map. 
 The emergency stop button has been included in the program, 
though in our experience it has never had to be used in SSNNGUI 50 
in practice. It does shut down the application completely, 
although it takes a little time to do so. 
 Among other functions, SSNN model spectra residuals should 
also highlight which wavelengths of the test protein spectra 
produce the most error. SSNN treats all wavelengths equally, so a 55 
larger error in one region of a spectrum could throw off the 
estimation. If this correlates with a region of the spectrum where 
the data quality is poor, the user may want to ignore this 
contribution to the NRMSD. Users should also check that model 
spectra have appropriate intensities at certain wavelengths. For 60 
example β-sheet-rich protein models should have a single 
negative peak between 215 nm and 220 nm, whereas α-helix-rich 
proteins should have negative peaks at 208 nm and 222 nm. 
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Comparison of SSNN and CDSSTR 
 
We previously ran SSNN1,2, and 3 48 times in a leave-one-out 5 
methodology using 47 spectra of CDDATA.48 as the reference 
data set and the omitted one as the test spectrum each time.11 We 
refer to this as SSNN-47. In this way we ensured that the test 
spectra spanned structural space and also that the structure 
annotation was the same for the reference set and the test spectra. 10 
Table 2 and Table SI1 show net the results (final rows) of the 
previous work and details of an analogous leave-one-out test 
performed here for CDSSTR (CDSSTR-47) using the executable 
version available on the CDPro web site. The sum of the absolute 
values of the deviations from the fractions of real structures is 15 
also given for SELCON3-47 in the final lines of the Table SI1. 
SELCON3-47 data are from 11. We also ran the leave-one-out test 
for SSNN-52 (i.e. CDDATA.48+5) and have shown the detailed 
results in Table SI1. 
 In summary, for the CDDATA.48 SELCON3 is best for high 20 
α-helix structures, SSNN is best for medium α-helix and ‘Other’ 
structures, and joint best for β-sheets. CDSSTR is joint best for 
distorted β-sheets. When reduced to 3 structure types α-helix, β-
sheet and Turns-plus-other (data not shown), SELCON3 remains 
best for α-helices and SSNN for β-sheets and Turns-plus-Other. 25 
The somewhat disconcerting result given in Table SI1 is that 
CDSSTR has the best spectral NRMSD (Table SI1) but this does 
not translate into the best structural predictions. It is satisfying to 
note that the augmented reference set, CDDATA.48+5, leads to 
the SSNN-52 results being better than all the CDDATA.48 30 
results.  
 As noted previously,11 it is important to inspect the model 
spectrum outputted by a fitting program. The metrics currently 
used to assess fit do not give extra significance to the 218 nm 
region of the spectrum which is a negative maximum for β-sheet 35 
structures and a negative minimum between two negative 
maxima for α-helical structures. This is illustrated for 
carboxypeptidase A which has low spectral NRMSDs for 
CDSSTR-47 of 0.075 and for SSNN-47 of 0.067, but high 
structural NRMSDs of 0.68 and 0.34 respectively. The overlay of 40 
their plots is given in Figure 2a, showing the difference in 
spectral structure that is ‘obvious’ to the eye but not to an equally 
weighted numeric estimate of spectral NRMSD that the SSNN 
model spectrum is not helical enough. Conversely Rat Intestinal 
Fatty Acid Binding Protein (Figure 2b) is modelled to be more 45 
helix than reality. CDSSTR has much larger structural NRMSD 
than SSNN but the spectral fit looks better, illustrating the 
comment made above about CDSSTR.  
 Another example is provided by rat intestinal fatty acid 
binding protein, where both CDSSTR-47 and SSNN-47 make 50 
reasonably good spectral models (NRMSDs: 0.065, and 0.076 for 
CDSSTR-47 and SSNN-47 respectively), but very bad structural 
estimations (NRMSDs: 0.81 and 0.76). This indicated by poor 
agreement between model and experimental spectra at 218 nm, 
due in this case to the fact that this highly β-sheet spectrum has 55 
unusually large magnitude which is not reflected in the reference 
set (Figure 2b).  
 Table 2 shows the performance of the programs on particular 
classes of proteins. Mixed α/β proteins remain the most 
challenging for all the programs and a critical human eye is an 60 
invaluable tool for assessing the output from any of the programs. 
Although SSNN-47 and CDSSTR-47 mixed α/β proteins 
estimates are done as well as certain other structure types, mixed 
α/β proteins are consistently badly done by all methodologies. 
 The challenge in estimating the Other class is that it is an 65 
amalgam of various undefined structures that have different 
spectral features. Putting these into one class implies they have 
similar spectra and structures—which is misleading.  
 
 70 
 
Figure 2. (a) Carboxypeptidase A experimental CD spectrum and 
best fit from CDSSTR-47 and SSNN-47. (b) Rat Intestinal Fatty 
Acid Binding Protein experimental spectrum and best fit from 
SSNN-47. 75 
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Table 2. Structural NRMSDs for SSNN-52 and CDSSTR-47 from the 
data in Table SI1 for different structural classes of protein. Here, except 
for ‘Overall’, there are only 3 structural classes α-helix, β-sheet and 
‘Other’.  “Errors” are one standard deviation of the variation between 5 
proteins in the class.  
Program Overall 
6-column 
> 50% α-
helix 
30%–50% α-
helix 
>30% β-
sheet 
>50% 
Other 
SELCON3-47 0.2±0.2 0.1±0.1 0.3±0.3 0.3±0.2 0.2±0.2 
CDSSTR-47 0.3±0.2 0.2±0.2 0.3±0.2 0.2±0.2 0.3±0.2 
 
 
SSNN-47 0.2±0.2 0.2±0.1 0.2±0.2 0.2±0.2 0.2±0.1 
SSNN-52  0.1 ± 0.1 
 
0.10±0.07 0.14±0.08 0.2±0.2 0.10±0.06 
 
Some examples 
To further illustrate SSNN and to give a new user some known 
examples to test their installation of the software, data sets for the 10 
biopharmaceutical product spectra of Figure 3 are included on the 
web site. The highly helical protein shows an exceedingly good 
fit with 83% helix and 0% sheet. The antibody spectral fit is not 
as good, but the key spectra features are reproduced with 5% 
helix and 38% sheet which is consistent with a slightly relaxed 15 
version of antibody crystal structures e.g. PDB 1IGT which is 
annotated by DSSP to be 6% helix and 47% sheet 18 and 
consistent with CDSSTR which suggests the spectrum is 3% 
helix and 35% sheet. The mixed structure asparaginase spectrum 
of Figure 3c has a small NRMSD and indicates 31% α-helix and 20 
16% β-sheet, which compares with the crystal structure values of 
31% and 23%.19 The lower estimates of sheet content from CD 
and SSNN on solution data compared with x-ray diffraction on 
crystals are not surprising given the dynamic nature of proteins in 
solution. 25 
 
 
 
  
 30 
 
Figure 3. CD spectra and SSNN BMUs and model spectra for a range of 
biopharmaceutical product proteins. (a) A highly helical protein, SSNN 
structure vector (0.85, 0.07, 0.00, 0.00, 0.02, 0.05). (b) Antibody 
spectrum with structure vector (0.01, 0.04, 0.23, 0.15, 0.23, 0.34). (c) 35 
Asparaginase spectrum with structure vector (0.17, 0.14, 0.09, 0.07, 0.23, 
0.31). Input data sets are available in SI. 
Conclusions 
We have made all parts of a neural network self organising map 
method of protein secondary structure determination from 40 
circular dichroism spectroscopy available a stand-alone program. 
SSNNGUI.app is a version that has been pre-trained with a 
currently available reference set. If a different reference set is 
desired, the first and second modules, SSNN1 and SSNN2 need 
to be run once for every new reference set used. These, and 45 
SSNN3 for structure estimation, are available in the second of 
two GUIs, named SSNN1_2.app. The output from the first two 
modules is internally used as input to SSNN3 which gives a 
secondary structure estimate for unknown proteins. All spectral 
data (reference set and test proteins) are formatted in our 50 
implementation as columns of 51 intensity points at 1 nm 
resolution from 240 nm to 190 nm in units of Δε (where the 
concentration is that of amino acids). Any other resolution or 
units can be sued as long as the reference and test spectra use the 
same. This means that a SOM secondary structure fitting 55 
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methodology is now available for use with new reference sets, 
e.g. for membrane proteins. 
 We have also shown that SSNN compares well with the 
statistical programs CDSSTR and SELCON3.11 Although on 
average the methods can each be deemed to perform best for 5 
some secondary structures. For proteins known to have a high α-
helix content, SELCON3 should be used to estimate structures. 
Both CDSSTR and SSNN are better at estimating β-sheet-rich 
proteins, and for intermediate and ‘Other’ proteins, SSNN is best. 
In practice by augmenting CDDATA.48 with 5 more reference 10 
spectra we have enhanced the performance of SSNN beyond that 
of the other methods in all but two cases. In practice, to obtain the 
most accurate picture of the structures of proteins it is advisable 
to use a few different secondary structure estimation 
methodologies, and trust them where a majority of them agree. If 15 
they agree then there can be confidence in the results and if they 
differ or the NRMSDs are high then care must be taken. Due to 
the simple metrics currently used by all fitting programs to assess 
goodness of spectral fit, we recommend complementing fitting 
programs with a visual inspection of the overlay of experimental 20 
data and model spectrum, particularly in the 215 nm region of the 
spectrum. 
 SSNN can be trained with pretty much any reference set for 
which structures are available. Thus SSNN could easily be 
adapted to a variety of data; examples could include CD data for 25 
membrane proteins, and infrared spectroscopy data.  
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The supplementary information given below includes detailed instructions on how to install SSNN and also the 
detailed output from SSNNGUI.app and CDsstr for 48 proteins used in leave-one-out mode (SSNN1 and SSNN2 
were run for the 48 sets of 47 spectra from CDDATA48). 
Installing the MATLAB MCR and SSNNGUI 
Download the appropriate version of SSNNGUI for your computer from 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/arodgergroup/research_intro/instrumentation/ssnn/ 
(this may take some time). Unpack or unzip the SSNNGUI package, and use the MCR installer to install the 
MATLAB Compiler Runtime, so first unpack or unzip it. Unfortunately, different MCRs are required for different 
operating systems and the Mathworks MATLAB website only makes available the MCR going back a few versions. 
Installing the MATLAB Compiler Runtime on a PC should be straightforward if the correct one is chosen; the XP 
version of SSNN1_2 works fine on Windows 7 Enterprise. If it does not work, make sure you have run through the 
MCR installation process. 
 The situation is more complicated for a Macintosh. For the SSNN_Mac2013a release, one should install MATLAB 
R2013a MCR, as other MCRs are not compatible. To run this MCR installer launch <InstallForMacOSX.app> (the 
default will be to install it in the <Applications/MATLAB/MATLAB_Compiler_Runtime> folder). Follow 
instructions on screen until it asks to you to do something with the DYLD_LIBRARY_PATH and XAPPLRESDIR. 
It is essential that every character within the relevant <> is correctly typed from the following instructions. Towards 
the end of the MCR installation, the MCR installer displays messages about DYLD_LIBRARY_PATH and 
XAPPLRESDIR. The relevant changes can be made in the Terminal application (found within the Utilities folder of 
<Applications>). In Terminal, type <cd ../> press enter. Repeat typing <cd ../>, press enter then <ls> enter until the 
list includes <Application> in the list of files. Then type <cd Applications/MATLAB>. Then enter the following (see 
Figure S1): <export 
DYLD_LIBRARY_PATH=/Applications/MATLAB/MATLAB_Compiler_Runtime/v81/runtime/maci64:/Applicatio
ns/MATLAB/MATLAB_Compiler_Runtime/v81/sys/os/maci64:/Applications/MATLAB/MATLAB_Compiler_Runt
ime/v81/bin/maci64:/System/Library/Frameworks/JavaVM.framework/JavaVM:/System/Library/Frameworks/JavaV
M.framework/Libraries>. You should be fine if copying and pasting from the MCR installer window or this paper, 
but remember to include the <export DYLD_LIBRARY_PATH=> before the /Applications. 
 If an error message e.g. <not a valid identifier> appears, check every character in the above text Then type <export 
XAPPLRESDIR=/Applications/MATLAB/MATLAB_Compiler_Runtime/v81/X11/app-defaults>, also mostly 
copied from the MCR installer.  
 Using the command <env> will show you all of the environment variables, and these should be there now, as 
above.  You can now quit Terminal. 
Click <next> in the MCR installation window. Click <Finish>. The MCR is now installed. 
 
 
Figure S1: The command to export the DYLD library path should look like this in Terminal if your computer is 
called Vince-Hall. 
 
Using SSNNGUI with pre-trained SSNN1 and SSNN2 
In the <SSNN_2013a_pkg> folder, launch the <SSNN_2013a.app> application. The best way to do this is using the 
shell. This is a file that is run in the command line, but does not require the user to input any command line 
commands. “Right-click” (or ctrl+tap touchpad in Mac) the <run_SSNN_2013a.sh> file, click <Open With Other…>, 
scroll to Utilities, then <Terminal.app>.  The user might have to select Enable All Applications. Then click open. A 
Terminal window should open, and might display an error message. Do not worry about that, just wait a few second, 
and the SSNN application should launch. 
 Place the required test file in the correct format (see <example_3proteins.txt>) in the same folder as 
<SSNN_2013a.app>. The instructions in the Protocol of Table 1 should then be followed for a protein of known 
concentration.  
 To run SSNNGUI first locate the folder with the trained maps and the test spectra by entering the file path in the 
field marked with <Enter FULL_filepath_from_Users_or_root_no_slash> or click the <Browse> button to find it 
graphically (select any file within the correct folder). In the next field enter the name of the test file with no file 
extension (no .txt on the end). Enter the number of test spectra in the test file in the appropriate field. Click the “Run 
SSNN one dataset” button. 
 SSNNGUI has an option be run with automatic adjustment of concentrations of the test proteins, but that is not 
covered in this article. So here, ignore the <Run SSNN many concentrations> button, and the <Min concentration>, 
<Step concentration> and <Max concentration> fields. 
 The outputs from SSNN3 are the following files: 
 
Spectral_NRMSD_vs_concentration_error_protein_1.pdf 
best_concentrations.txt 
all_NRMSDs.txt 
all_NRMSDs_sorted.txt 
 
Then in the folders with names like “53p40x40MAP_5_BMUs_28000ITER_0_06L0_60_Conc”: 
Which_are_BMUs1_spectra_of_Winners.txt 
Which_are_BMUs2_The_training_set.txt 
Which_are_BMUs3_locations_of_Winners.txt 
ssnn_residuals.txt 
ssnn_real_spectra.txt 
ssnn_predicted_spectra.txt 
SSNN_parameters_extended.txt 
RMSDspect.txt 
plots_with_residuals 
 
 If SSNN is taking too long to run on a laptop computer, it can be put in standby and the run will continue when it 
is opened again. If there is a problem, open the log viewer (for example Console) to see more output, and any error 
messages. All of the windows can be closed after the plots of model against experimental CD spectra have been 
displayed. Do not close any windows before SSNN has stopped running. There should be one figure per protein 
spectrum if running the SSNN one data set, or wait for the NRMSD against concentration plots, one per protein 
spectrum if running the SSNN many concentrations. If you are running the program from the command line (this is 
the case if running it from the .sh file), then there will be a lot of output from the SSNN. 
 
Running SSNN re-trainable, or “SSNN1_2” 
Assuming that the appropriate MCR is installed (see Running SSNN3 above), one should be able to run 
SSNN1_2.app. When the user double-clicks on the SSNN application, it will take a few second to start up (Figure 
S2). 
SSNN1 
SSNN1 requires a reference set to be loaded in as a .txt file with the following format. Each protein CD spectrum and 
structure vector is a column of 57 entries (CD intensities for 240–290 nm at 1 nm spacing followed by 6 structure 
types summing to 1.00). The column vectors are placed side by side in the same file, in a tab or comma delimited 
format. For example, the reference set (CDDATA.48+5) used to train this version of SSNN has 53 proteins in an 
input file of size 57×53. That is CD intensities at 51 nm points, and 6 structure types, for 53 proteins. This input file is 
loaded using the SSNN graphical user interface (GUI, not “SSNNGUI”), designed for this purpose before SSNN1 is 
run. The structure information is not used in the training of SSNN1, only the spectral data are used at this stage. 
SSNN1 outputs a spectra map, which is then used by SSNN2 to give the corresponding structures map, and by 
SSNN3 to make models of the test protein spectra, and give structure estimations.  
 
SSNN2 
SSNN2 requires the same input file as SSNN1 as well as the SSNN1 output. The spectra in the input file are used to 
locate their representations on the spectra map, then the structures of each protein are added to the structure map at 
the same coordinates. SSNN2 outputs a structures map to correspond to the spectra map.  
 
Figure S2: shows the SSNN1_2 application, which incorporates SSNN3. 
 
SSNN1_2.app 
The application SSNN1_2.app is available from  
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/arodgergroup/research_intro/instrumentation/ssnn/. It 
runs SSNN1, SSNN2, and SSNN3. The instructions below assume that the pretrained version SSNNGUI has been 
successfully run by the user. It is available in two Macintosh versions: MATLAB R2011a for Mac OS X 10.6.8 and 
MATLAB R2013a for OS X 10.8, as well as a MATLAB R2011b version for Windows XP, and a R2013a Windows 
7 version. This application can be used to train SSNN with any data set of the correct format. We have provided 
CDDATA.48 and CDDATA.48+5 (see above). For the SSNN1_2_Mac2011a release (see below) the MATLAB 
R2011a MCR needs to be installed as described above. 
 To run the application, double click on the SSNN1_2*.app icon, then wait for the application to launch. Figure S2 
shows the screen which controls the running of the application.  SSNN1_2* means some file with a name that starts 
with “SSNN1_2”. 
 
i. In the top left there is an editable text field called <FOLDER for reference set for training>. For this field 
the user has two options: either to type in the full folder path from “/Users/” to the folder in which the 
reference set file is located or click on “Browse…” to navigate to it graphically. The reference set path and 
save path don’t visibly update, but they are actually entered once the user has clicked on the “Browse…” 
button..   
ii. The second field is for editable text (<reference set FILE with .extension>), this is the name of the 
reference set file to train SSNN with. It should be named with the extension. It is made to take .txt files. 
One has to type in the reference set name, there is no option to select it graphically, this is for code reasons..   
iii. The same options are available for the third field as for the first. This is called <path to save to>. This is a 
folder in which all output .txt files and figures will be saved, it can be the same as the reference path/folder. 
One can skip training if one changes the Weights and Structures folder date to today’s, in which case they 
should not worry about entering anything into the second field. 
iv. In the fourth field, <name of text file NO .extension>, the user should type the name of the test spectrum 
file without the .txt extension, for folder naming purposes in the code. This file should have number of 
rows matching “Spectrum size”, and columns matching <How many test proteins>, and contain just spectra 
in the same range as the reference set file (in our case 51 rows of data from 240 – 190 nm in steps of 1 nm). 
One has to type in the test set name, there’s no option to browse.                                   
v. On the right side of the GUI, in the box with the thin green border, there are 10 fields. The first is 
“Spectrum size”, this is where the user should tell SSNN1_2 how many wavelength points there are. (Data 
are in 1 nm steps in the reference sets provided.)  
vi. The second field on the right is <Number of proteins> to tell SSNN1_2 how many columns there are in the 
reference set file loaded.  
vii. Field 3 is <Training set size>. This will be smaller than the reference set size only if the user wants to train 
the SOM in leave-one-out-cross-validation; the SOM can be trained with one protein less than the full set 
size.  
viii. <Structure types> is the number of structure types that have been assigned in the chosen reference set (6 in 
those supplied).  
ix. <Map length one side> is so that SSNN can make a square map with the length or width of the number 
entered here.  
x. < Initial neighbourhood size> is how much of the map should be modified in the first iteration of training to 
make it more similar to the best matching unit, BMU, at the centre of the neighbourhood and the protein 
spectrum that was chosen first. A neighbourhood is needed to cluster, otherwise dissimilar spectra would be 
near each other. The neighbourhood size will decrease with iterations to make the clustering more precise.  
xi. <Initial learning rate> is how fast the BMUs will become more like the reference set. This decreases with 
iterations.  
xii. < Number of iterations> this is the length of training of the SOM. We found that 28 000 iterations gave the 
best results (lowest structure estimation NRMSD) with our choice of map size, reference set size etc..  
xiii. <Which is test protein?> allows the user to exclude a protein (referenced by its number describing its 
position in the list) from the training set. If the user wants to train with the full reference set, then this field 
should be left empty, and <Training set size> should have the same number as <Number of proteins>. The 
10th field  
xiv. < How many test proteins?> asks how many proteins will be in the test file.  
xv. At the bottom of the GUI there are three fields that are to be used if the intensities of the test spectra need to 
be scaled, if for example the pathlength or concentration is likely to be in error. The fields are  
xvi. <Min concentration>, < Step concentration>, and < Max concentration>. These are left empty if not 
required, they are for use when running “SSNN many concentration”, and are not covered in this article. 
 To run the first two modules of SSNN1_2*.app, hit the <Train SSNN> button at the top left. Once the <Train 
SSNN> button has been clicked, there will be a pause before any output appears, then a window should pop up 
saying that 100 iterations have been completed, then further windows, counting up in 1000s from 1000. If you skip 
training, after modifying the name of the Weights and Structures folder to have today’s date, then the figures will be 
much quicker to appear, see below. 
SSNN3 part of SSNN1_2 
Once the SOM has been trained by running SSNN1 and SSNN2 as outlined above, a <Weights_and_Structures…> 
folder will have been created. Then the <SSNN3 one concentration> button of SSNN1_2 can be clicked to produce 
the structure estimations for the test protein(s) as in the SSNNGUI version described above and in the main text. 
SSNN3 has finished running, when the final protein model against experimental CD spectrum plot pops up. This 
means one can close all the windows, there should be one for each spectrum in the test set.  
 For troubleshooting in Mac OS X 10.6.8, Console can be useful, as there will be some rather verbose output from 
SSNN1_2 appearing here. (This may not work for 10.8.x’s Console, so try running it in the command line using the 
shell.) The Windows equivalent is Event Viewer. In Linux various applications are available including MultiTail, 
System Log Viewer, KSystemLog, Xlogmaster and swatch. 
 
 
Table SI1: Structure vectors outputted from SSNN-47 and CDSSTR-47 for all proteins in CDDATA.48 from the CDPro web site 
tested in a leave-one-out methodology. SSNN was trained with 47 proteins 28,000 iterations, a map size of 40×40, initial 
neighbourhood of 20, BMUs = 5, L0 = 0.1, t1 = 7,000 iterations, and a k1 = 5×10–6. CDSSTR-47 was run using the executable code 
available at http://lamar.colostate.edu/~sreeram/CDPro/main.html 1 using input files based on CDDATA.48 and SSDATA.48 but 
with one spectrum removed to be the test spectrum and structure each time. Average SELCON3 performance from 2 is also 
included. 
 
Protein 
number Protein name Method a-regular a-distorted b-regular b-distorted Turns Other Spectral NRMSD Structural NRMSD Fit minus real: a-regular Fit minus real: a-distorted Fit minus real: b-regular Fit minus real: b-distorted Fit minus real: turns Fit minus real: other CDSSTR NRMSD – SSNN NRMSD
! "#$%&'"()*)+,&- ./"0 12111 12111 121!3 12145 12673 12817 12111
9:;;<.#3= #12114 121>6 12>1! 12!>7 12614 12>!5 12!3> 125>1 #12114 121>6 1267= 1213> #121=5 #1264> 123>6
;;??#56 121!5 121>6 12178 12!16 126>4 12568 12>86 12147 121!5 121>6 121=6 1211= #12135 #12176
6 @0A)B)0-:/BCD()'/&"E/ ./"0 12!>4 12!!5 12!>4 12148 126!3 1264= 12111
9:;;<.#3= 12!5> 12!6> 12!84 12144 12616 12637 121== 12!8= 121!3 12117 121>1 1211> #121!6 #12134 12185
;;??#56 12!65 12!13 12!=3 12!11 12661 126== 121>> 12!16 #121!3 #121!! 121>5 12113 12118 #12161
> @D/&C0"*/-F,&"E/ ./"0 12>31 12618 121== 12156 121!6 12>!> 12111
9:;;<.#3= 12675 12!83 12143 121=6 12!7= 12!48 121>1 12367 #12155 #12136 121!= 12161 12!=5 #12!!= 1261>
;;??#56 126== 12!71 121=3 12186 12!!8 1264! 1216! 12665 #1218> #12168 #1211> 121!1 12!13 #12166
3 @G%(,&- ./"0 1213= 12186 12!3! 12!14 12>!6 12>67 12111
9:;;<.#3= 12!!7 12!13 126!> 12!6! 12!45 1263! 12!!5 12535 121=! 12136 121=6 121!6 #12!!= #1217= 123>=
;;??#56 121=> 121=8 12!=1 12!13 126=! 12>1= 121=> 12!17 12168 121!3 12164 #12115 #1213! #1216!
5 H#0"A*)'0)H%0,&- ./"0 12158 12!!! 1267= 12!6> 126!8 1261= 12111
9:;;<.#3= 12!11 12141 12!55 12!16 126!! 12>>= 12137 12>!4 12133 #1216! #12!>6 #1216! #12115 12!>1 12!4>
;;??#56 121=3 12!!1 12635 12!!4 126!7 126>> 12138 12!68 121!7 #1211! #12136 #12113 12116 12168
8 $/&A/-I)&/E-J()*/,&- ./"0 12111 12167 12643 12!48 12664 12656 12111
9:;;<.#3= #121!3 12113 126== 12!34 1266= 12>>5 12!=! 12!!7 #121!3 #12163 #121!= #1213= #12116 1217> 121>6
;;??#56 1211> 121>5 1268= 12!=6 1266! 12>1> 1268> 12178 1211> 1211= #1216= #12163 #12117 1215!
= $)K,&/-J"&A(/"*,A-<(CLE,&-M&B,H,*)(./"0 12184 12!>7 12!=6 12184 12!41 12>86 12111
9:;;<.#3= 12!66 12148 12181 12133 12!!= 1258! 12!!3 12!47 1215> #12136 #12!!6 #12165 #121=> 12!44 12!!3
;;??#56 121=3 12!!6 12!3= 121=! 12!=> 12366 12!>= 12173 12115 #12168 #12165 12116 #121!= 12181
7 9"(H)&,A-@&BCD("E/ ./"0 12157 12!13 12!=1 12!!8 12631 12>!6 12111
9:;;<.#3= 1216> 121>3 12148 12153 12!17 128=4 12181 12655 #121>5 #121=1 #121=3 #12186 #12!>6 12>8= 121!4
;;??#56 1213> 12157 12!16 12187 12!>! 12547 12153 126>8 #121!5 #12138 #12187 #12137 #12!14 12678
4 "0LB"-ABCN)*(,LE,&)'/&-)(-9O@./"0 1215> 12176 126!1 12!!1 126!1 12>>5 12111
9:;;<.#3= 121!1 121>5 12!37 12177 12!=8 125>5 12!1= 12!=> #1213> #1213= #12186 #12166 #121>3 12611 1211>
;;??#56 12151 121=> 12!3= 121=7 12!5> 12347 12187 12!=! #1211> #12114 #1218> #121>6 #1215= 12!8>
!1 "#9BCN)*(CLE,&- ./"0 12184 12135 12617 12!18 12611 12>=! 12111
9:;;<.#3= 12167 1213! 12!5> 121=> 12!36 12533 12186 12!58 #1213! #12113 #12155 #121>> #12157 12!=> 121==
;;??#56 12151 1213> 12!=5 1214= 12!47 123>= 12!1= 12171 #121!4 #12116 #121>> #12114 #12116 12188
!! 9)0,A,&-@ ./"0 12564 12665 12111 12111 12133 12616 12111
9:;;<.#3= 12563 12671 121>6 121!7 1215! 1217> 1216> 12!!1 #12115 12155 121>6 121!7 1211= #12!!4 1218!
;;??#56 12344 12!47 1211= 121!6 12175 12!47 12163 12134 #121>1 #1216= 1211= 121!6 1213! #12113
!6 9)&A"&"K"0,&-@ ./"0 12111 121>7 12>64 12!>5 126>8 12686 12111
9:;;<.#3= 121== 121=8 12!7= 12!61 12615 12>>8 126>3 12641 121== 121>7 #12!36 #121!5 #121>! 121=3 12633
;;??#56 12161 1215! 12>63 12!>1 126!6 1268> 12151 12138 12161 121!> #12115 #12115 #12163 1211!
!> 9"(H)+CL/LE,D"E/-@ ./"0 12653 12!6= 12!!! 12156 126!6 12633 12111
9:;;<.#3= 12!66 12!17 1266! 12!6> 1266> 12613 121=5 12871 #12!>6 #121!4 12!!1 121=! 121!! #12131 12>>=
;;??#56 12!=7 12!13 12!44 12175 12616 126>6 1218= 12>36 #121=8 #1216> 12177 121>> #121!1 #121!6
!3 9C*)AB()N/-9 ./"0 126!3 12!43 12111 12111 126>> 12>54 12111
9:;;<.#3= 12613 12!8! 12!11 121=8 12!=! 12641 1215> 12>15 #121!1 #121>> 12!11 121=8 #12186 #12184 12!35
;;??#56 12!47 12!53 1218> 12158 12615 12>63 12153 12!8! #121!8 #12131 1218> 12158 #12167 #121>5
!5 PA).!-P&D)&%A0/"E/ ./"0 12!46 12!6= 12147 12171 126!1 1264> 12111
9:;;<.#3= 12614 12!3= 12!13 121=7 12!84 1264! 12134 12143 121!= 12161 12118 #12116 #1213! #12116 1213>
;;??#56 12!4> 12!38 12176 121=8 126!8 12678 12151 12156 1211! 121!4 #121!8 #12113 12118 #1211=
!8 P0"E*"E/- ./"0 1216! 1217= 12665 12!!= 12617 12>36 12111
9:;;<.#3= #1211> 1216! 12!54 1214= 12!83 1255! 121=! 12!=> #12163 #12188 #12188 #12161 #12133 12614 1211!
;;??#56 121!4 1215= 12!56 1217> 12!55 125>3 12146 12!=6 #12116 #121>1 #121=> #121>3 #1215> 12!46
!= Q0"K)D)+,&- ./"0 12614 12!17 12!17 12!17 12683 1261> 12111
9:;;<.#3= 12!>8 12!!1 12!35 12146 126!1 12>14 12131 126=> #121=> 12116 121>= #121!8 #12153 12!18 12!17
;;??#56 12!7> 12!!4 12145 1217= 1265> 1268> 121>8 12!85 #12168 121!! #121!> #1216! #121!! 12181
!7 '#9(CE*"0,&- ./"0 12118 12178 12644 12!8! 12!14 12>>4 12111
9:;;<.#3= #121!> 12111 126>5 12!38 126=> 12>31 12!!7 12667 #121!4 #12178 #12183 #121!5 12!83 1211! 12!51
;;??#56 12113 12183 12>18 12!5! 12!57 12>!= 12311 121=7 #12116 #12166 1211= #121!1 12134 #12166
!4 O(//&-Q0%)(/EA/&*-J()*/,&-./"0 12113 12183 12>3= 1214> 12!4! 12>1! 12111
9:;;<.#3= 121=3 12178 126!4 12!>! 1263! 12634 12!57 12>4> 121=1 12166 #12!67 121>7 12151 #12156 12>37
;;??#56 1216> 12157 12>>3 12!!1 12!46 1267> 1214> 12135 121!4 #12118 #121!> 121!= 1211! #121!7
61 O0CA/("0D/BCD/#>#LB)ELB"*/-D/BCD()'/&"E/./"0 12!=6 12!16 12!!5 1214> 126!= 12>1! 12111
9:;;<.#3= 12!=7 12!6= 12143 121=! 12!=6 12>81 12164 12!!4 12118 12165 #1216! #12166 #12135 12154 121=5
;;??#56 12!=1 12!!4 12!15 12176 1266> 12>1! 121>! 12133 #12116 121!= #121!1 #121!! 12118 12111
6! O0%*"*B,)&/-./D%A*"E/ ./"0 12!77 12!36 12!31 12148 12!=6 12686 12111
9:;;<.#3= 12!87 12!6= 12141 12188 12!8= 12>=4 1213! 12!=3 #12161 #121!5 #12151 #121>1 #12115 12!!= 12164
;;??#56 12!37 12!6> 12!68 12148 126!3 1264> 121>3 12!33 #12131 #121!4 #121!3 12111 12136 121>!
66 R/N)'0)H,&- ./"0 125>= 1266> 12111 12111 12!15 12!>8 12111
9:;;<.#3= 1256= 12648 121>4 121!! 12186 12186 121!3 12145 #121!1 121=> 121>4 121!! #1213> #121=3 12183
;;??#56 1258> 12!45 12118 12115 12141 12!3! 12135 121>! 12168 #12167 12118 12115 #121!5 12115
6> R/N/(C*B(,&- ./"0 123=7 12!4= 12111 12111 12!!! 126!5 12111
9:;;<.#3= 123!8 12661 121=1 12181 12!67 12!13 12161 12!7> #12186 1216> 121=1 12181 121!= #12!!! 12!33
;;??#56 123=7 12!46 12163 121!7 12!15 12!73 12131 121>4 12111 #12115 12163 121!7 #12118 #121>!
63 ."*-M&*/E*,&"0-Q"**C-@A,D-$,&D,&'-J()*/,&./"0 1215> 1218! 123>6 12!56 12!56 12!56 12111
9:;;<.#3= 12!!> 12!1> 12!31 12!15 1268> 126=4 12185 12717 12181 12136 #12646 #1213= 12!!! 12!6= 1215!
;;??#56 12!5! 12145 12664 12!1! 12615 126!4 121=8 12=5= 12147 121>3 #1261> #1215! 1215> 1218=
  
Protein 
number Protein name Method a-regular a-distorted b-regular b-distorted Turns Other Spectral NRMSD Structural NRMSD Fit minus real: a-regular Fit minus real: a-distorted Fit minus real: b-regular Fit minus real: b-distorted Fit minus real: turns Fit minus real: other CDSSTR NRMSD – SSNN NRMSD
!" #$%&'($) *+,' -.!/0 -.!1" -.-!- -.-0- -.-"- -.123 -.---
45667*809 -.!:2 -.!12 -.-:! -.-"1 -.3/3 -.3"1 -.-0- -.0"0 8-.--: -.--3 -.-2! -.-31 -.303 8-.!-: -.1-/
66;;8"! -.!:: -.!32 -.-!2 -.-02 -.3!1 -.1-- -.-02 -.30" 8-.--2 8-.-3/ -.--2 -.--2 -.-91 8-.-23
!2 <,=>,>+)5+?@ABCD+$,%+ *+,' -.!99 -.323 -.-:: -.-91 -.3"" -.!02 -.---
45667*809 -.!/1 -.392 -.-99 -.-2! -.32" -.!!: -.-12 -.-2- -.-32 -.-3" 8-.-33 8-.-33 -.-3- 8-.-3: 8-.-!:
66;;8"! -.!/- -.39/ -.-:1 -.-29 -.339 -.!20 -.-!" -.-:: -.-31 -.-3: 8-.--" 8-.--2 8-.-1: -.-3:
!9 <@%CE@F+) *+,' -.!-! -.!39 -.-32 -.-09 -.!/: -.!!3 -.---
45667*809 -.!": -.39: -.-22 -.-09 -.3!- -.1!2 -.-2/ -.1!9 -.-"2 8-.-1/ -.-"- -.--- 8-.39: -.3-" -.39/
66;;8"! -.3/" -.3:3 -.-"- -.-21 -.!"9 -.!"" -.-"- -.30: 8-.--9 8-.-12 -.-10 -.-32 8-.-03 -.-10
!: G@CD'CH($) *+,' -.":! -.!!! -.--- -.--- -.-"! -.300 -.---
45667*809 -.":9 -.1-2 -.-!3 -.--1 -.-1" -.-0/ -.-3- -.-/3 -.--" -.-:0 -.-!3 -.--1 8-.-39 8-.-/" -.-13
66;;8"! -.2"/ -.39! -.--1 -.--! -.-"3 -.330 -.-13 -.-2- -.-99 8-.-"- -.--1 -.--! 8-.--3 8-.-1-
!/ ;&='+,%+) *+,' -.-/0 -.3-3 -.-:3 -.3-9 -.!:/ -.1!: -.---
45667*809 -.3:! -.303 -.-:1 -.-": -.322 -.19" -.-09 -.!!- -.-:: -.-0- -.--! 8-.-0/ 8-.3!1 -.-09 -.-:/
66;;8"! -.311 -.3!3 -.-/2 -.-/2 -.!0/ -.1-" -.-19 -.313 -.-1/ -.-!- -.-3" 8-.-33 8-.-0- 8-.-!1
1- I,J,($) *+,' -.319 -.3!1 -.-/0 -.-9" -.39" -.1/2 -.---
45667*809 -.-0- -.-1! -.301 -.3-: -.!!! -.00/ -.-9/ -.3": 8-.-/9 8-.-/3 -.-0/ -.-11 -.-09 -.-"1 -.3-0
66;;8"! -.3!! -.33! -.333 -.-:0 -.3/" -.192 -.-/0 -.-"" 8-.-3" 8-.-33 -.-39 -.--/ -.-!- 8-.-!-
13 I,BK,'H&F($) *+,' -.!9: -.!:9 -.--- -.-19 -.3/0 -.!-0 -.---
45667*809 -.13" -.!3" -.-29 -.-03 -.31- -.!1! -.-"9 -.3:: -.-19 8-.-9! -.-29 -.--0 8-.-20 -.-!: -.-2/
66;;8"! -.!2: -.!0- -.-3: -.-1: -.3:! -.!"0 -.-9: -.33/ 8-.-3- 8-.-09 -.-3: -.--3 8-.-3! -.-"-
1! I?C%J?CD'@=+B,>+)L($,%+*+,' -.!3- -.31" -.-01 -.-29 -.!13 -.131 -.---
45667*809 -.01! -.!39 -.-1! -.-"3 -.33- -.3"1 -.-0- -.139 -.!!! -.-:! 8-.-33 8-.-32 8-.3!3 8-.32- -.3:2
66;;8"! -.!"/ -.3"/ -.-0/ -.-": -.3/9 -.!9/ -.-"2 -.313 -.-0/ -.-!0 -.--2 8-.--/ 8-.-10 8-.-10
11 I+J%($CD+$) *+,' -.-"3 -.3"0 -.!1" -.3"3 -.32" -.!01 -.---
45667*809 -.-3/ -.-03 -.!"3 -.3!2 -.!1- -.11! -.-90 -.!30 8-.-1! 8-.331 -.-32 8-.-!" -.-2" -.-:/ -.3-!
66;;8"! -.-0! -.3-/ -.!"3 -.303 -.3/1 -.!20 -.-10 -.333 8-.--/ 8-.-0" -.-32 8-.-3- -.-!: -.-!3
10 IB+,'H&F($) *+,' -.-13 -.-13 -.1-9 -.30! -.32" -.1!1 -.---
45667*809 -.-31 -.-"9 -.!"1 -.332 -.!03 -.130 -.-9" -.31/ 8-.-3: -.-!2 8-.-"0 8-.-!2 -.-92 8-.--/ -.-91
66;;8"! -.-12 -.-"" -.131 -.312 -.39! -.!:: -.-19 -.-22 -.--" -.-!0 -.--2 8-.--2 -.--9 8-.-1"
1" *?CA,$,%+) *+,' -.3"- -.309 -.-03 -.-2: -.!1" -.1"/ -.---
45667*809 -.!3: -.30: -.33: -.-:- -.3:1 -.!09 -.-3: -.1/0 -.-2: -.--3 -.-99 -.-3! 8-.-"! 8-.33! -.!/:
66;;8"! -.3:: -.3"3 -.-2! -.-29 -.!-9 -.1!" -.-1- -.-/2 -.-1: -.--0 -.-!3 8-.--3 8-.-!: 8-.-10
12 *(HC$&='+,%+)M *+,' -.331 -.-/9 -.!3: -.331 -.!3: -.!0! -.---
45667*809 -.332 -.-/! -.300 -.-/2 -.!!- -.11! -.-2/ -.!-3 -.--1 8-.--" 8-.-90 8-.-39 -.--! -.-/- -.-::
66;;8"! -.3-0 -.-/1 -.3:2 -.3-: -.!!: -.!:- -.-:9 -.33! 8-.--/ 8-.--0 8-.-1! 8-.--" -.-3- -.-1:
19 6&H%>('($)NI; *+,' -.393 -.313 -.-/: -.-:- -.!!" -.!/" -.---
45667*809 -.33/ -.-:/ -.321 -.3-" -.3/2 -.1!: -.-"2 -.3:3 8-.-"! 8-.-0! -.-2" -.-!" 8-.-!/ -.-11 -.3"3
66;;8"! -.322 -.3!2 -.-/0 -.-9: -.!!: -.1-/ -.-"2 -.-1- 8-.--" 8-.--2 8-.--0 8-.--! -.--1 -.-30
1: 6&H%>('($)$CKC *+,' -.331 -.3-! -.-2" -.-91 -.!/" -.1"1 -.---
45667*809 -.!33 -.312 -.30- -.-/9 -.3/- -.!1- -.-02 -.219 -.-/: -.-10 -.-9" -.-!0 8-.3-" 8-.3!1 -.0"!
66;;8"! -.39: -.3"" -.-21 -.-21 -.!!1 -.13: -.-": -.3:" -.-2" -.-"1 8-.--! 8-.-3- 8-.-9! 8-.-1"
1/ 6&J+BCO(A+)5(%F&>,%+ *+,' -.--- -.-3: -.!0: -.33/ -.!/: -.132 -.---
45667*809 -.-13 -.-09 -.!"1 -.31: -.!30 -.13! -.313 -.30- -.-13 -.-!/ -.--" -.-3/ 8-.-:0 8-.--0 8-.-12
66;;8"! -.-20 -.-22 -.!-0 -.3-/ -.!12 -.1!3 -.-:: -.392 -.-20 -.-0: 8-.-00 8-.-3- 8-.-2! -.--"
0- 70)<@%CE@F+ *+,' -.0!3 -.!00 -.-0/ -.-19 -.332 -.310 -.---
45667*809 -.!2/ -.32" -.3!1 -.-9/ -.3:9 -.39" -.-!2 -.009 8-.3"! 8-.-9/ -.-90 -.-0! -.-93 -.-03 -.10:
66;;8"! -.1:0 -.!32 -.-"- -.-19 -.3-/ -.!-0 -.-12 -.-// 8-.-19 8-.-!: -.--3 -.--- 8-.--9 -.-9-
03 7?+BFC'@%($) *+,' -.!:! -.311 -.-9- -.-/" -.!3" -.!-2 -.---
45667*809 -.!": -.3"2 -.3-9 -.-2" -.30: -.!9- -.-!: -.!3: 8-.-!0 -.-!1 -.-19 8-.-1- 8-.-29 -.-20 -.-!/
66;;8"! -.!09 -.322 -.-2! -.-2" -.39: -.!:! -.-13 -.3:/ 8-.-1" -.-11 8-.--: 8-.-1- 8-.-19 -.-92
0! 7&FCB);+=BC%(%)P,=>CB) *+,' -.--- -.-3/ -.!/1 -.30- -.!3/ -.1!/ -.---
45667*809 8-.--1 -.-3/ -.!!2 -.31/ -.!!3 -.1:2 -.3:- -.-/! 8-.--1 -.--- 8-.-29 8-.--3 -.--! -.-"9 -.-"1
66;;8"! -.--: -.-1: -.!:2 -.309 -.!-: -.130 -.30" -.-0- -.--: -.-3/ 8-.--9 -.--9 8-.-33 8-.-3"
01 7B(C%+)I?C%J?,>+)#%CF+B,%+)*+,' -.!12 -.!3- -.-/- -.-20 -.3!0 -.!92 -.---
45667*809 -.10/ -.3:- -.-9" -.-23 -.32" -.39" -.-!1 -.!!: -.331 8-.-1- 8-.-3" 8-.--1 -.-03 8-.3-3 -.330
66;;8"! -.!:0 -.3/: -.-9! -.-"9 -.30! -.!09 -.-3: -.330 -.-0: 8-.-3! 8-.-3: 8-.--9 -.-3: 8-.-!/
00 MJC8=@>C=?BCF+)4)Q"R4S)A+$,>&B+A* ,' -.-!- -.-!- -.-!- -.-!- -.-!- -./-- -.---
45667*809 -.--2 -.-13 -.-:! -.-"! -.-/2 -.9!" -.-2: -.332 8-.-30 -.-33 -.-2! -.-1! -.-92 8-.39" -.3-2
66;;8"! -.-!- -.-!3 -.-!9 -.-!1 -.-!9 -.::! -.-39 -.-3- -.--- -.--3 -.--9 -.--1 -.--9 8-.-3:
0" MJC8=@>C=?BCF+)4)Q/-R4S)A+$,>&B+A*+,' -.-!- -.-!- -.-!- -.-!- -.-!- -./-- -.---
45667*809 -.-1: -.-10 -.-9" -.-2- -.331 -.291 -.-0" -.321 -.-3: -.-30 -.-"" -.-0- -.-/1 8-.!!9 -.-30
66;;8"! -.-1- -.-00 -.-:2 -.-"" -.-/9 -.2:9 -.-2: -.30/ -.-3- -.-!0 -.-22 -.-1" -.-99 8-.!31
02 *(HC$&='+,%+)Q!-R4S)A+$,>&B+A)*+,' -.-!- -.-!- -.-!- -.-!- -.-!- -./-- -.---
45667*809 -.--0 -.-12 -.-:! -.-0: -.3-3 -.9!2 -.-22 -.332 8-.-32 -.-32 -.-2! -.-!: -.-:3 8-.390 -.3-:
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Abstract 
 
Tens of thousands of people have limbs amputated each year, causing great loss of 
ability in people’s lives. 1 Pattern recognition of myoelectric signals has the potential to 
restore the functionality of a missing limb by providing an intuitive control of an 
artificial one. Here we report on HASSANN: Hand Activation Signals SOM Artificial 
Neural Network, a self-organising map (SOM) methodology for performing the 
myoelectric pattern recognition stage of BioPatRec. BioPatRec is a software platform 
for processing myoelectric signals to control prosthetic arms and hands. 2 HASSANN 
has been evaluated in a classification task of 11 individual hand and wrist motions. In 
offline testing of how data patterns are recognised, it was found that all movement 
classes could be recognised from the myoelectric signals. The HASSANN methodology 
is ready to be tested in real-time control of prosthetics. The accuracy is high in offline 
testing, 0.90 ± 0.08, which would likely be accurate enough for use by a patient. 
However, algorithm accuracy usually reduces significantly when performing real-time 
testing. So the real-time tests will show if this software can be used in its current form. 
Introduction 
 
Amputations and prosthetics 
 
Every year there are about 2,000 arm amputations, and about 65,000 leg amputations at 
the Symes level (the ankle above both malleoli or bumps 3) and higher in the USA, 
according to Brenner et al. 2008. 1 The number of amputations in the UK is around 
6000 a year. 4 According to Le Blanc et al. 5 , in 2008 there were an estimated 10 
million amputees living in the world, 30 % of these being arm amputees, so 3 million 
people, 2.4 of which were in developing countries. Of the arm amputations, 59 % were 
below the elbow, 28 % above the elbow, 8 % were to shoulder level, 5 % were hand and 
wrist. 
With such a large number of people missing limbs, along with those born with limb 
defects that cause loss of function, there is great need to provide replacement limbs the 
enable much of the use of natural limbs as possible.   
Currently very little in the way of robotic arms is available commercially, and most of 
those that are available have a simple open hand–close hand movement. In fact, today 
there is no commercially available arm/hand that uses pattern recognition-based control. 
 
The prosthetics community seems to agree that there are five basic types of grasp that 
the human hand performs daily:  
1. The pincher grasp (with thumb, index and middle fingers together) 
2. Key grasp (thumb resting on the side of the index finger) 
3. Hook grasp (used to carry things e.g. books, suitcases) 
4. Spherical grasp (for holding a ball) 
5. Cylindrical grasp (for holding a cylindrical object) 6 
 
The most advanced prosthetic hand control technology that is available clinically 
depends on myoelectric signal (MES) control. 7 The free dictionary defines myoelectric 
as being “of or pertaining to electrical impulses generated by muscles of the body, 
which may be amplified and used esp. to control artificial limbs.” 3  
BioPatRec  
 
In this paper, we report on a software pattern recognition methodology developed for 
control of robotic prostheses of the upper limb that use myoelectric signals, it is labelled 
HASSANN, and will be part of the BioPatRec software platform. Any artificial 
electrical control of movements needs to be able to recognise patterns to determine 
which ways the person wishes to move, and should provide as natural limb movement 
as possible. BioPatRec with HASSANN is one such methodology.  
BioPatRec can be found here: https://code.google.com/p/biopatrec/. It is a platform used 
for collaboration on robotic prosthetic limb control. At this point the limiting factor in 
producing replacement limbs that fully compensate for natural limbs, with the complete 
range of motions and abilities is the control software. BioPatRec is available to provide 
this control. The platform is meant for testing control software; so there is no one 
prosthetic being studied by the BioPatRec team. The aim is to use it for a wide variety 
of limb designs. The end goal is to have robotic limb control algorithms robust enough 
for clinical implementation, which will be put into microcontrollers that can run 
MATLAB. 
 
The aim of this work has been to provide a new development to the pattern recognition 
stage of BioPatRec called HASSANN, Hand Activation Signals SOM Artificial Neural 
Network. HASSANN has been designed to be used for the 4th stage of BioPatRec: 
pattern recognition, which is the core stage (see the stages below). HASSANN is not yet 
available on the BioPatRec website. 
 
HASSANN was derived from software for performing pattern recognition on circular 
dichroism (CD) spectroscopic data to estimate protein secondary structures. 8-10 The 
Secondary Structure Neural Network, SSNN, software that HASSANN is based on can 
be found here: 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/arodger/arodgergroup/research_i
ntro/instrumentation/ssnn/. SSNN has three modules: one for clustering the spectral 
data, one for mapping the structures of the proteins to their CD spectra, and one to 
accept query or test spectra with unknown structures in order to model them, and 
provide estimations of those unknown structures. 
 
As SSNN is a SOM methodology, it can be applied to essentially any data set. A SOM 
is a Machine Learning clustering methodology that makes high-dimensional data easier 
to view, it also preforms pattern recognition to condense that high-dimensional data into 
a small amount of easy-to-understand, low-dimensional knowledge for the user. We 
have adapted the SSNN code (and renamed it HASSANN) to be a software package that 
can be used to interpret pre-processed electrical signals from muscles to control robotic 
limbs. We have used the MES recorded by the BioPatRec team to train HASSANN and 
to test it. These data are available in the Data Repository folder in the 
BioPatRec_ETT.zip download on the website: reference 11. This repository enables the 
comparison of different pattern recognition methodologies. 12 
Details of HASSANN and BioPatRec 
 
HASSANN was trained with the data from the BioPatRec data repository once earlier 
stages of BioPatRec had pre-processed it. 
There are 5 stages that the BioPatRec data go through: 
 
1. Signal recording 
2. Signal processing 
3. Feature selection and extraction  
4. Pattern recognition 
5. Real-time limb control 
 
These five stages are how the software platform runs, but let us explain the advantages 
of BioPatRec and HASSANN. While literature agrees that at least 5 movements are 
used by the hand, BioPatRec works with 11 pre-set movements (10 active and 1 rest), 
see the list below:  
 
1. open hand 
2. close hand 
3. flex hand (move hand from wrist in direction of palm) 
4. extend hand (move hand from wrist in direction of back of hand) 
5. pronation (place palm down) 
6. supination (place palm up) 
7. side grip or hook grasp (e.g. for opening a fridge door/carrying suitcases) 
8. fine grip (similar to pincher) 
9. agree (thumb up, fingers bent in) 
10. pointer (index finger pointing) 
11. rest (resting position of hand) 
 
So more movements are available than the literature says are required, and there are 
many advantages to using myoelectric data, as BioPatRec does. The method of 
gathering the neuromuscular data is non-invasive, involving just the placement of 
electrodes on the skin. The electrode detects the passing of the action potential through 
the muscle fibres. Each electrode stores the value of the sum of all action potentials 
once they have travelled through the muscle fibres to the surface of the skin. 6 A key 
element of the advantage of using myoelectric data is the autonomous nature of control 
of limbs in a manner similar to natural movement. 13 However, when using certain 
prosthetic limbs for the first time, the patient needs to be trained, as the muscles that 
emit the control signals are not necessarily exactly the same as those in the recordings in 
the reference set, or those signals used in the normal function of a natural, biological 
arm. Different people might have different motor unit structures (see “Electrical activity 
of natural muscles”). As such, use of the prosthetic will require lots of concentration. 
7,14 HASSANN, and BioPatRec seek to minimise this effort by intelligently interpreting 
the signals for quicker recognition. 
Some earlier prosthetics might require the hand to return to the starting or rest position 
before moving to the next position. A limb controlled by BioPatRec can switch from 
one movement to the next without having to rest first. There are videos of prosthetic 
hands controlled by BioPatRec being tested and demonstrated on the YouTube channel 
NCALOI. 15  
 
Other methodologies 
 
Our software uses pre-processing, and it is generally good practice, due to the huge size 
and complexity of the MES. This is because dimensionality reduction needs to be 
performed on the data.  
Pattern recognition algorithm accuracy in defining the correct classes (or movements) 
hinges mostly on the representation of the continuous time waveforms as feature 
vectors. 
Therefore, feature vectors must be selected to reduce to a minimum the error of 
controlling the limbs. A feature set that distinguishes between movements as clearly as 
possible needs to be selected. 16 
 
Various methods of pre-processing have been employed, Chu et al. in reference 17 used 
PCA and SOM for the non-linear feature projection, followed by an MLP for the 
classification stage. An MLP is a multilayer perceptron, which is a type of artificial 
neural network that is trained by making guesses, and having those corrected against the 
known answers. This is called supervised learning. 
The use of PCA simplifies the structure of the classifier, and saves computational time. 
This is followed by SOM non-linear mapping, because they find it makes it easier to 
separate the different classes, compared with PCA alone. Then the final stage is the 
MLP for classification. 
 
This is a wise architecture for machine learning (ML), as it has been found that applying 
successive rounds of ML techniques to a data set produces the best results. For example 
that used by Schmidhuber 18, where unsupervised–learning methodologies are applied in 
a hierarchical manner. In unsupervised learning, a methodology is used to study data 
where the correct classifications are not known (data mining). The aim here is to take 
unlabelled data, find patterns in it, and come up with new correlations or relationships. 
This is opposed to supervised learning (which uses labelled data), where the 
methodology is corrected each step, and the aim is generalisation to unknown data. 
 
The focus of the work by Schmidhuber is only on the errors, and in correcting them. 
The number of errors reduces each layer, with the output from layer n being input for 
layer n+1. Therefore, the higher-level predictors have less difficulty predicting the input 
to the next layer than do the lower level predictors. 
 
A hierarchy of statistical and or machine learning techniques may produce much better 
classification, but would also take a lot more computational time, and computational 
time must be kept low for things used in real-time. When a receiver of a prosthetic limb 
is using it, they need the limb to respond quickly, low latency. A response time of more 
than about 300 ms would result in unacceptably low speeds of movement. 16  
 
Electrical activity of natural muscles 
 
In the body, myoelectric signals, or electromyographic (EMG) signals, are generated by 
skeletal muscles when they are electrically or neurologically stimulated. These muscles 
are attached to the tendons and bones, and are under conscious control, as they are part 
of the somatic nervous system. They also come under subconscious control for 
regulatory purposes. However, the signals that cause skeletal muscle activation always 
originate with nerve impulses. 6 
Change in force applied by muscles is made possible by adding together responses to a 
series of stimuli and by employing more motor units or SMUs. An SMU, or single 
motor unit, is a collection of muscle fibres and the motor neuron that innervates the 
muscle fibres. The SMUs are naturally arranged to contain varying numbers of muscle 
fibres: those for gentle, dexterous motions have only 3–10 fibres, while others used for 
large, forceful motions contain several hundred muscle fibres.  
An action potential in an SMU can cause a twitch, but continued muscle contraction 
needs many firings. When a ramping up of muscle power is needed, the smallest muscle 
units will be employed first, then larger and larger units, until the full force of all units 
is applied. 6,19 The resting potential of skeletal muscles is about –70 mV to –90 mV, 
which is similar to that of a neuron. 
The instantaneous myoelectric signal obtained from the electrodes contains no 
information, as it is stochastic, so a contraction needs to be recorded over some time. 
This time is usually in the 100s of ms.16 The variance of the MES depends on the level 
of contraction of the muscles. Harder contractions produce more variance. 20 Due to 
differences in structure and size of different people's muscles, there are differences 
between people in the myoelectric signals received from them, and therefore the 
features extracted from that data. Of course, amputation and congenital defects can 
greatly change the shape, size and structure of muscles. Changes in weight and/or the 
positioning of the electrodes might also modify the MES recorded. Therefore the pattern 
recognition, or classifier, methodology must be able to allow for these differences, and 
remain efficient in its functioning. Certain movements produce rather deterministic 
patterns, while other contraction types are nearly random in nature. 16   
  
Methods 
 
BioPatRec has previously tested various pattern recognition algorithms: Regulatory 
Feedback Networks (RFN), Linear Discriminant Analysis (LDA), multilayer perceptron 
(MLP). 12 Other classification methodologies used to perform pattern recognition on 
MES include hidden Markov models (HMM), and Gaussian mixture models (GMMs), 
dynamic artificial neural networks, genetic algorithms, fuzzy logic classifiers, 
PCA and self-organising maps. 13,17 
Glossary 
BMU – best matching unit, the map resident spectra that go into making the model of 
the spectrum. 
DoF – degrees of freedom 
EMG –electromyogram  
GMM – Gaussian Mixture Model 
GUI – Graphical User Interface 
HMM – hidden Markov models 
LDA  – Linear Discriminant Analysis 
MES – myoelectric signals 
MLP  – MultiLayer Perceptron 
RFN – Regulatory Feedback Networks  
PCA – Principal Component Analysis 
SMU – single motor unit, the fibres and neurons that power muscles 
SOM –  Self-Organising Map, also called Kohonen Map, SOFM, where “F” stands for 
feature. 
 
Data acquisition and signal processing for BioPatRec 
 
The BioPatRec team recorded the myoelectric signals by using 4 and 8 disposable 
electrodes, for individual and simultaneous motions respectively. These were equally 
spaced around the most proximal third of the forearm, one proximal and one distal in 
each pair. The electrodes are disposable, and bipolar. They are made of silver and silver 
chloride (Ag/AgCl), and their diameter is 1 cm. The positive terminal of the bioelectric 
amplifier was consistently connected to the most proximal electrode (proximal to the 
body).  
 
The myoelectric signals were segmented into time windows of 200 ms, from which 4 
signals features were extracted (mean absolute value, wave length, zero crossing, and 
slope sign changes). If the mean absolute values of entire time course recordings were 
used, they would lose too much of the features, and end up with flat signals containing 
no information. Most signal means would look too similar, which would make 
classification nigh impossible. Further details in the data acquisition, signal processing 
and data repository can be found in reference 21. 
 
The features from all channels for a specific time window form a feature vector 
characterizing a particular movement. The feature vectors are fed into the pattern 
recognition algorithm rather than the raw myoelectric signal itself. This is because 
trying to use the raw data for pattern recognition would produce classification of 
movements with very poor success rates, which would cause the prosthetics to be 
unusable, remember that the response time should be under 300 ms. 16 The recordings 
from one patient are 36,000 by 4 by 10 data elements, and there are 20 patients. 
 
The data recorded can also be cropped so that areas with no activity are cut out. This is 
measured by the cTp, or contraction time percentage, which is usually about 70. So, 15 
% of the time–series is cut from the beginning of the recording, and another 15 % from 
the end of the recording. 12 
The pattern recognition algorithms in BioPatRec are given 27 signal features in the 
time, and in the frequency domains. 12  
 
Data sets 
 
For presentation to the pattern recognition methodology, the data were divided into 12 
training sets, 6 validation sets and 6 test sets when using each patient’s data set from the 
repository named “10mov4chForearmUntargeted”. This repository is for 10 movements 
plus rest, with 4 electrodes producing 4 channels placed on the forearm. Untargeted 
refers to the placing of the electrodes on the arm, see reference 12. Four electrodes were 
enough because the use of just 4 electrodes has been tested and found to be sufficient 
for 10 movements. The “rest” is a standard signal that can be added for any movement. 
The signals were digitised at 2 kHz with a resolution of 14-bits.  
The data was recorded while the subject performed the contraction for 3 seconds, then 
rested for 3 seconds, then repeated this 3 times. 12,21-23 
Summary of SOM architecture used by HASSANN 
 
Once the datasets were compiled, and the software was ready to be adapted to the MES 
data. 
As a SOM, HASSANN performs its pattern recognition by clustering the data into 
groups where the signals have similar features. It then looks up the signals again, and 
assigns a value of 1 to the training set signals only (not interpolations between MES). 
These are known to belong to certain categories (movements).  
With the BioPatRec myoelectric data the signals each correspond to patients attempting 
to perform 1 of 11 movements (10 hand and wrist movements plus the resting position). 
HASSANN tags each signal with a vector of 11 numbers summing to 1.00. For signals 
corresponding to the nth movement there will be a 1 at the nth position, and a zero in 
each of the other 10 positions.  
In the final stage, when HASSANN decides which movement is desired, judging by the 
signal received, it will give a vector of 11 numbers that sum to 1.00. The largest number 
will correspond to the movement it has decided is desired. In this sense, the output is 
similar to that of a fuzzy logic methodology. This decision will be given to the next 
stage of BioPatRec to deal with: the Real time control software. 
 
 
 
 
More explicit HASSANN methodology 
 
The SOM was designed by Teuvo Kohonen in 1982, and is known as the Kohonen 
Map, or the Self-Organising Feature Map (SOFM). 25 
 
For a full description of the HASSANN methodology please refer to earlier papers on 
this by Hall and Rodger et al.  8,9,24 In these references, the methodology of SSNN, 
Secondary Structure Neural Network, is discussed. However, here is a more detailed 
account of how HASSANN operates. 
 
 
Stage 1: clustering signal vectors 
  
HASSANN is a methodology for clustering data sets using a 40 by 40 node square grid. 
Here, each myoelectric time-course signal is represented by a vector, which is placed on 
a map (in a node) to cluster it with all other signals. This is done after the BioPatRec 
pre-processing stages, so only the features of the MES are clustered.  
To begin with, each map node has a vector of pseudorandom numbers populating it. 
Next, a randomly selected pre-processed signal of 52 numbers is shown to the map, and 
the most similar vector of random numbers is found; this is called the BMU, or best 
matching unit.  
Using a learning rule, every element of the BMU vector on the map is made more 
similar to the signal vector selected. A neighbourhood of the BMU is defined based on 
the initial neighbourhood radius, and the neighbouring nodes are made more similar 
using the same learning rule, but weighted so that nodes closer to the BMU will learn 
faster than those at the periphery of the neighbourhood. 
This is repeated for a set number of iterations. This number is usually thousands, but it 
must be much larger enough that each of the signal vectors in the training set is 
represented, and there is time to learn. The learning rate each iteration is about 0.08 to 
0.1, so several iterations are required for each sample vector. This ends the longest stage 
of training. By this point, the map or SOM should have randomly selected each pre-
processed signal vector many times, and clustered all signals into groups. There are no 
distinct boundaries, like fuzzy logic where each sample will have several memberships, 
all summing to 1.00.   
 
There are many more virtual myoelectric signal nodes than experimental signal nodes, 
as the map interpolates between signals to allow for slight changes in each signal that 
might represent the pre-set movements with noise or slight changes. This also allows for 
missing data. 
 
 
Stage 2: tagging map vectors with movements 
 
The trained SOM now needs to be told which signals correspond to which of the 11 pre-
set movements:  
 
To do this HASSANN searches its map for the BMUs of the training set vectors 
(neglecting the virtual vectors for this first part) and assigns to each a vector of 11 
numbers summing to 1.00, with a ‘1’ in the nth position and ‘0’s in the other 10 possible 
positions for the nth movement. These movement vectors are in a second map with 
coordinates that correspond to the first map. The 11-element movement vectors come 
from the training set.  
Next, HASSANN looks for each virtual signal node on the first map, makes a weighted 
sum of the movement vectors of the 5 nearest experimental signals from the second 
map, and assigns this sum as the movement vector for the virtual signal node on the 
second map. At the end of stage 2 all signal vector nodes (experimental and virtual) 
have movement vectors associated with them in a second map with the same 
coordinates as the first.  
 
Stage 3: deciding which movement is desired 
 
Once HASSANN’s SOM is fully trained, it can be used to decide which movement is 
needed by the patient with the prosthetic arm, depending on the myoelectric signals it 
receives from the patient via the electronics. The real-time control uses the SOM to 
interpret the signals input to it. HASSANN finds the b BMUs of the real-time* data, and 
makes a weighted sum of the movement vectors and outputs that as the decision of 
                                                
* This is done in an offline test using just the recorded data, and then in a real-time test 
with real-time/live limb control. 
 
which movement to make. (Here “b” is the number of BMUs used in the calculation.) 
The same is done to make a model MES spectrum, as can be seen in Figure 1(d). 
The most important text output is the decision vector, which is in the format of the input 
movement data: The elements of this vector of 11 numbers are the 11 movements: 
Ideally a 1.00 for the element corresponding to the decided upon movement, and zeros 
for movements HASSANN decides are not needed at this time. More likely output 
would be vector of elements with numbers between 0 and 1, where a certain element 
has the highest number, and therefore wins, thus telling the BioPatRec system to tell the 
robotic arm to move using that movement. The output movement vector always sums to 
1.00. 
 
 
 
What HASSANN outputs look like 
 
The model of the test spectrum is plotted along with the test spectrum itself, and a 
residual. There is also an NRMSD value on the plot, see Figure 1(d). The NRMSD is 
the normalised root mean squared deviation, or the RMSD divided by the range of the 
model data, see equation 1, below. 
                 
(1) 
where xi counts the elements of the MES spectrum vector, experimental or model, N is 
the number of elements in the spectrum, M is the maximum number, and m the 
minimum number in the model data. 
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Figure 1: What a good result from the MES clustering should look like. Figure a) is the 19th level of the 
clustered MES spectra map, b) is the movements map (this shows the movements are all clustered in the 
right corner), c) shows the locations of the training set MES BMUs marked with R#, and the MES 
spectrum that went into making the model MES spectrum for this particular test is marked with a U# in 
red. d) shows the model MES spectrum in blue (dashed line), the experimental spectrum in black (solid 
line), the residual in faint red (dotted line at the bottom), and the NRMSD. 
 
 
Characteristics of HASSANN training  
 
The way the map clusters in Stage 1 depends on the learning equation:  
 𝑙𝑒𝑎𝑟𝑛𝑖𝑛𝑔   =   𝐿! ∗ 𝑒𝑥𝑝!!!∗!  
                         (2) 
where L0 is the initial learning rate, approximately the rate of the first iteration. L0 was 
set to 0.1. k1 is a small value that depends on L0 and the number of iterations: from t to 
T, the final iteration. k1 is given by this equation: 
 𝑘!   =   −𝑙𝑛(𝑓𝑖𝑛𝑎𝑙_𝐿/𝐿!)𝑇   
           (3) 
Where final_L is the final learning rate (for the last iteration), which was set to 0.01, so 
k1 comes out as 0.000461. 
 
 
The neighbourhood radius is given by equation 4 below, from 8 : 
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   (4) 
where r is the radius, t is the number of iterations, r0 is the initial radius, t1 is a learning 
parameter valued at about a third of the number of iterations. This equation says that the 
neighbourhood radius will decrease linearly with iterations, until t = t1, at which point 
the radius will be one node. The value of t1 is set to 1/3 of total iterations. 
 
In Figure 2, we see the GUI (graphical user interface) for selecting the training 
parameters for HASSANN. The map length determines the size of the square map. A 
SOM with 40 as the map length would have 40 x 40 nodes.  
 
  
Figure 2: the GUI to select training parameters for HASSANN SOM. 
 
Looking at Figure 2, we can see the initial neighbourhood size: an initial neighbourhood 
size of 20 would select a circle of nodes, with radius 20 nodes, around the BMU to have 
their MES spectrum made more similar to the training set spectrum selected at random 
from the set in a particular iteration.  
The initial neighbourhood radius, is very important for clustering, as this defines which 
nodes will be trained to be more like the training set spectrum during each iteration of 
training. This radius decreases in size through the iterations to allow for increased fine-
tuning of the clustering with later iterations.  
 
The initial learning rate is called L0 in equation (2), it is the first value by which the 
vectors in the nodes are updated in the first iteration if they are inside the radius 
mentioned above. 
 
The number of iterations is linked to the initial learning rate: a higher L0 means that the 
SOM requires a shorter training period, but the training period should be long enough 
that all nodes get updated/trained well.  
 
Number of BMUs (Figure 1(c)) is how many MES spectra from the map nodes go into 
creation of the model spectrum, as can be seen in Figure 1(d). This gives the number of 
BMUs for the third stage of SOM: testing. The second stage of the SOM also has a 
BMU number for clustering the movement information; this is set in the code. 
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Results 
 
To find parameters that would cause it to train well, HASSANN underwent multiple 
validation runs. Figure 1 shows the results from the 61st MES spectrum in the test run. 
Figure (a) is a surface plot of the MES spectra. It can be seen that the clustering looks 
reasonable from this figure of the 19th element in the feature vector. In Figure (b), we 
see the clustered movements. Figure (c) shows the BMU locations: the top-left corner is 
the location of the virtual MES spectrum that created the model plotted in Figure (d). 
Interestingly, it is far from any experimental, MES BMUs. The model plotted in (d) 
shows the experimental MES spectrum and the residual as well. The model has an 
NRMSD of 0.00939, which is extremely good: a value of 0.03 or lower is good.   
 
The mean RMSD for 66 tests (6 repeats of 11 spectra) with the best parameters from 
validation was 0.0371 to 3 significant figures. These training parameters were as 
follows: the length of the square map was 40, the initial radius of the neighbourhood 
was 40, the initial learning rate was 0.1, the number of iterations used was 5,000, and 
the number of BMUs was 1. Additional parameters: the learning rate parameter k1 was 
set to 4.61*10-4, and t1 was set to a third of total iterations. 
 
See Figure 2 for the HASSANN parameter selection, not all of the possible parameters 
are modifiable in this GUI; one would have to go into the code.  
 
The confusion matrix for the test run with the above parameters is shown in Figure 3, 
below. The confusion matrix is a plot of actual classes on the vertical axis, versus 
classes perceived by HASSANN on the horizontal axis. The numbers range from 0.00 
for ‘in all tests this signal is not ever recognised as the movement on this square’, to 
1.00 for ‘this signal is recognised as the movement on this square 100 % of the time’. 
So, ideally, there should be a diagonal from (1,1) to (11,11) that is entirely dark red 
(1.00), then everywhere else would be dark blue (0.00). This would show that the signal 
for each movement is recognised correctly in 100 % of tests.  
This confusion matrix shows that there is mostly correct recognition, with a mean 
accuracy of 0.90 ± 0.08, with the standard deviation as the error.  
Here the blue surrounding the red diagonal shows that neighbouring movements are not 
recognised as each other, as it should be. For example the point 7,6 shows that 
movement 6 is not recognised as movement 7. It is in fact recognised as movement 6 
(correctly) 100 % of the time. This is why all other squares in that row are dark blue. 
 
 
Figure 3: Confusion matrix from HASSANN; movements on vertical axis, predictions on horizontal axis. 
If the SOM were recognised the different movement classes perfectly, it would show a dark red line 
across the diagonal from top-left to bottom-right on the coordinates (1,1) through to (11,11). (The 12th 
column is just a plotting element.) This figure shows that each class is recognised correctly most of the 
time. The accuracies are shown in the diagonal squares. Mean accuracy for movement recognition is 
0.90±0.08.  
 
 
MES and corresponding movement classification 
 
The overall mean of RMSE for the 66 test spectra is 0.037. The training set was 12x11, 
and the validation set was 6x11 in size.  
 
Going back to Figure 1: this shows an example of a very good result. This is from the 
validation run 1, trial 61. The NRMSD of 0.00939 is very good, and we can see that the 
model (dashed blue) fits the experimental signal (black). The residual might be seen in 
faint, dotted red about the horizontal zero line. Figure (a) shows that the spectrum map 
has only 1 peak at this, the 19th element of the feature map. That shows there is only 1 
feature that peaks at element 19, of 52 that make up the spectrum. This map looks well 
clustered. Figure (b) shows that the movements have all clustered in the corner set aside 
for movement 11, so this is successful. Figure (c) shows the BMUs of experimental 
MES and movements, these are mostly clustered at the bottom, far from the red U1 (top 
left) that represents the BMU of the model spectrum in Figure (d). Despite this, the 
model is very good.  
 
A worse example of modelling MES spectra can be seen in Figure 4 below. 
 
Figure 4: As Figure 1, except results from the 60th trial spectrum of the movement 11 (rest hand) 
validation run. Figure (d) shows that this model, with an NRMSD of 0.0612 is not as good that shown in 
Figure 1, but still reasonable. 
 
Figure 4 shows worse results (than that of Figure 1), but the model (in Figure (d)) is still 
of reasonable quality. This is from validation run 1 as well, spectrum 60. 
Here Figures (a) and (b) are the same as in Figure 1(a) and (b), as this is the same 
validation run. Figure (c) is very similar to that of Figure 1 as well, except the where the 
model (red ”U1”) is in a different position. This is one of the virtual spectra from the 
top right of the map, close to only a few of the experimental spectra. The RMSE of this 
validation run was 0.0371. 
 
For different validation runs and tests, these maps are different each time, as the initial 
numbers populating them are pseudorandom. In Figure 5 in, the Discussion, it can be 
seen that the maps of Figures (a), (b) and (c) are different from those of Figures 1 and 4. 
That is because results shown in Figure 5 are from the test run, once the parameters 
were optimised. 
 
 
Discussion 
Next stage: Real-time testing 
 
The next stage of testing would see the N subjects participate in the real-time evaluation 
for individual and simultaneous motions. Subjects would be both those who have 
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missing limbs, and those with fully, complete limbs. This testing would be done with 11 
motions and 4 electrodes, this would be called HASSANN–RT, where RT stands for 
‘real time’. This has not been done, due to lack of time, with both authors writing up 
their PhD theses. 
Thus far, HASSANN has only classified individual movements (one at a time) for 
BioPatRec. Another stage for HASSANN would be to recognise patterns in MES 
generated by simultaneous movements of the arm-wrist-hand prosthetic. These are 
when the subject moves their hand doing two or more of the movements at the same 
time, in the same manner that natural hands move: e.g. opening hand while moving to 
pronate (palm down). 
 
Table 1: A summary of the MES data gathered from test subjects, DoF is degrees of freedom. 
 Individual Simultaneous HASSANN-RT 
Motions 11 27 (3 DoF) 11 
Electrodes 
(bipolar) 
4 8 4 
Subjects 20 17 N 
 
 
MES and corresponding movement classification 
 
In Figure 1 (d), the NRMSD is extremely small, as the model MES spectrum is 
extremely good; this is the model for the movement 11, or “rest”. Likely, the NRMSD 
is so good because the MES spectrum of the rest movement is quite different from other 
movements, and so classification is easier. This is probably also the reason the U1 BMU 
that the model comes from is so far from most experimental BMUs marked with R# on 
the BMU locations plot of Figure (c).  
 
It is interesting that such good spectral NRMSDs can come from models made with just 
one node, or BMU. In ref 8 Hall and Rodger et al. found that protein’s circular 
dichroism (CD) spectra were best when using 5 BMUs to make the model spectra. This 
is because the proteins all have different CD spectra. While the limb MES models are 
likely able to use just 1 BMU because the MES repeats from one type of movement 
should all be very similar if produced by the same muscles of the same person, using 
the same equipment. 
 
For the sake of completeness, and to show how the maps are different each re-training, 
we have included results from the offline test run of HASSANN, see Figure 5. Figure 
5(a) shows a very similar map to that of Figures 1 and 4 (a) (this is still feature map 
element 19 shown), but the coordinates are flipped around. The peak in Figure (b) is in 
the corner, as it should be, but the positions of this map do not correspond to those of 
Figures 1 and 4 (b).  
Figure (c) map looks different as well, but the U1 BMU is still far from the R# BMUs. 
The BMUs have still clustered in a very similar way: there are a few large clusters, real 
spectra R7 – R11 are all close together, as in previous maps, R65, R51, R20 and R3 are 
all in parts of the map with sparse BMU coverage. 
 
 
Figure 5: The results from the test run after the validation. Note how Figures (a), (b) and (c) are different 
from those above, as this is a separate map training.  
 
This model MES spectrum looks good; it probably produced the correct movement 
prediction for the prosthetic limb. This model is of the rest movement; if we look at the 
confusion matrix, we see that the movement was predicted correctly 100 % of the time, 
so this model definitely led to a correct movement prediction. 
Confusion Matrix 
 
In Figure 3 in the Results, we see the confusion matrix from the offline test; here there 
is a good, red diagonal across all movements. Eight movements are recognised with 90 
% or more accuracy, using this patient’s data. This leaves only 3 movements that are not 
above this threshold. 
The worst movement recognition is recognised correctly 69.2 % of the time, this is 
movement 3: flex hand. The second worse is shared between movements 2 and 5, or 
“close hand” and “pronation” both at 84.6 % accurate, the rest are very good, especially 
movements 6 and 11, supination (palm down) and rest.  
 
It was noted above, that some movements produce MES that are very deterministic, 
while others are rather stochastic. Likely this is one reason some movements have bad 
accuracies, but certainly some of the reason is to do with training parameters that need 
to be optimised. Some of the reason is due to the pseudorandom numbers populating the 
initialised spectral map, and the pseudorandom selection of training spectra to compare 
with the map. These accuracies may also vary depending on which test subject the MES 
came from. 
 
Perhaps the number of iterations, at 5000, was too small to allow all nodes to fully take 
on the forms of all of the MES. 5000 iterations and 40x40 = 1600 nodes.  
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Let us examine this, the experimental spectra are selected at random from the training 
set, and the number of times a node of the map is updated depends on the number of 
times it falls within the neighbourhood of the BMU.  
 
We will use equation 5, below, which is the area of a circle rearranged, here for ¼ of the 
circle’s area. This is because the smallest area is when the BMU is in the corner, so the 
area of the neighbourhood is ¼ of the area of a circle with radius r. Then rearranging the 
first part of equation 4 for t, to become equation 6, we can find when at least half the 
map should be selected, and at most all of the map’s 1,600 nodes.  𝑟 = 4𝑎𝜋  
  
           (5) 𝑡 = 1 −    𝑟 − 1𝑟0 − 1 𝑡! 
           (6) 
The area we want is at least 800 nodes (a = 800). If we enter these values, r comes out 
as 32 nodes. Using equation 6, with r0 is 40 nodes, t1 is 1,667 iterations (number of 
iterations divided by 3), we find that for t = 341 iterations (rounding down), at least half 
of the map is updated each iteration.  
 
This is only an estimate, as, in these calculations, the circle of neighbourhood is defined 
as being a perfect circle, while in HASSANN’s map it is a roughly circular shape made 
of squares. Nevertheless, we can get an idea of how many times the nodes are updated 
during training.  
Considering that the learning rate is initially 0.1, and after 341 iterations has reduced 
slightly to 0.0854, see equations 2 and 3, with a k1 value of 0.0002. This means each 
node that always falls in the neighbourhood region is made similar to real MES spectra 
341*0.0854 = at least 29 times (rounding down). (A learning rate of 1.00 would 
immediately make a node exactly the same as the training spectrum, but this would be 
no good for clustering.) 
So, we can be reasonably sure that the nodes are updated sufficiently, even noting that 
few would fall within the neighbourhood every iteration. 
 
The corner and edge nodes would be the locations of the most extreme spectra, and in 
the BMU locations maps of Figures (c) in 1, 4, and 5, at least seven clusters can be 
made out. The SOM clearly knows where the effective borders of the full set of 11 
clusters are, this can be seen from the accuracy rates. 
 
For the SOM to be acceptable for real-time limb control the diagonal from top-left to 
bottom-right would have to be complete and very clear, as the movements need to be 
recognised as what they are intended to be with a very high accuracy.  
 
Work by Ortiz-Catalan et al. reported on in reference 12 shows that the accuracies of 
pattern recognition algorithms in offline tests are usually significantly higher that the 
real-time accuracies for the same systems. In the real-time tests reported on in that 
paper, people used the pattern recognition algorithm in question, as part of BioPatRec, 
to control actual robotic arms. Ortiz-Catalan et al. reported the following for LDA: 
offline mean accuracy 92.1 ± 4 %, real-time mean accuracy 67.1 ± 10 %. There were 
similar values for MLP and RFN, so there is a significant step down in accuracy over all 
of those algorithms.  
Conclusion 
 
HASSANN, the self–organising map derived from SSNN, the SOM developed for 
finding protein secondary structures from circular dichroism, has been adapted for the 
pattern recognition stage of real-time robotic prosthetic, limb control software 
benchmarking platform, BioPatRec.  
The HASSANN SOM methodology has attained the accuracy value of 0.90 ± 0.08 for 
offline tests with the 11 hand and wrist movements (10 movements plus rest). The next 
stage is for HASSANN to perform the real-time test with full-limbed, and disabled 
people with robotic, prosthetic arms. After that, HASSANN will be trained with 
simultaneous prosthetic hand movements for more natural control, and later tested in 
real-time. 
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